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In early pregnancy prolonged exposure to stress is known to have profound adverse 
effects on reproduction and is associated with suppressed progesterone secretion and 
consequent disturbance of the pregnancy-protective ytokine milieu, thus threatening 
early pregnancy maintenance. Maternal neuroendocrine responses to stress in early 
pregnancy are poorly understood. Therefore, we design d experiments to (1) study 
the hypothalamo-pituitary-adrenal (HPA) axis responses to stress in early pregnant 
mice, to discover whether and how responses change d (2) to determine the effect 
of stress in early gestation on pregnancy hormones, with a particular focus on the 
secretion and regulation of prolactin. To establish the effects of stress in early 
pregnancy (day 5.5) two different ethologically relevant stressors were used: 
lipopolysaccharide (LPS) or 24h fast stress, to mimic situations that may potentially 
arise during pregnancy in women: infection or hunger. HPA axis secretory responses 
to immune stress in early-mid pregnancy were robust and comparable to that in 
virgins. Vasopressin rather than the usual CRH neurone esponses play a key role in 
maintaining this. However, the mode of action of glucocorticoids in mediating 
pregnancy complications is not yet established. Prolactin, and its hypothalamic 
control mechanisms, is a key candidate to mediate br in-to-body responses to stress. 
Prolactin has important roles in progesterone secretion, pregnancy establishment and 
immune regulation. We hypothesised that stress would negatively affect prolactin 
and its neuroendocrine control systems. Prolactin is mainly under the inhibitory 
control of dopamine, released predominantly from the tuberoinfundibular dopamine 
(TIDA) neurones. Prolactin also negatively feeds back on itself via prolactin 
receptors on the TIDA neurones and janus kinase (JAK)2/signal transducer and 
activator of transcription (STAT)5 signalling. Both immune and fasting stressors 
strongly inhibited basal prolactin secretion in early p egnancy, accompanied by a 
mild increase in activation of TIDA as shown by elevated Fos expression, compared 
to virgins. In addition, pregnancy attenuated LPS-induced recruitment of parvo-
cellular paraventricular nucleus neurones and increased activation of brainstem 
noradrenergic nuclei which could potentially contribute to altered control of the 
dopamine-prolactin system. Following either immune or fast stress in early 
pregnancy ovine prolactin was able to drive enhanced expression of phosphorylated 
(p)STAT5. However, stress alone did not alter pSTAT5 implying it is not exclusively 
responsible for the stress-reduced prolactin observed in early pregnancy and another 
stress-induced stimulus must be activating TIDA neurones in these mice. LPS did not 
alter dopamine activity the median eminence (DOPAC: dopamine ratio) suggesting 
dopamine does not underlie stress-reduced prolactin secretion and other mechanisms 
must be considered. Direct effects of LPS, or its associated cytokines, on pituitary 
lactotrophs to inhibit prolactin secretion is a possible candidate. To investigate the 
effect of proinflammatory cytokines on the prolactin system in early pregnancy, d5.5 




increased TIDA activation, however, only TNF-α decreased plasma prolactin and 
progesterone, suggesting additional TNF-alpha action at the pituitary. As prolactin is 
anxiolytic we further proposed that stress would have  more profound effect on 
elevated plus maze performance in pregnant mice. However, early pregnant mice 
were generally more anxious vs. virgins regardless of LPS treatment. Taken together 
data show that stress in early pregnancy reduces prolactin and progesterone 
secretion, contributing to pregnancy complications/failure, but the neuroendocrine 
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Chapter 1: General Introduction 
 
1.1 Background  
Successful pregnancy is reliant on the interaction and co-ordination of many 
physiological processes. Pregnancy is highly susceptibl  to disruption, with 
spontaneous miscarriage occurring in around 15% of clinically recognised 
pregnancies. However, the total percentage of reproductive loss is likely to be much 
higher if the losses that occur prior to clinical recognition are included (Brown, 
2008). There are many potential causes for pregnancy f ilure with the most common 
in early pregnancy being chromosomal abnormalities of the foetus. There are also a 
number of other factors including endocrine abnormalities and environmental factors 
which threaten pregnancy such as maternal stress, hunger and infection/the immune 
system response (Arck, 2001, Brown, 2008). Many of these encounters or stimuli can 
result in disruption of maternal physiological processes in an attempt to overcome or 
compensate for the problem e.g. to maintain homeostasis, conserve energy, etc.  
The main physiological systems that may be disrupted and hence threaten pregnancy 
success are the hypothalamo-pituitary-gonadal (HPG) axis, the dopamine-prolactin 
system, the immune system and the hypothalamo-pituitary-adrenal (HPA) axis. The 
disturbance of any of these can risk pregnancy maintenance and induce foetal 
programming of physiology and behaviour. 
 
1.2 Introduction to the major physiological systems involved in pregnancy success 
and failure  
Pregnancy establishment and maintenance requires suitable activation and responses 
from a number of physiological systems for reproductive success including 
endocrine, neuroendocrine, neuronal, paracrine etc. responses. Disruption at any of 
these levels has adverse reproductive outcomes. Thi chapter will be limited to 
discussion on the HPG axis, the dopamine-prolactin system, the immune system 
(cytokine responses/balance) and the HPA axis, along with their interactions. 
Adaptations and responses in human pregnancy are outlined (where possible), along 






1.2.1 The hypothalamo-pituitary-gonadal (HPG) axis 
The hormones of the HPG axis are the principle hormones responsible for regulating 
reproduction and for controlling the female reproductive cycles in rodents and 
humans. Briefly, gonadotrophin releasing hormone (GnRH) is secreted from the 
hypothalamus which stimulates the anterior pituitary o secrete luteinizing hormone 
(LH) and follicle stimulating hormone (FSH). LH and FSH consequently bind to 
receptors in the gonads and stimulate release of sex steroids (follicular oestrogen and 
corpus luteum progesterone in females) (reviewed in (Vadakkadath Meethal and 
Atwood, 2005)). Disruption of the components of theHPG axis at any level can 
compromise reproduction and lead to infertility or pregnancy failure. 
 
1.2.2 The dopamine-prolactin system 
Prolactin is an essential reproductive hormone in women and rodents and facilitates a 
number of pregnancy-related processes, including uterine implantation and lactation. 
Prolactin is mainly under the inhibitory control of dopamine, originating from 
tuberoinfundibular (TIDA) neurones in the hypothalamus but it can also regulate its 
own secretion through a short loop negative feedback system on the TIDA neurones 
(Freeman et al., 2000). Prolactin levels rise throughout pregnancy in women and 
there is a profound change in the secretory rhythm of prolactin in rodents during 
early pregnancy. As pregnancy progresses the neuroendocrine control of prolactin 
release is altered to allow a state of hyperprolactin emia to develop e.g. in late 
pregnancy prolactin negative feedback is absent in rodents (Grattan et al., 2008).  
 
1.2.3 The immune system 
The most important components of the cellular immunosystem in pregnancy are the 
helper T (Th) cells which produce and secrete a number of different pro- and anti-
inflammatory cytokines (reviewed in (Guerin et al.,2009)). Successful pregnancy is 
dependent upon procuring an appropriate maternal cytokine balance, to provide an 
immune milieu that is suitable for implantation and foetal development. A number of 
endocrine factors influence the immune system, for example progesterone and 
prolactin. Progesterone is considered an immunosterid and facilitates maternal 
tolerance to the foetus, whilst facilitating in providing a pregnancy-protective 





1.2.4 The hypothalamo-pituitary-adrenal (HPA) axis 
Activation of the HPA axis by stress exposure triggers neurones in the 
paraventricular nucleus (PVN) of the hypothalamus to release corticotrophin-
releasing hormone (CRH) and vasopressin. These two neuropeptides synergistically 
induce secretion of adrenocorticotrophic hormone (ACTH) from pituitary 
corticotrophs (Lamberts et al., 1984). ACTH subsequently stimulates the release of 
the glucocorticoids (cortisol in humans, corticosterone in rodents) from the adrenal 
cortex. Glucocorticoids support a wide array of physiological systems and have 
important roles in immunity/inflammation, metabolism, reproduction and neural 
function (Sapolsky et al., 2000). Hormones of the HPA axis typically suppress the 
HPG axis and stress has profound detrimental effects on reproduction, particularly 
during pregnancy. Stress is implicated as a cause of pregnancy failure in women and 
rodents (Nakamura et al., 2008) and adverse programming of the health of the 
offspring in later life (Seckl and Meaney, 2004). In addition, multiple studies indicate 
a stress-induced immune-endocrine disequilibrium, with a number of mediators, such 
as cytokines, implicated to contribute to stress-induced pregnancy loss (Arck et al., 
1995, Nakamura et al., 2008). 
 
1.3 Role and adaptations in neuroendocrine systems in pregnancy 
The maternal brain is a major force for driving crucial physiological changes during 
pregnancy, including being responsible for preparation of the uterine environment 
prior to pregnancy establishment. Drive from the brain to the reproductive organs 
comprises a number of key neuroendocrine systems which regulate vital reproductive 
hormones necessary for pregnancy establishment and m intenance. In addition, they 
signal mating and implantation, ensure a suitable hormone and immune environment 
for foetal development (avoiding foetal rejection) a d prepare the mother/foetus for 
parturition and post-natal life (Douglas, 2010). A great number, possibly all, 
neuroendocrine hormones are involved in these complex processes and underlie 
adaptations of maternal physiological systems including fertility, appetite and 
metabolism, emotion, stress response and behaviours (R ssell et al., 2003, Douglas 
et al., 2007, Brunton et al., 2008, Parker et al., 2011b). Maternal appetite and 




tissue for milk production and lactation following parturition (Douglas et al., 2007). 
Immediately following birth the mothers exhibit a dramatic change in behaviour and 
start feeding, nurturing and defending their offspring. This maternal behaviour is a 
consequence of changes in the activity of neural cicuits in late pregnancy, controlled 
by pregnancy hormones which also hold these behaviours until delivery. These 
changes alter emotionality and allow activation of maternal behaviours but the 
sudden withdrawal of pregnancy hormones can have adrse effects such as 
depression  (Slattery and Neumann, 2008) 
 
1.3.1 The hypothalamo-pituitary-gonadal axis  
The HPG axis is vital for the development and regulation of many systems in the 
body, including reproductive and immune systems. The hormones of the HPG axis in 
women and rodents are the principle hormones responsible for regulating 
reproduction and control the female reproductive cycles (reviewed in (Vadakkadath 
Meethal and Atwood, 2005)).  As mentioned previously hypothalamic GnRH 
stimulates the anterior pituitary to secrete LH andFSH and in turn LH and FSH 
induce the release of sex steroids. The HPG axis is regulated both at the 
hypothalamic and pituitary levels. 
 
1.3.1.1 Regulation of the hypothalamo-pituitary-gonadal axis 
1.3.1.1.1 Activin, follistatin and inhibin  
Activin from the periphery can alter regulation of gonadotrophins at different levels. 
It selectively exerts effects on FSH at the pituitary level, stimulating FSH synthesis 
and secretion from gonadotrophs. It can also up-regulate gene expression of GnRH 
receptors, altering the synthesis and release of both FSH and LH in response to 
GnRH. Lastly, activin is able to induce GnRH secretion from GnRH neurones in the 
hypothalamus, again stimulating both FSH and LH secretion. In contrast, inhibin and 
follistatin, produced in the gonads, negatively regulate gonadotrophin release by 
preventing activin from binding to its receptors (Gregory and Kaiser, 2004) (see 








Kisspeptin peptides have been recently identified as essential upstream regulators, 
integrating central and peripheral signals with GnRH secretion (d'Anglemont de 
Tassigny and Colledge, 2010). The distribution of kisspeptin neurones in the 
hypothalamus varies between species and gender. Utilizing immunocytochemistry 
and in situ hybridisation techniques, the distribution of these neurones in rodents 
have been localised to discrete regions in the hypot alamus. In the adult female 
mouse brain they have been found in the arcuate nucl us, as a periventricular 
continuum of cells within the rostral section of the t ird ventricle, including the  
anteroventral periventricular nucleus (AVPV), and also a low density of cells in the 
dorsomedial nucleus and posterior hypothalamus (Clarkson et al., 2009). Kisspeptin 
fibres have been identified in close proximity to GnRH neurone cell bodies in the 
preoptic area in adult female mice and rats and are suggested to modulate the 
preovulatory GnRH and LH surges. The AVPV is sexually dimorphic in rodents, 
with females displaying a greater number of kisspeptin neurones than males. In 
primates, kisspeptin fibres from the neurones originating the arcuate nucleus come 
into close contact with GnRH neurone axons in the median eminence and are 
proposed to regulate pulsatile GnRH release (d'Anglemont de Tassigny and 
Colledge, 2010). In humans exogenous kisspeptin treatm nt (intravenous; i.v) 
potently stimulates the HPG axis, increasing plasma LH in males and females (Dhillo 
et al., 2005, Dhillo et al., 2007).  
 
1.3.1.1.3 Sex steroid feedback 
Sex steroids provide feedback loops to regulate GnRH release from the 
hypothalamus (see Figure 1.1). This occurs indirectly as GnRH neurones do not 
express receptors for oestrogen (ERα) (or androgens). It is suggested that kisspeptin 
neurones are responsible for mediating sex steroid act ons on GnRH neurones 
through sex steroid inhibition of kisspeptin expression in the hypothalamus. The 
majority of kisspeptin neurones express receptors for oestrogen receptor alpha in the 
female and male mouse brain (Smith et al., 2006) and also progesterone receptors, as 
shown in the ewe (Smith et al., 2007), consistent with a role for sex steroid feedback 
on the HPG axis. The idea of a simple negative feedback model on kisspeptin has 








 brain areas while suppressing it in others. In femal  rodents, sex steroids decrease 
expression of kisspeptin in the arcuate nucleus, and increase expression in the AVPV 
(Gottsch et al., 2006) (see Figure 1.2). The mechanism by which this occurs remains 
to be fully elucidated (d'Anglemont de Tassigny andColledge, 2010). It has recently 
been reported that kisspeptin is vital for the oestrogen feedback-induced full 
preovulatory LH surge in sheep (Smith et al., 2011) and oestrogen induces rhythmic 
expression of kisspeptin-1 receptor in GnRH secreting cells in the hypothalamus 
(Tonsfeldt et al., 2011). In rodents, the surge regulation of GnRH is mediated by 
oestrogen feedback acting in an inhibitory manner until the afternoon of proestrous, 
at which point it switches to stimulate robust GnRH release. Tonsfeldt et al. (2011) 
propose oscillators in the GnRH neurones are modulated by oestrogen to cause the 
surge, possibly through up-regulation of kisspeptin receptors which was observed 
following high oestrogen levels in vitro.  
 
1.3.2 Pregnancy establishment  
In cycling females (non-pregnant) the HPG axis is responsible for signalling 
development of the ovarian follicle by triggering the secretion of the sex steroids 
from the ovarian follicle and driving oocyte maturation. LH-driven ovulation (release 
of the mature egg) then occurs followed by the conversion of the follicle to the 
corpus luteum. The corpus luteum secretes progesterone, under the control of LH, 
and prepares the endometrium for implantation of a developing blastocyst. If a 
fertilised oocyte does not implant the corpus luteum dies after around one week (or 
within a day of ovulation in rodents) (Douglas, 2010). Rodents, in order to maximise 
reproductive efficiency, have a shorter luteal phase nd LH is not solely responsible 
for sustaining progesterone secretion for implantation. 
 
1.3.3 The neurogenic reflex 
In female rodents, copulation induces a neurogenic reflex that triggers the pituitary to 
release prolactin in a series of repeated peaks on a background of increasing basal 
prolactin secretion in early gestation (Larsen and Grattan, 2010). Both the neurogenic 
reflex, which also drives LH secretion, and the induced prolactin surges are pivotal 
for prolonged corpus luteum function and the secretion of progesterone (state known 








 human chorionic gonadotrophin (hCG) in humans (Douglas, 2011). Prolactin surges 
in early pregnancy are associated with altered arcuate nucleus dopamine activity 
(Andrews et al., 2001). Dopamine normally inhibits prolactin secretion in virgins but 
it is intermittently inhibited itself by the prolactin releasing factor oxytocin which 
increases following copulation (Helena et al., 2009, Bertram et al., 2010). 
 
1.3.4 Human chorionic gonadotrophin 
Following implantation the conceptus, surrounded by trophoblast layers, produces 
and releases high levels of hCG which access the mat rnal circulation and signal to 
rescue the corpus luteum and sustain progesterone release which is essential for 
pregnancy establishment (Druckmann and Druckmann, 2005, Arck et al., 2007). 
hCG is also able to bind to LH receptors located on the endometrium due to 
possessing an identical α subunit to LH and, thus, can communicate with the 
maternal tissues to facilitate the implantation process. Recent evidence suggests that 
hCG influences the endometrial milieu, increasing receptivity and implantation 
success (Perrier d'Hauterive et al., 2007, Paiva et al., 2011) and something similar 
has also been observed in mice (Perrier d’Hauterive, personal communication, 
unpublished). It has been shown that hCG increases the production by human 
endometrial epithelial cells of growth factors and cytokines with known roles in 
receptivity and trophoblast function (interleukin-11), blastocyst migration and 
adhesion (CXCL10) and blastocyst development (granulocyte macrophage colony-
stimulating factor) (Paiva et al., 2011). Angiogenic activity of hCG has also been 
reported through LH receptor activation in the endometrium and hCG promotes 
angiogenesis partly by stimulating vascular endometrium growth factor (VEGF) 
(Berndt et al., 2006).  
 
1.3.5 Progesterone 
Progesterone is a key pregnancy hormone and is crucial for both the establishment 
and maintenance of pregnancy. Progesterone is known to be essential for pregnancy 
maintenance as blocking progesterone binding sites results in abortion in a number of 
mammalian species, including humans (Szekeres-Bartho et al., 2001, Arck et al., 
2007). Mice do not suffer from “abortions”, however, the presence of resorption sites 




Progesterone supports a number of processes required for pregnancy, including 
ovulation and development of the uterine and mammary gl nds. The production of 
progesterone increases during gestation and the major source of progesterone is 
initially the corpus luteum in humans and rodents, however, progesterone production 
in pregnancy is eventually sustained by the placenta in women (Arck et al., 2007). In 
addition to its endocrine effects progesterone alsofacilitates establishment of a 
pregnancy protective immune environment for the developing foetus (Piccinni et al., 
1995). 
Two progesterone receptor isoforms (PR-A and PR-B; members of the nuclear 
receptor superfamily of transcription factors) are expressed in various reproduction 
tissues. The transcriptional activity of these receptors controls the uterine immune 
milieu, endometrial receptivity and decidualisation, as revealed from mice lacking 
progesterone receptors (Arck et al., 2007). Female ic with a null mutation for the 
progesterone receptor gene display a number of defects in all reproductive tissues. 
These include an inability to ovulate, uterine hyperplasia, extremely limited 
mammary gland development and an inability to display sexual behaviours (Lydon et 
al., 1995). Studies which target the two PR isoforms individually demonstrate that 
they are functionally distinct transcription factors. For example, in  mice where PR-B 
was ablated, PR-A activation alone was sufficient for pregnancy establishment and 
maintenance but mice displayed reduced pregnancy-stimulated mammary-gland 
morphogenesis (Mulac-Jericevic et al., 2003). Mice wh re PR-A had been ablated 
were infertile (associated with defective implantation), demonstrating that PR-B 
activation alone is not adequate for pregnancy establi hment (Mulac-Jericevic et al., 
2000). Therefore, the expression of both these receptor isoforms seems to be crucial 
for appropriate and sufficient tissue responses to progesterone in pregnancy. 
 
1.4 The prolactin system 
Prolactin is an essential reproductive hormone in women and rodents and is required 
for lactation. However, prolactin is described as a ‘pleiotropic’ hormone (it has a 
single gene which controls several distinct and apparently unrelated phenotypic 
effects (Grattan and Kokay, 2008)) and is now recognised to have over 300 
biological activities including not just reproductive but also homeostatic roles (Bole-




multiple sources from which it is synthesised and secreted, although this 
predominantly takes place in the pituitary (Ben-Jonathan, 1996, Freeman et al., 
2000). Prolactin has several unusual features among the pituitary hormones. Firstly, 
prolactin is mainly inhibited by the hypothalamus and is spontaneously secreted to 
high levels if this inhibition is disrupted. This i in contrast to normal secretion from 
all other pituitary hormones which require stimulation from the hypothalamus. 
Secondly, the classical hormone-mediated feedback system is absent for prolactin as 
the primary target for prolactin is not an endocrine organ. Prolactin is involved in 
regulating its own secretion through a short-loop feedback system where it feeds 
back on the hypothalamus (arcuate nucleus). Thirdly, prolactin acts on many 
different cell types over the body and, lastly, prolactin can be produced in the brain 
and function as a neuropeptide in addition to a neuroendocrine hormone (Freeman et 
al., 2000, Torner, 2002, Grattan and Kokay, 2008). 
 
1.4.1 Pituitary synthesis of prolactin 
The cells in the anterior pituitary gland that are responsible for synthesising and 
secreting prolactin are termed the lactotrophs (or mammotrophs). These cells 
comprise 20-50% of the cellular population in the anterior pituitary gland depending 
on the sex status of the animal and have been identified in the mouse, rat and human 
using species specific antibodies. In the rat prolactin-containing cells are sparsely 
distributed in the lateroventral region of the anterior pituitary lobe and as a band 
adjacent to the intermediate lobe (Freeman et al., 2000). Lactotrophs display 
morphological heterogeneity (e.g. they differ in shape, secretory granule size, and 
prolactin content) (Velkeniers et al., 1988, De Paul et al., 1997) as well as functional 
heterogeneity. For example, depending on regional distribution, lactotrophs from the 
outer zone of the anterior pituitary respond more t thyrotrophin releasing hormone 
than those in the inner zone. In contrast, this is reversed for dopamine-responsive 
lactotrophs which are more dense in the inner zone (Freeman et al., 2000).   
 
1.4.2 Extra-pituitary prolactin synthesis, secretion and roles 
1.4.2.1 The brain 
Prolactin immunoreactivity has been reported in many brain regions including the 




Multiple studies have been conducted to prove prolactin is synthesised locally in the 
brain (independent of the pituitary) rather than just accumulating in neurones from 
circulating sources. For example, some well-known pituitary prolactin stimulators 
(e.g. oestrogen) have been shown to induce hypothalamic prolactin production (Ben-
Jonathan, 1996). Many putative functions have been attributed to prolactin in the 
brain including control of releasing/inhibiting factors and regulation of the sleep-
wake cycle (Ben-Jonathan, 1996). Prolactin in the brain is involved in the regulation 
of several neuropeptides and neurotransmitters, the best known being the TIDA 
neurones (Grattan and Kokay, 2008).  
 
1.4.2.2 The placenta and decidua 
The placenta: The placenta has a number of endocrine roles in addition to its bi-
directional foetal-maternal metabolic transport actions. It has a number of secretory 
products including the placental lactogen (PL) family which has been identified in 
many animals including rats (Colosi et al., 1988, Shiota et al., 1997), mice (Shida et 
al., 1992, Yamaguchi et al., 1994) and humans (Handwerger and Freeman, 2000). 
Human placental lactogen (hPL) is known to be involved in maternal metabolism 
during pregnancy and is also implicated in the regulation of foetal growth, along with 
placental growth hormone (Freemark, 2006).  
As gestation progresses rodents, like women, also secrete PLs and at least two types 
have been identified in the rat. The rat placenta displays many prolactin-like 
molecules that are structurally similar to pituitary p olactin and act by activating 
prolactin receptors (Gertler and Djiane, 2002). Thus PLs are able to mediate similar 
effects to prolactin via prolactin receptors in other areas including the decidua and 
ovary/corpus luteum. At mid-gestation, when prolactin peaks diminish, PLs take over 
the role of prolactin in driving the secretion of progesterone from the corpus luteum. 
Simultaneously, PLs suppress prolactin secretion by triggering the prolactin negative 
feedback loop and increasing dopamine secretion (Lee and Voogt, 1999). PLs 
themselves are not subjected to negative feedback and thus they keep prolactin at 
relatively low levels at this time, until levels rise again at the end of gestation. This 
increase in prolactin occurs despite PL presence due to reduced dopamine secretion 
from TIDA neurones which become hyporesponsive to prolactin, allowing a large 





The decidua: Decidualisation is a critical step in the initiation and establishment of 
pregnancy in women. The main roles of the decidualised endometrium include 
providing a nutritive environment for the developing foetus throughout gestation and 
it also acts as a barrier protecting the foetus e.g. from the maternal immune system. 
A multitude of growth factors, cytokines and hormones, including prolactin, provide 
important signals for initiation and maintenance of decidualisation (Jabbour and 
Critchley, 2001). The human decidua, unlike the placenta, produces a prolactin-like 
molecule that is indistinguishable from pituitary prolactin in terms of immunological 
and biological criteria (Tomita et al., 1982, Freeman et al., 2000), except prolactin 
transcription is driven by an alternative promoter (Gerlo et al., 2006, Emera et al., 
2011). The temporal expression pattern of decidual prolactin and prolactin receptors 
indicates a likely role in epithelial cell differentiation and implantation in humans 
(Jones et al., 1998). Other potential functions of decidual prolactin in early 
pregnancy include a role in trophoblast cell growth, angiogenesis and immune 
regulation (Jabbour and Critchley, 2001). In mice, d cidual prolactin has been 
reported to silence expression of IL-6 and 20-α-hydroxysteroid dehydrogenase 
(HSD) genes, both of which are known to be detrimental to pregnancy maintenance: 
IL-6 for its pro-inflammatory properties and 20-α-HSD for its progesterone 
catabolism action (Bao et al., 2007). 
 
1.4.2.3 The mammary glands and milk  
Endogenous immunoreactive prolactin is detected in the epithelial cells of the 
lactating mammary gland of the rat and in the milk itself (Freeman et al., 2000). 
Although a portion of the prolactin in milk likely originates from the pituitary and 
travels to the mammary gland through the circulation, milk from both humans and 
rats has been found to contain more prolactin variants than those found in serum 
suggesting the mammary gland either modifies the prolactin sequestered and/or 
produces prolactin itself. Indeed, the mammary gland is the site where the 16-kDa 







1.4.2.4 The immune system 
Prolactin is produced by a number of immune cells, for example, multiple 
lymphohemopoietic cells, such as peripheral blood lymphocytes (mainly T 
lymphocytes/cells) and monocytes. Prolactin plays an important role in regulating 
immune responses in animals and humans. As prolactin is involved in activating 
multiple immune responses it is implicated in a number of autoimmune diseases e.g. 
rheumatoid arthritis, celiac disease (De Bellis et al., 2005). Evidence suggests that 
lymphocytes are a source of prolactin in mice (Gala and Shevach, 1994), rats (Di 
Carlo et al., 1995) and humans. Immune cells from the thymus and spleen, in 
addition to peripheral lymphocytes contain prolactin mRNA and release bioactive 
prolactin (similar to pituitary prolactin) in rodents and humans (Freeman et al., 
2000).  
 
1.4.3 Prolactin secretion in non-pregnant animals 
A circadian rhythm of prolactin secretion is observed in women (Freeman et al., 
2000, Ben-Jonathan et al., 2008) and in rodents there is a change in rhythm at 
proestrous (Freeman et al., 2000). In humans, the maximum levels of plasma 
prolactin are reported to be during sleep and the low st levels during the waking 
hours (Sassin et al., 1973, Parker et al., 1974, Caufriez et al., 2009). In rats, a 
preovulatory prolactin surge occurs during the afternoon of proestrous and this  
coincides with a surge of LH (Egli et al., 2010).  
During pregnancy in women the levels of prolactin increase and this is reported in 
early pregnancy by 6 weeks (Ben-Jonathan et al., 2008), although it is not known 
whether the circadian rhythm is maintained. The secretory profile of rodents differs 
from women: as mentioned previously copulation induces the neurogenic reflex 
which generates a large nocturnal and a smaller diurnal prolactin surge on top of a 
steadily increasing basal level of prolactin through early-mid pregnancy (Grattan and 
Kokay, 2008, Larsen and Grattan, 2010).  
 
 
1.4.4 Prolactin releasing factors 
The search for a main prolactin-releasing factor/regulator has spanned decades. It is 




factors contribute to suppressing the inhibitory action of dopamine on prolactin 
release. 
 
1.4.4.1 The opioids 
Opioids induce prolactin release by inhibiting dopamine, and are thus considered a 
prolactin releasing factor. The rat hypothalamus contains the soma of three classes of 
opioids: pro-opiomelanocortin, enkephalins and endorphins. These regulate TIDA 
neurones via kappa (κ) and mu (µ) receptors. In rats, during the prolactin surges at 
proestrous, during pregnancy, and during suckling, these interactions between 
opioids and the opioid receptors on TIDA neurones ar  especially extensive (Ben-
Jonathan et al., 2008). The inhibitory effects on dpamine release may be mediated 
by dynorphin neurones in the arcuate nucleus which ave terminals close to the 
TIDA neurones (Grattan et al., 2008).  
 
1.4.4.2 Serotonin 
Serotonin also stimulates prolactin secretion (Van de Kar et al., 1995, Ben-Jonathan 
et al., 2008). Serotonergic neurones originating in the raphe nucleus terminate in the 
arcuate nucleus, and lesions of the raphe nucleus pr vent both sucking and stress-
induced rise in prolactin in rats (Ben-Jonathan et al., 2008). However, there is 
conflicting data regarding the effect of serotonin agonists on the activity of TIDA 
neurones, and serotonin does not increase prolactin release in vitro (Freeman et al., 
2000). It is possible serotonin exerts its effects on prolactin by stimulating other 
putative prolactin-releasing factors e.g. oxytocin (serotonin or serotonin agonist i.c.v 
treatment increases plasma oxytocin levels on rats (Jørgensen et al., 2003)).  
 
1.4.4.3 Thyrotrophin-releasing hormone  
Thyrotrophin-releasing hormone (TRH) is reputed to stimulate prolactin release and 
is known to increase in human pregnancy (Amino et al., 1981). TRH neurones are 
located in the PVN, have terminals in the median emin nce and secrete TRH into the 
portal blood system, which is associated with increased pituitary prolactin secretion. 
TRH induces a rapid rise in cellular calcium, leading to elevated prolactin release, as 
well as induction of the prolactin gene (via protein k nase C and calcium-dependent 




TRH was thought to take place in the pituitary where TRH receptors type 1 are 
located on the lactotrophs (Pfleger et al., 2004); however, a study in rats reported that 
TRH also works at the hypothalamic level, modulating the functional output of TIDA 
neurones (altering firing patterns) and consequently reducing its inhibitory effect on 
prolactin (Lyons et al., 2010, van den Pol, 2010).  
 
1.4.4.4 Vasointestinal peptide  
Vasointestinal peptide (VIP) is considered a less potent prolactin secretagogue than 
TRH. VIP neurones originate from the suprachiasmatic nucleus (SCN), with its 
fibres innervating the dopamine neurones in the arcuate nucleus (Egli et al., 2010). 
Lactotrophs produce and secrete VIP which maintains n elevated basal prolactin 
level by increasing intracellular cAMP and PKA activa on. Although prolactin 
secretion is mildly increased by VIP in primary human pituitary cells, in humans, 
VIP is not considered a potent prolactin secretagogue. In addition, in VIP receptor 




Oxytocin, produced by neurones in the PVN and SON, has been reported to be a 
crucial prolactin-releasing factor, playing a role in the regulation of prolactin 
secretion (McKee et al., 2007). The action of oxytocin on prolactin release is thought 
to be partly controlled by VIP. In support of this it has been found that fibres of VIP 
neurones also innervate oxytocin neurones in the PVN (Egli et al., 2010). Oxytocin is 
released at the times of heightened prolactin secretions e.g. afternoon of proestrous, 
following oestradiol administration and also during stress (immobilization in non-
pregnant animals) (Ben-Jonathan et al., 2008). Indeed, administration of an oxytocin 
antagonist to rats blocks the proestrous prolactin surge (Freeman et al., 2000) and 
prevents suckling-induced prolactin secretion (Kennett et al., 2009). 
Oxytocin is transported from the PVN via axons to the neural lobe where it is 
released from its terminals in the posterior pituitary (Freeman et al., 2000) and can 
travel to the lactotrophs. Oxytocin receptors have be n identified on a sub-population 
of the lactotrophs (Breton et al., 1995). In rats, oxytocin is reported to be crucial for 




ovariectomized (OVX) rats. Administration of an oxytocin antagonist (that cannot 
cross the BBB) before cervical stimulation in OVX rats abolished prolactin surges 
(McKee et al., 2007). 
 
1.4.4.6 Oestradiol 
Prolactin release is also modulated by oestradiol, the circulating concentration of 
which rises between diestrous and proestrous phases of the oestrous cycle, and 
induces the prolactin surge on the afternoon of proest us. It has been proposed that 
elevated oestrogen levels facilitate the oxytocin stimulatory actions on lactotrophs 
and increase prolactin release. The action/response t  oxytocin at the lactotrophs is 
elevated during the afternoon of proestrous when oestr gen levels are high compared 
to diestrous.  This is due to an increase in the number of oxytocin-responding 
lactotrophs and magnitude of their Ca2+i responses. An increase in oestrogen levels 
on proestrous may facilitate the action of oxytocin on lactotrophs, possibly through 
oestrogen sensitisizing the lactotrophs to oxytocin (Tabak et al., 2010). In addition, 
oestrogen also seems to contribute to prolactin releas  by inhibiting the activity of 
TIDA neurones, as observed by the reduced 3,4-dihydrox phenylacetic acid 
(DOPAC; dopamine metabolite):dopamine ratio in the median eminence of 
oestrogen-treated OVX rats (DeMaria et al., 2000). 
 
1.4.4.7 Kisspeptin 
It has been recently reported that kisspeptin also regulates prolactin release (as well 
as LH) by inhibiting the hypothalamic dopamine neurones in female rats (Szawka et 
al., 2010).  Kisspeptin treatment i.c.v induced prolactin release in a dose-dependent 
manner in oestrogen-treated OVX rats (no effect withou  oestrogen). Correlating 
with the increase in prolactin, Fos expression in tyrosine-hydroxylase-
immunoreactive neurones in the arcuate (TIDA neurones) was reduced in oestrogen-
treated OVX rats (no effect without oestrogen), as w DOPAC concentration and 
the DOPAC:dopamine ratio in the median eminence. In anterior pituitary cell 
cultures kisspeptin, with or without oestrogen, did not modify prolactin release. 
Thus, the data provide evidence for the role of kisspeptin in prolactin regulation 





1.4.5 Prolactin inhibitory factors 
Pituitary derived prolactin is typically under the inhibitory control of dopamine 
which is released from neurosecretory hypothalamic neurones. Prolactin is thought to 
be regulated by three different dopaminergic system: the TIDA, tuberohypophyseal 
(THDA), and the periventricular hypophyseal (PHDA) dopamine neurones (Grattan 
and Kokay, 2008). TIDA neurones, situated in the arcu te nucleus, provide the main 
source of dopamine which they release from their nerve terminals in the median 
eminence. Dopamine then diffuses into capillaries of the pituitary portal blood 
vessels and is transported to anterior pituitary where it  inhibits the release of 
prolactin via activating its receptors on lactotrophs (Demarest et al., 1985). 
Dopamine activates D2 receptors located on the lactotrophs and can tonically inhibit 
secretion of prolactin (Freeman et al., 2000).  
Thus an increase in the activity of TIDA neurones is associated with reduced 
prolactin secretion. Accordingly, the expression of F s (neuronal marker of 
activation) in TIDA neurones has previously been repo ted to reflect changes in 
prolactin secretion, following an immune challenge (Hollis et al., 2005). Fos is not 
unequivocally considered a reliable predictor of basal TIDA activation (Hoffman et 
al., 1994) and other techniques to measure dopamine activity at TIDA neurones can 
also be employed. For example, the content in the median eminence of the metabolite 
of dopamine, DOPAC, is used to indicate TIDA/dopamine activity and an inverse 
relationship between  prolactin levels and DOPAC levels in the median eminence has 
been demonstrated (Shieh and Pan, 2001). In addition, the DOPAC:dopamine ratio in 
the median eminence is also commonly used to measur dopamine activity (Andrews 
and Grattan, 2003). 
 
1.4.6 Prolactin receptors and signal transduction 
Mice express different isoforms of the prolactin receptor, termed the short and long 
forms. The long form is predominantly located in the hypothalamus. While both the 
long and short form of the prolactin receptor are expr ssed in the arcuate nucleus, the 
long-form is more highly expressed here (Pi and Grattan, 1998, Bakowska and 
Morrell, 2003). The short and long prolactin receptors display identical extracellular 
portions (thus both bind prolactin), but they differ in their ability to activate 




The intracellular domain in the long form of the prolactin receptor is constitutively 
associated with the tyrosine kinase, janus kinase 2 (JAK2). When prolactin binds the 
long form receptor it induces dimerization of the receptor molecules, followed by 
rapid phosphorylation of JAK2 (<1min) (Freeman et al., 2000) (see Figure 1.3). 
JAK2 then recruits and phosphorylates latent cytoplasmic proteins known as the  
signal transducer and activator of transcription (STATs). Phosphorylated (p) STAT 
molecules form homo- and hetero-dimers which translocate to the nucleus and bind 
to specific promoter sequences of target genes (Grattan, 2002). Prolactin signal 
transduction in numerous tissues is reported to invlve several STATs, including 
STAT1, STAT3, STAT5a and STAT5b (Bole-Feysot et al., 1998).  
The short form of the prolactin receptor does not activ te the JAK-STAT pathway 
upon ligand binding; however, it mediates some of the actions of prolactin through 
mitogen-activated protein kinase (MAPK) pathways. These short form receptors are 
also expressed in the arcuate nucleus and could potentially have a role in regulating 
neuronal function (Grattan et al., 2008). In addition, prolactin is reported to regulate 
phosphorylation of tyrosine hydroxylase protein in TIDA neurones with multiple 
interacting signal transduction pathways implicated to be involved, such as protein 
kinases A and C, and the extracellular regulated kinases (ERK) 1 and 2 (Ma et al., 
2005b, Grattan and Kokay, 2008). 
Expression of prolactin receptors is remarkably lowin the brain, except for in the 
choroid plexus which facilitates the active transport of prolactin into the brain. 
Prolactin receptor mRNA and binding sites are present in low levels in the rat 
hypothalamus, medial pre-optic area and in the median eminence (Ben-Jonathan, 
1996). In the PVN, colocalisation of prolactin receptors with oxytocin and 
vasopressin neurones has been reported (Grattan et al., 2001a). Expression of the 
long form of the prolactin receptor on magnocellular oxytocin neurones in the SON 
and PVN is associated with prolactin regulation of oxytocin neurone activity. In 
addition, in non-pregnant rats i.c.v prolactin injection reduces oxytocin neurone 
firing (Kokay et al., 2006). In humans, high-affinity prolactin binding sites have also 
been reported in the choroid plexus, hypothalamus and hippocampus. As in the rat, 
the number of these sites are greater in hypothalamus of women compared to men 








During pregnancy the expression of prolactin receptor mRNA in the choroid plexus 
increases by gestation day 7 and remains high throug out pregnancy and lactation 
with basal levels returning following weaning (Grattan et al., 2001a). This suggests 
increased access of prolactin to brain structures during gestation and lactation. 
Likewise, levels of prolactin receptor protein in the hypothalamus appear to increase 
during pregnancy and lactation with the most dramatic changes occurring in the SON 
and PVN magnocellular neurones. Expression of the long-form prolactin receptor on 
oxytocin neurones significantly increase during this period (Kokay et al., 2006). 
The mechanism controlling the increased expression of brain prolactin receptors 
during pregnancy and lactation is not clear. During pregnancy the high levels of 
oestrogen are reported to drive increased production of the short and predominantly 
the long forms of the prolactin receptor in chloroid plexus, aiding the entry of 
prolactin to the brain (Augustine et al., 2003, Pi et al., 2003). It may be that prolactin 
along with other pregnancy hormones (e.g. progesterone, oestrogen) all have a role in 
mediating the up-regulation of prolactin’s own receptors during pregnancy (Grattan 
et al., 2001a).  
 
1.4.7 Prolactin negative feedback 
Prolactin activates a short-loop feedback system to regulate its own secretion by 
activating receptors on TIDA neurones (see Figure 1.4). The long form of the 
prolactin receptors are expressed on TIDA neurones (Kokay and Grattan, 2005) and 
ligand-induced activation stimulates expression of the tyrosine hydroxylase gene.  
Tyrosine hydroxylase is the rate-limiting enzyme involved in the biosynthesis of 
dopamine. Therefore, prolactin induces dopamine synthesis and indirectly suppresses 
its own synthesis(Grattan and Kokay, 2008). This is termed prolactin negative 
feedback (Ma et al., 2005a, Ma et al., 2005b). Activation of the TIDA neurones via 
prolactin receptor binding involves activation of the JAK2/ STAT5 signalling 
transduction pathway (Grattan et al., 2001b, Ma et l., 2005a).  pSTAT5b is reported 
to specifically mediate prolactin negative feedback on the TIDA neurones. In rats, 
nuclear translocation of pSTAT5 is induced by ovine prolactin administration 
intraperitoneally (i.p) (Lerant et al., 2001). STAT5b deficient mice express elevated 
serum prolactin levels, although mRNA levels and immunoreactivity of tyrosine 






































that pSTAT5b is crucial for mediating prolactin negative feedback in TIDA neurones 
(Grattan et al., 2001b).  
 
1.4.8 The prolactin system in pregnancy 
Prolactin is essential to rodents and facilitatory in women to drive the secretion of 
progesterone. It acts as a luteotrophic hormone by maintaining the integrity of the 
corpus luteum following mating and is reported to be a potent survival factor for 
human granulosa cells. If prolactin levels are dimin shed the formation of the corpus 
luteum is compromised (Perks et al., 2003). In rodents prolactin drives progesterone 
secretion in two ways: it potentiates the steroidogenic effects of LH (through 
interaction with the LH receptors) and inhibits 20-α-HSD, an enzyme which 
inactivates progesterone (Freeman et al., 2000). The prolactin secretion in early 
pregnancy in rodents is thought to be essential for rescuing the corpus luteum and 
mice lacking prolactin receptors are unable to achieve pregnancy as a result of 
implantation failure due to decreased LH receptor expr ssion in the corpus luteum, 
high 20-α HSD levels and inadequate progesterone levels (Bachelot et al., 2009). At 
mid-pregnancy, these prolactin peaks diminish and placental lactogens (PLs) take 
over the role of prolactin to drive progesterone secretion from the corpus luteum. 
Simultaneously, PLs trigger negative feedback on prolactin secretion and thus levels 
of prolactin decrease at this time until rising again at the end of gestation (Lee and 
Voogt, 1999). The secretory profile differs in women compared to rodents (see 
Figure 1.5). In women, increasing prolactin levels are reported in early pregnancy, 
from around gestation week 6, up to term (Ben-Jonathan et al., 2008). It has been 
reported plasma prolactin levels increase from around 6ng/ml (at week 8) to 
210ng/ml near term (Biswas and Rodeck, 1976) and hPL is secreted after gestation 
week 6 in maternal and foetal circulations and alsoincreases as pregnancy proceeds 
(Handwerger and Freeman, 2000).  
 
1.4.8.1 Prolactin negative feedback during pregnancy 
Prolactin negative feedback is maintained during early-pregnancy prolactin surges 
(Demarest et al., 1983, Grattan et al., 2008). Accordingly, TIDA neurones display a 







































surges and increased activity between them, thus allowing initiation and termination 
of the surges (McKay et al., 1982). However, during late pregnancy and lactation, 
there is an absence of short-loop negative feedback on TIDA neurones by prolactin 
(Grattan and Averill, 1995). TIDA neurones become less able to secrete dopamine in 
response to prolactin, resulting in a state of hyperprolactinemia. Several 
physiological changes in the regulatory pathways that control prolactin secretion 
occur during late pregnancy. The placenta produces placental lactogens in rodents 
(Lee and Voogt, 1999) and humans (Handwerger and Freeman, 2000). These bind to 
and activate prolactin receptors and are not subject to the normal inhibitory control 
by dopamine. Therefore, the short-loop feedback is bypassed in late 
pregnancy/lactation. This allows continued activation of the prolactin receptors, 
resulting in elevated progesterone secretion while simultaneously suppressing 
prolactin release itself (Grattan, 2002). TIDA neurones have also been shown to have 
a weakened capacity to respond to prolactin in late pregnancy, with reduced TIDA 
activation compared to early gestation (Grattan and Averill, 1995, Andrews et al., 
2001). Prolactin secretion is able to resume at this time despite the continued 
presence of placental lactogens. Negative feedback is also impaired during lactation, 
providing the high prolactin levels required for milk production and maternal 
behaviour (Grattan et al., 2008). Suckling also stimulates prolactin release via a 
suckling-induced reduction in TIDA neurones activation (Selmanoff and Gregerson, 
1985).  
During late pregnancy and lactation, prolactin’s ability to induce STAT5b 
phosphorylation and nuclear translocation is suppressed. This appears to be 
associated with a rise in suppressors of cytokine signalling (SOCS) mRNA which 
may underlie the reduced TIDA neurone dopamine output and high prolactin levels 
observed during this period (Anderson et al., 2006a). SOCS act as feedback 
inhibitors of signalling for a number of cytokines that utilize the JAK/STAT 
pathways and are involved in suppressing STAT phosprylation and thus dampen 








1.5 Immune system in pregnancy 
1.5.1 The cellular T system 
The most important components of the cellular immunosystem in pregnancy are the 
helper T (Th) cells (reviewed in (Guerin et al., 2009)). Briefly, these cells can be 
differentiated into two polarised forms (Th1 and Th2) which display different 
effector responses. Th 1 cytokines (e.g. TNF-α) stimulate various cell-mediated 
cytotoxic and inflammatory responses. Th 2 cytokines (e.g. IL-10) are involved in B 
cell antibody production and are required for the secretion of hPL and hCG 
(Druckmann and Druckmann, 2005). The Th1:Th2 paradigm has recently been 
extended to include Th17 cells (producers of pro-inflammatory cytokine IL-17) and 
regulatory T (Treg) cells. Th17 cells are involved in induction of inflammation and 
the pathogenesis of rejection, while Treg contribute to immunoregulation  and 
peripheral tolerance (Saito et al., 2010).  
 
1.5.2 Immune balance in pregnancy 
It has been proposed that normal pregnancy is charaterised by a Th2 bias. High 
levels of Th2 cytokine production and release have been reported to be involved 
foetal allograft survival and pregnancy maintenance (Piccinni et al., 1995, Piccinni, 
2006). Pregnant women with a history of successful pregnancies have significantly 
higher concentrations of Th2 cytokines in the first t imester compared to women 
undergoing unexplained recurrent spontaneous abortion who have significantly 
higher concentrations of Th1 cytokines compared to the women with successful 
pregnancies. Therefore, this study supports the theory that there is a Th2 bias in 
normal successful pregnancy (Raghupathy et al., 2000). However, evidence exists to 
the contrary with a study reporting a Th2 predominance in recurrent foetal loss (Saini 
et al., 2011).  Together these studies indicate that early pregnancy maintenance is 
dependent upon procuring a suitable cytokine balance, with slightly higher levels of 
Th2 cytokines and lower levels of pregnancy-threatening Th1 cytokines.  
 
1.5.3 Uterine dendritic cells 
Uterine dendritic cells in humans and mice are proposed to control foetal tolerance 
and rejection (Kammerer et al., 2000, Gardner and Moffett, 2003, Blois et al., 




the innate immune response and maintenance of toleranc  (Arck et al., 2007). 
Immature dendritic cells are characterised by low production of pro-inflammatory 
cytokines, high production of IL-10, and enhanced ability to induce regulatory T 
cells with suppressive actions, which all contribute to promoting pregnancy 
maintenance. These immature dendritic cells are found in early pregnancy decidua in 
women (Kammerer et al., 2000) and mice (Blois et al., 2005b).  
 
1.5.4 Progesterone as an immunosteroid 
Alongside its endocrine effects progesterone acts as an ‘immunosteroid’ facilitating 
maternal tolerance to the fetal ‘semi-allograft’. In this capacity, progesterone blocks 
very early T-cell lymphopoiesis (Tibbetts et al., 1999) and plays a role in providing a 
pregnancy protective immune milieu (Arck et al., 2007). It has been shown that 
progesterone favors development of Th cells which produce Th2 cytokines and an 
increase in Th2 cytokine production has been implicated to be involved in fetal 
allograft survival (Piccinni et al., 1995). Progesterone exerts an anti-abortive effect 
by stimulating progesterone-induced blocking factor (PIBF). It has been shown 
treatment with anti-PIBF IgG results in increased splenic natural killer (NK; 
lymphocytes which are a major component of the innate immune system) cell 
activity, and the rate of NK activity correlates with the rate of resorptions. Therefore, 
the antiabortive effect of PIBF in mice appears to be mediated by reducing NK 
activity (Szekeres-Bartho et al., 1997a) via interfering with arachidonic acid 
metabolism. It has been reported that neutralization of endogenous PIBF by a PIBF-
specific antibody terminates pregnancy in mice (Szekeres-Bartho et al., 1997a, 
Szekeres-Bartho et al., 1997b). Lymphocytes and decidual CD56+ cells synthesize 
PIBF and alter cytokine secretion. PIBF changes the cytokine profile of activated 
lymphocytes, favouring production of Th2 cytokines over Th1 cytokines. For 
example, PIBF increases interleukin (IL)-10 production and decreases IL-12 
production (Szekeres-Bartho and Wegmann, 1996).  However, a study in humans 
failed to demonstrate the expression of progesterone eceptor mRNA in human 
decidual NK cells, thus, in women a direct role progesterone in attaining a suitable 
PIBF and cytokine environment is not clear (Henderson et al., 2003). 
In addition, progesterone has been found to inhibit ma ure dendritic cells as well as 




indicating progesterone directly suppresses the ability of mature rat decidual cells to 
drive proinflammatory responses (Butts et al., 2007).  
 
1.5.5 Prolactin regulation of cytokine balance 
Prolactin, along with its wide variety of reproduction specific actions e.g. initiation 
and maintenance of lactation, is known to have a role in immunomodulation (Yu-
Lee, 2002). Prolactin regulates the cytokine profile, and has been demonstrated to 
modulate production of IL-10 and IL-12 in a stimulus-specific fashion (Matalka and 
Ali, 2005). Prolactin is often referred to as a cytokine itself, with activation of its 
receptor driving intracellular JAK/STAT signaling. In addition, some features of cell 
responses common to prolactin are also associated wi h other cytokines, such as 
suppressors of cytokine signaling (SOCS) (Anderson et al., 2006a). Thus cross-talk 
between the responses can occur and have been reported in some tissues such as the 
mammary glands. Prolactin has been found to regulate SOCS3 expression and 
prolactin-induced SOCS3 acts as an anti-proliferative agent in breast cancer cells 
(Barclay et al., 2009). 
In addition, prolactin has been shown to be protectiv  against inflammation 
following severe trauma (Knoferl et al., 2000), as h  oestrogen (Jarrar et al., 2000). 
Gender appears to play a role in trauma response with female patients having higher 
survival rates than males (Morris et al., 1990), supporting the idea female hormones 
may have a provide protection against hemorrhage and/or septic complications. It has 
been reported that male trauma patients have a higher susceptibility for infections, 
correlated with heightened serum proinflammatory cytokines such as IL-6  compared 
to females (Oberholzer et al., 2000). In rodent models, trauma-hemorrhage leads to 
depressed immune function and increased infection, m rbidity and mortality. 
However, the administration of prolactin, as well as oestrogen, protected against 
trauma-hemorrhage, reducing plasma levels of IL-6 and corticosterone and 
subsequently improving survival to septic shock (Zellw ger et al., 1996, Knoferl et 
al., 2000). These studies suggest that under stress conditions prolactin and oestrogen 
protect against inflammation and improve immune respon es. 
Prolactin and oestrogen also suppress IL-6 gene expression in female reproductive 
tissues (Deb et al., 1999a). During pregnancy decidual expression of IL-6 is 




associated with pregnancy failure. These two hormones down-regulate the 
expression of the gp130 component of the IL-6 receptor complex (Kurebayashi et al., 
1997, Deb et al., 1999a). Decidual prolactin is also known to silence other genes 
thought to be detrimental to pregnancy, such as 20α-HSD (enzyme responsible for 
degrading progesterone) (Bao et al., 2007). 
 
1.6 Effect of stress on the neuroendocrine system 
As indicated earlier, environmental conditions and stress can disrupt the 
neuroendocrine systems in an attempt to overcome or compensate for the adverse 
stimuli e.g. to maintain homeostasis, conserve energy, etc.  
 
1.6.1 Stressors 
Stress can be experienced due to acute or sustained exposure to adverse conditions 
and are generally categorized as either psychological or physical. Different brain 
circuitries deliver information about these stress types to the hypothalamo-pituitary-
adrenal (HPA) axis: stressors which pose an immediat  physiological threat are 
primarily relayed directly from the brainstem, while psychological stressors are 
mainly processed through the limbic forebrain (Herman and Cullinan, 1997). 
Psychological stressors can be mild such as a novel en ironment or sustained noise, 
or it can be severe such as physical and mental abuse, or a repeated high pressure 
environment (e.g. high work demands/responsibility). Physical stressors include 
immune stress, hunger (including poor diet) or physical insult. Acute stressors appear 
abruptly over a relatively short period of time and lead to acute, transient symptoms 
(Douglas, 2010). Stress hormones and other mediators e.g. neurotransmitters, 
cytokines, are required for adaptation to stress (process termed “allostasis”) in order 
to maintain homeostasis. When released in response t  stressors they promote 
adaptation and are generally beneficial often preventing further damage/effects 
(McEwen, 2004). In contrast, during chronic stress pi odes which are of a longer 
duration and are recurring, these mediators are not turned off and are overused. This 
results in escalating changes that lead to wear-and-tear on the body/brain (termed 
“allostatic load/overload”) which can cause long-term health problems (McEwen, 
1998). For example, allostatic overload can lead to impaired immunity, 




brain nerve cells. These are often observed in cases of depressive illnesses and 
chronic anxiety disorders (McEwen, 2004).  
 
1.6.2 The stress system and hypothalamo-pituitary-ad enal axis 
The stress system coordinates the adaptive responses f the individual to stressors 
and its activation results in behavioural and peripheral changes that allow the return 
to homeostasis and increase the chance of survival. The stress system encompasses 
the HPA axis, and the locus coeruleus–noradrenaline utonomic systems (Tsigos and 
Chrousos, 2002). Stress is defined as the activation of HPA axis and the consequent 
release of its hormones (Parker and Douglas, 2010). Exposure to stress triggers the 
increased secretion of CRH and vasopressin from hypot alamic PVN. During 
periods lacking stress both of these hormones are secr ted in a circadian, pulsatile 
pattern (2-3 secretory pulses per hour) (Engler et al., 1989) and the amplitude of the 
pulses increases in the early morning (Horrocks et al., 1990). These two 
neuropeptides act synergistically to induce secretion of ACTH from the pituitary 
corticotrophs (Lamberts et al., 1984). During acute str ss, the amplitude and 
synchronization of the CRH and AVP pulses into the hypophyseal portal system 
significantly increases, leading to a rise in ACTH secretion (Charmandari et al., 
2005). ACTH subsequently stimulates the release of the glucocorticoids (cortisol in 
humans, corticosterone in rodents) from the in the cells of the zona fasciculata of the 
adrenal cortex (see Figure 1.6). Glucocorticoids are the final effectors of the HPA 
axis and they carry out their roles through ubiquito sly distributed intracellular 
glucocorticoids receptors (Charmandari et al., 2005).  Glucocorticoids are known to 
support a wide array of physiological systems and have important roles in 
cardiovascular tone, immunity/inflammation, metabolism, behaviour, reproduction 
and neural function (Sapolsky et al., 2000).  
 
1.6.3 Glucocorticoid negative feedback  
Glucocorticoids have an important role in regulating basal HPA axis activity and 
terminating the stress response and exert negative feedback effects on  the HPA axis 
via extra-hypothalamic centres, including the hippocampus (Jacobson and Sapolsky, 
1991, Furay et al., 2008), as well as the hypothalamus and the pituitary to suppress 




feedback limits the duration of tissue exposure to glucocorticoids, minimising the 
catabolic, immunosuppressive and anti-reproductive effects of these hormones 
(Charmandari et al., 2005) and it also prevents stres  hormone depletion so as to  
maintain levels sufficient enough to mount successive tress responses (Sapolsky et 
al., 2000, Tasker and Herman, 2011). Glucocorticoid type II receptors are 
responsible for the negative feedback control of CRH and ACTH release 
(Charmandari et al., 2005). Chronic stress attenuates the negative feedback system 
by glucocorticoids, reportedly involving alterations in glucocorticoid receptor 
expression in the higher centres of the HPA axis: prefrontal cortex and hippocampus 
(Mizoguchi et al., 2003). 
 
 1.6.4 Mode of action of glucocorticoids 
Glucocorticoids bind to and activate cytoplasmic glucocorticoid receptors resulting 
in their translocation to the nucleus. Here they interact as homodimers with the 
specific glucocorticoid responsive elements (GREs) in the promoter regions of 
hormone-responsive genes (e.g.lipocortin-1) and regulate the expression of 
glucocorticoid-responsive genes positively or negatively (Charmandari et al., 2005). 
However, the main anti-inflammatory effects of glucocorticoids appear to be 
predominantly due to interaction between the glucocorticoid receptor and 
transcription factors, such as nuclear factor-κB (NF-κB) and activator protein-1 (AP-
1), which mediate the expression of pro-inflammatory genes (Hayashi et al., 2004).  
 
1.6.5 The autonomic nervous system  
The autonomic nervous system (ANS) rapidly responds to stressors and controls a 
wide variety of functions. The sympathetic and/or pa asympathetic nervous systems 
(SNS, PNS) are involved in regulating a number of different areas including the 
cardiovascular, respiratory, gastrointestinal, renal, and endocrine systems. The 
parasympathetic system is able to aid or inhibit sympathetic functions through either 
by reducing or increasing its activity, respectively (Tsigos and Chrousos, 2002, 
Charmandari et al., 2005).  
Both the neuroendocrine and the ANS stress responses converge on the adrenal 









response takes place over a slower timescale and vi hypothalamic-pituitary 
hormones induces adrenal glucocorticoid secretion. The autonomic response is much 
faster and is triggered by sympathetic neural outputs (Tasker and Herman, 2011). 
Typically, stress rapidly and transiently increases adrenaline and noradrenaline 
secretion from the adrenal medulla and from sympathetic nerve endings (which 
innervate the smooth muscle of the vasculature, skeletal muscle and many organs 
including the heart, kidneys, etc.) (Tsigos and Chrousos, 2002). These 
catecholaminergic hormones carry out a more rapid stres  response than 
glucocorticoids and supply an immediate energy source by mobilising glucose, and 
redirecting blood supply to from less essential processes to skeletal muscle. This 
allows ‘flight’ if necessary and facilitates stress coping mechanisms. In addition to 
peripheral responses, central ANS and SNS responses to tress induce activation of 
noradrenergic pathways from the brainstem to the limbic system and hypothalamus 
(Douglas et al., 2005, Douglas, 2010). Central adrenaline serves as an alarm system 
that reduces neurovegetative functions (e.g. eating, sleeping), accompanied by 
increases in endocrine/autonomic responses to stress (Tsigos and Chrousos, 2002).  
 
1.6.6 Noradrenaline and the hypothalamo-pituitary-adrenal axis 
A reciprocal neural connection exists between CRH and the LC-noradrenaline 
system (see Figure 1.7). CRH and noradrenaline stimulate each other, the latter 
principally through α1-adrenergic receptors (Tsigos and Chrousos, 2002). 
Noradrenaline from brainstem nuclei (A1, A2 and A6 cell groups in particular) is a 
major excitatory input to the PVN (Pacak et al., 1995a) and α1-adrenergic receptor 
agonists stimulate HPA axis activity (Itoi et al., 2004). However, noradrenaline has 
also been found to have inhibitory as well as stimulatory effects on CRH activity and 
HPA axis response to stress via α1-adrenergic receptors. In addition, central 
blockade of these receptors does not prevent restraint stress-induced increase in CRH 
mRNA expression in the PVN, thus, induction of HPA effects via noradrenergic 
inputs is stress specific and is utilised by most but not all stressors (Douglas, 2005a). 
 
1.6.7 Stress-induced behavioural responses 
Interactions of noradrenaline with various neuroendocrine systems leads to 




shown in humans to mediate amygdala (principle brain region involved in fear 
conditioning) activity in humans when processing emotional stimuli (van Stegeren et 
al., 2005). Studies in rodents suggest that elevated noradrenaline levels/activity in the 
hypothalamus, amygdala and LC are involved in the provocation of anxiety and/or 
fear following stress exposure (Tanaka et al., 2000, Morilak et al., 2005). Thus, the 
central noradrenergic system is thought to be involved in a number of anxiety 
disorders, especially panic disorders and post-traumatic stress. This is supported by 
the finding that an α2-adrenergic agonist effectively alleviates anxiety symptoms  
while an α2-adrenergic antagonist intensifies them in patients wi h anxiety disorders,  
suggesting the central noradrenergic system is linked to emotional responses 
(Charney, 2003, Itoi and Sugimoto, 2010). 
 
1.6.8 Effect of stress on the hypothalamo-pituitary-gonadal axis 
Stress is well known to disrupt and suppress reproductive function in humans 
(Nakamura et al., 2008). For example, under-nutrition and intensive exercise in 
adolescents is associated with delayed menarche (Rogol et al., 2000), and a number 
of different stressors are known to reduce fertility (Nakamura et al., 2008, Ruder et 
al., 2009, Douglas, 2010). Limited studies in non-pregnant humans and primates 
suggest that CRH suppresses gonadotrophin secretion (Olster and Ferin, 1987, 
Barbarino et al., 1989). In contrast, it has been repo ted i.v. administration of human 
CRH had no inhibitory effect on gonadotrophin secretion in pre- or post-menopausal 
women (Fischer et al., 1992). However, there are many reports in rodents that acute 
stress disrupts gonadotrophin secretion, reduces LH pulsatility (Li et al., 2003) and 
elevates prolactin release (Gala, 1990, Poletini et al., 2006). Typically stress 
increases progesterone secretion in non-pregnant female mammals (Nakamura et al., 
1997), which could be partly accounted for by the associated increase in prolactin 
secretion as prolactin is known to drive progesteron  secretion. 
 
1.6.8.1 Potential mechanisms mediating stress-suppression of the HPG axis  
Mounting evidence suggests that stress suppresses the activity of the HPG axis, 
particularly its central regulator, the GnRH pulse generator. It is thought that 








systems and the limbic brain (Li et al., 2010) via projections to the LC. The LC 
noradrenergic neurones project to the preoptic area where they have been 
demonstrated to inhibit GnRH neurones via gamma aminobutyric acid (GABA) 
secretion/activation (Mitchell et al., 2005).  
Hypothalamic mRNA expression of kisspeptin and its receptor are down-regulated in 
the mPOA and arcuate nucleus following a variety of stressors (e.g. restraint, 
immune challenge) in female rats (Kinsey-Jones et al., 2009) and CRH 
administration i.c.v in female mice. In light of the role of kisspeptin signalling in 
regulating the HPG axis, this suggests that stress-r duced kisspeptin expression may 
contribute to stress-related suppression of LH release (Kinsey-Jones et al., 2009). 
 
1.6.8.2 Stress-induced cytokines and the HPG axis 
Stress-related cytokines can also affect the brain and pituitary, and subsequently the 
HPG axis. Cytokines are thought to potentially gain access to the brain via a number 
of different pathways, including the ‘leaky’ blood brain barrier regions (e.g. in the 
arcuate nucleus or via the brainstem). It has been shown that stress-induced cytokines 
can inhibit GnRH pulse generator activity. For example, LPS administration to rats 
has been reported to suppress the electrical activity of the GnRH pulse generator, 
reflected in reduced LH pulsatile secretion, which is at least partially mediated by 
TNF-α (Yoo et al., 1997).  
 
1.6.9 Effect of stress on prolactin secretion 
Acute stress typically increases prolactin secretion in non-pregnant rodents and 
humans (Nicoll et al., 1960, Armario et al., 1996, Freeman et al., 2000). Chronic 
sustained stress (around-the-clock intermittent foot sh ck) to both male and female 
(non-pregnant) rats increases anterior pituitary prolactin mRNA levels after 1 day 
and more so after 3 days. However, after 14 days there was no significant difference 
in prolactin mRNA compared to controls, with levels returning to pre-stress values 
(Dave et al., 2000).  Various stressors have been dmonstrated to induce prolactin 
secretion in rodents, such as immune challenge, restraint stress and ether exposure  
(Freeman et al., 2000). In humans, circulating prolactin levels have been shown to 
increase following the Trier social stress test (Kudielka and Wüst, 2010). However, 




al., 1995). Thus, the effect of different stressors on prolactin can be species/strain-
specific e.g. restraint stress increases prolactin in C57BL/6 mice but not in BALB/cJ 
mice (Meerlo et al., 2001). It has been reported that t e stress effects on prolactin are 
dependent on the pre-stress levels of prolactin: stres  enhances prolactin release if 
pre-stress levels are low, and suppresses its release if pre-stress levels are high, for 
example, during the proestrous afternoon surge (Gala, 1990). However, in female 
rats it has been reported that the prolactin secretory response to stress is dependent  
upon the plasma levels of ovarian steroids rather tan pre-stress levels (Poletini et al., 
2006). Ether stress increased both low (e.g. morning of proestrous, OVX rats) and 
high (e.g. oestrogen-treated OVX rats) plasma prolactin levels. However, stress 
reduced the high prolactin levels observed on the afternoon of proestrous and also in 
OVX rats treated with oestrogen and progesterone. Thus data suggest oestrogen and 
progesterone modulate stress-induced prolactin releas , regardless of pre-stress 
levels. Poletini et al. (2006) also investigated the role of the LC in the prolactin stress 
response but found that lesions to the LC did not affect the degree of the prolactin 
stress response. LC lesions did, however, suppress th  prolactin surges on the 
afternoon of proestrous, and in oestrogen-treated and oestrogen and progesterone-
treated OVX rats, indicating a specific role in ovarian steroid-induced prolactin 
surges. 
 
1.7 Effects of stress on the neuroendocrine system during pregnancy 
1.7.1 HPA axis 
Typically human gestation is associated with increased HPA axis function as 
pregnancy progresses, leading to elevated circulating ACTH and cortisol. Total and 
free plasma cortisol levels rise in parallel across pregnancy, and elevated levels are 
observed as early as gestation week 11. The precise cause(s) of increased ACTH is 
currently unclear but may include placental synthesis and release of CRH and 
ACTH, pituitary desensitization to cortisol negative feedback or heightened response 
to corticotrophin releasing factors e.g. vasopressin and CRH (Lindsay and Nieman, 







1.7.2 Foetal programming 
The foetus is protected from the effects of maternal hypercortisolism by the placental 
enzyme 11-β hydroxysteroid dehydrogenase (11β-HSD2) in early gestation. Active 
glucocorticoids, cortisol and corticosterone, are converted by 11β-HSD2 in the 
placenta into their inactive metabolites (cortisone a d 11-dehydrocorticosterone, 
respectively). This ensures foetal glucocorticoid levels are lower than maternal 
concentrations, which is critical as exogenous glucocorticoids have been associated 
with foetal growth retardation in both humans and experimental animals (Seckl et al., 
2000). Epidemiological data suggests that a non-optimum foetal environment in 
utero has profound effects, permanently and adversely programming the physiology 
of the foetus (so called ‘foetal programming’). Prenatal elevated levels of 
glucocorticoids, for example due to maternal stress, may lead to increased risk of 
cardiovascular, metabolic and neuroendocrine disorders in later life (Seckl and 
Meaney, 2004).  
 
1.7.3 Early Pregnancy 
1.7.3.1 HPA axis basal activity in early pregnancy 
In rodents in early pregnancy, the secretion of ACTH and corticosterone is similar to 
virgins in the early light phase when HPA axis activity is at the circadian nadir. The 
expression of CRH and vasopressin genes in the parvocellular PVN, and 
glucocorticoid and mineralocorticoid receptor mRNA in the PVN and hippocampus 
are also unchanged in early pregnancy (reviewed in (Brunton et al., 2008)). 
However,  the circadian pattern of  basal HPA activity alters in very early pregnancy 
with peak circulating concentrations of ACTH and cortic sterone attenuated in the 
late light phase compared to di-oestrous (Atkinson and Waddell, 1995). It has been 
reported that the circadian pattern continues to be suppressed as pregnancy 
progresses, with corticosterone levels decreasing until mid-pregnancy in the rat, 
when levels then begin to rise once more (Atkinson and Waddell, 1995). A similar 
reduced basal HPA axis profile is observed in women during early pregnancy. 
Typically, salivary cortisol levels are found to be markedly lower in early gestation 
compared to late pregnancy, with the difference betwe n nadir and peak cortisol 





1.7.3.2 HPA axis responses to stress in early pregnancy 
Studies into the HPA axis responses to stress in women are limited and 
glucocorticoid release in response to stress in early pregnancy is only sparsely 
reported. Acute stress tests such as the Trier Social Stress Test (public speaking) at 
the start of the second trimester of pregnancy reveal that cortisol levels robustly 
increase (Nierop et al., 2008), however, it is not clear what the effects of prolonged 
stress are on cortisol secretion in early pregnancy. I  a study investigating perceived 
stress levels in women during early pregnancy, no correlation was apparent between 
the degree of perceived stress and salivary cortisol (Obel et al., 2005). Unfortunately 
this study did not report pregnancy outcome and from the literature it is not possible 
to categorically conclude that high cortisol levels always result in pregnancy loss or 
programming (Nakamura et al., 2008). A study into the effects of stressful work on 
pregnancy found no correlation with pregnancy loss, although cortisol levels were 
not measured (Fenster et al., 1995). 
In rodents, HPA axis responses to stress exposure in mid pregnancy are robust and 
do not differ from virgin animals (Arck et al., 1995, Brunton et al., 2008). Rodents 
that are exposed to stress at the peri-implantation period display increased secretion 
of ACTH, despite the risk to pregnancy due inhibition of progesterone. As in virgins, 
transient high levels of glucocorticoids prevail in early pregnancy following stress, 
suggesting this alone may not be acutely detrimental to pregnancy maintenance and 
homeostasis can be restored via rapid negative feedback  (Douglas, 2010). However, 
in women the peri-implantation window may be particularly sensitive to stress and 
glucocorticoid action as elevated salivary cortisol levels are associated with foetal 
loss during this period (Nepomnaschy et al., 2006), while studies performed during 
the later stages of early pregnancy in women do not report this association (Douglas, 
2010). 
 
1.7.3.3 Reproductive hormones and stress in early pregnancy 
1.7.3.3.1 hCG responses to stress in early pregnancy  
The main gonadotrophin in early (first trimester) human pregnancy is hCG and 
reports on the effects of stress on hCG release are vari d and conflicting. Stressful 
situations have been shown to reduce circulating hCG (low hCG is associated with 




or to increase circulating hCG levels (Kharfi Aris et al., 2007). Therefore, hCG is not 
considered a reliable first trimester marker or predictor of miscarriage. 
 
1.7.3.3.2 LH and prolactin responses to stress in early pregnancy  
The effects of stress on LH and prolactin secretion in pregnancy have not been 
extensively studied in humans and thus are not report d in the literature to my 
knowledge. Although maternal smoking is reported to ecrease placental hormone 
levels generally (e.g. placental growth hormone, hCG, hPL) (Coutant et al., 2001, 
Varvarigou et al., 2009) it is not known or been reported what the responses to other 
stressors are. Rodent studies provide an insight into the effects of stress on pregnancy 
hormones which may alter gonadotrophin responses.  In rodents LH secretion is 
typically suppressed by rising levels of exogenous pregnancy hormones progesterone 
and oestrogen via negative feedback mechanisms acting centrally and at the pituitary 
(Li et al., 2003, d'Anglemont de Tassigny and Colledg , 2010). Therefore, stress-
disrupted progesterone in early pregnancy (see next section) may impact on LH 
release due to reduced negative feedback. This theory is supported by the finding that 
immune stress in early pregnant mice increases LH secretion (Erlebacher et al., 
2004), however these mice also displayed  attenuated ovarian expression of LH 
receptors which would decrease steroidogenesis.  
 
1.7.3.3.3 Progesterone responses to stress in earlypregnancy 
Increasing evidence for a reduction in progesterone (a d PIBF) following stress in 
early pregnancy is emerging in mice, which is in cotrast to the elevated stress-
induced progesterone levels in non-pregnant rodents (Nakamura et al., 1997). 
Various stressors, including 24h noise and immune stres ors, have been reported to 
reduce circulating progesterone in early pregnancy (Joachim et al., 2003, Blois et al., 
2004, Erlebacher et al., 2004, Parker and Douglas, 2010, Parker et al., 2011b). Noise 
stress on day 5 of pregnancy in an abortion-prone mouse model (DBA/2J-mated 
CBA/2J female mice) significantly decreases progesterone and PIBF levels and 
increases in the percentage of resorptions (Joachim et al., 2003). However, injection 
of the progesterone derivative Dydrogesterone, immediat ly prior to stress exposure, 
abrogated stress-induced resorptions in a dose-depen nt manner. In addition, PIBF 




increased with Dydrogesterone treatment (Joachim et al., 2003), highlighting the 
importance of progesterone for pregnancy maintenance. I  women, low progesterone 
levels in early pregnancy have been shown to be predictive of later pregnancy failure 
(Elson et al., 2003, Arck et al., 2008). 
 
1.7.4 Late pregnancy 
1.7.4.1 HPA axis basal activity in late pregnancy 
It is difficult to assess the maternal HPA axis in late pregnant women due to the fact 
that the placenta also produces and secretes HPA axis peptides/steroids (Chen et al., 
1986, Sasaki et al., 1988). This is not the case in rodents where very late pregnancy 
and birth is associated with attenuated basal activity of the HPA axis in the rat 
(Brunton et al., 2008). For example, expression of CRH and vasopressin mRNA in 
the pPVN are reduced (Johnstone et al., 2000), associ ted with decreased CRH 
content in the median eminence (Ma et al., 2005c) and reduced mRNA expression of 
POMC (the ACTH precursor) (Brunton et al., 2008). It is possible that heightened 
glucocorticoid negative feedback may underlie the reduced basal HPA activity, 
supported by reports of elevated glucocorticoid receptor mRNA levels in the 
hippocampus during late pregnancy. However, functioal studies in late pregnant rats 
do not confirm an active increase in negative feedback and therefore reduction in the 
forward drive, rather than increased negative feedback, may underlie 
hyporesponsiveness of the HPA axis to stress in late pregnancy (Johnstone et al., 
2000).  
As pregnancy progresses circulating corticosterone lev ls rise from mid-pregnancy 
until term in the rat (Atkinson and Waddell, 1995). In women plasma cortisol levels 
have been reported to increase progressively from gestation week 12 to week 26, at 
which point they stabilise until parturition (Carr et al., 1981). Throughout gestation 
the metabolic clearance of corticosterone is sustained at pre-pregnancy levels in 
rodents, although free corticosterone levels declin due to an increase in 








1.7.4.2 HPA axis responses to stress in late pregnancy 
Stress-induced HPA axis activity is strongly reduced by late pregnancy in women 
(Kammerer et al., 2002) and rodents (Douglas et al., 2003, Russell et al., 2008) and 
presumably protects the foetus from the adverse programming effects of 
glucocorticoids. In women, exogenously administered CRH does not evoke an 
increased circulating ACTH or cortisol response in late pregnancy (Schulte et al., 
1990) and they also become insensitive to cold stres  with suppressed salivary 
cortisol levels (Kammerer et al., 2002). In rats, HPA axis responses to various 
psychological stressors (e.g. noise stress, forced swimming (Neumann et al., 1998)) 
and physical stressors (e.g. immune challenge (Brunton and Russell, 2008)) decline 
in the last week of pregnancy, reflected as decreased ACTH and corticosterone 
secretion. HPA axis hyporesponsiveness continues throug  parturition (Neumann et 
al., 2003) and lactation until weaning takes place (Windle et al., 1997). 
 
1.8 Stress and the immune system in pregnancy 
Mounting evidence indicates an immune-endocrine disquilibrium in response to 
stress, with a number of mediators (including cytokines) implicated to contribute to 
stress-induced pregnancy loss (Arck et al., 1995, Nakamura et al., 2008). Reciprocal 
regulation exists between the central nervous system (CNS) and the immune system, 
whereby immune factors/cytokines crosstalk with the neuroendocrine-endocrine 
systems. The CNS signals to the immune system via the endocrine stress responses 
previously mentioned, and the immune system signals to the CNS via cytokines. 
Cytokines are considered important in alerting the CNS to immune challenge and 
during inflammation they are produced and released from the affected area and 
immune cells and signal to the brain, causing fever and sickness symptoms (Webster 
et al., 2002). Dysregulation of the delicate communication system threatens 
pregnancy maintenance. 
 
1.8.1 HPA regulation of the immune system 
The release of stress-induced HPA axis hormones, including CRH, ACTH and 
glucocorticoids, may strongly influence maternal immune balance and affect 
pregnancy outcome (Nepomnaschy et al., 2007). For example, central CRH is 




reduced splenic NK cell activity) in rats. Administration of a CRH receptor 
antagonist i.c.v to day 16 pregnant rats antagonised heat-induced 
immunosuppression, reversing NK cell activity. This suggests immunosuppression 
produced by heat stress is mediated by the central CRH system (Nakamura H, 2001). 
Circulating glucocorticoids modulate the transcription of multiple cytokines and 
upregulate transcription of anti-inflammatory cytokines IL-4 and IL-10, while 
suppressing pro-inflammatory/pregnancy-disturbing cytokines such as IL-1, IL-2, IL-
6 and TNF-α (Arck, 2001, Webster et al., 2002). The anti-inflammatory properties of 
glucocorticoid action are primarily due to inhibition of transcription factors nuclear 
factor kappa enhancer of activated B cells (NFκB) and/or activator protein 1 (AP1) 
which typically induce proinflammatory gene expression (De Bosscher et al., 2000). 
Cortisol has also been reported to suppress NK activity, which is thought to be 
beneficial to pregnancy success since induction of NK activity threatens foetal 
survival (Arck, 2001), and reduce circulating dendritic cells (Suda et al., 2003). 
Therefore, it seems strange that stress-induced glucocorticoid, in light of its 
protective immune effects, does not prevent foetal loss. It may be that physiological 
levels of glucocorticoids are immunomodudulatory but stress-induced levels are 
immunosuppressive (Webster et al., 2002) and disrupt the maternal immune balance 
threatening pregnancy.  
 
1.8.2 Effect of immune system and peripheral cytokines on the brain and pituitary 
Peripheral sources of cytokines are primarily the immune cells which respond to 
bacteria or other infections. Other sources include cells in the reproductive system 
such as in the ovary, uterus/decidua, placenta, and the pituitary, which secrete 
cytokines in responsive to infective factors and stressors (Parker et al., 2011a). 
Cytokine release following infection/inflammation can directly or indirectly impact 
on reproductive organs, as well as the brain. Cytokines are released into the blood 
system and can thus travel throughout the body. For example, LPS administration 
induces secretion of a number of pro-inflammatory cytokines such as TNF-α, IL-6 
and IL-1β into the circulation. TNF-α is reported to alter ovarian follicular responses 
to gonadotrophins, reducing progesterone secretion and LH receptor mRNA 
(Erlebacher et al., 2004). The pituitary corticotrophs, gonadotrophs and lactotrophs 




Buckingham, 2003, Zaldivar et al., 2011) and may impact on secretion of hormones 
such as ACTH, LH and prolactin (indirectly reducing progesterone).  
 
1.8.2.1 Mechanisms of peripheral cytokines gaining access to the brain 
Circulating peripheral cytokines can profoundly affect the brain. There appears to be 
two main communication pathways to do this: (i) a neural route via the primary 
afferent neurones innervating the site of infection, resulting in cytokine production 
by microglial cells; and (ii) a humeral route involing proinflammatory cytokine 
production/release by phagocytic cells in the circumventricular organs (CVOs) and 
choroid plexus, leading to production of central cytokines that can diffuse into the 
brain parenchyma (Dantzer, 2009). Alternatively they could utilize the specific but 
limited active transport system into the cerebrospinal fluid to gain direct access to 
neurones with cytokine receptors (Ericsson et al., 1995, John and Buckingham, 
2003). In addition, LPS and cytokines may act on the brain by inducing COX2 
expression and thus driving local prostaglandin synthesis in the cerebral 
microvasculature (such as in the brainstem) which drives neuronal activation (Rivest 
et al., 2000, Rivest, 2001). 
 
1.8.2.2 Effect of immune system and peripheral cytokines on the HPA axis 
Immune signals from LPS and cytokines (including TNF-α and IL-1) are able to 
activate the HPA axis. They drive CRH and vasopressin gene expression in the 
hypothalamus, stimulating ACTH secretion from the pituitary and glucocorticoid 
release from the adrenals, thus are considered to be stressors (Brunton and Russell, 
2008). The responses of the brainstem and forebrain to TNF-α and IL-1β are similar 
to LPS, however, IL-6 does not induce activation (Rivest, 2001).  
 
1.8.2.3 Effect of immune system and peripheral cytokines on the dopamine-prolactin 
system 
In the brain and pituitary it is not only the HPA axis that is affected by immune 
signals. In male mice LPS administration i.p reduce prolactin secretion, associated 
with increased activation of noradrenergic brain stem (A1, A2 and A6) and TIDA 




dopamine turnover in the hypothalamic-pituitary axis, along with decreasing 
prolactin secretion, in male mice (de Laurentiis A, 2002).  
 
1.8.3 Expression and roles of central cytokines 
In addition to peripheral cytokines entering the brain, some cytokines are 
constitutively expressed in brain itself (e.g. IL-1, IL-6 and TNF-α) and can therefore 
exert their effects there directly. Cytokines and their receptors are produced in a 
number of cell types in the brain including glia, neurones and macrophages, and in 
several different brain regions including the hypothalamus, hippocampus and 
brainstem nuclei (Schiepers et al., 2005). In contrast to the periphery, genes encoding 
anti-inflammatory cytokines (e.g.IL-10) are expressed at much lower levels than pro-
inflammatory cytokines (e.g. TNF-α) (Szelényi, 2001). 
The exact role of central cytokines is yet to be fully determined, although it is 
thought they have key roles in neuronal cell death and survival (Webster et al., 
2002), neuronal development and plasticity, learning a d memory (Schiepers et al., 
2005). High levels of proinflammatory cytokines can have detrimental effects on 
brain cell function. For example, following CNS insult  IL-1 promotes neuronal 
damage and exacerbates inflammatory processes in the brain by promoting 
production/ release of other proinflammatory cytokines (Anisman and Merali, 2002). 
 
1.8.4 Effect of stress on central cytokines 
In addition to peripheral cytokines, central cytokines are also involved in the 
interaction of the immune system with the HPA axis (see Figure 1.8). Exposure to 
acute stressors increases expression of proinflammatory cytokines both peripherally 
and centrally. LPS peripheral immune stimulation induces expression and 
immunoreactivity of IL-1β protein in the hypothalamus, hippocampus and prefrontal 
cortex in rats (Nguyen et al., 1998) and also rapidly increases TNF-α levels in the 
hypothalamus (Sacoccio C, 1998). In contrast, chronic psychosocial stress reduces 
IL-1β and TNF-α mRNA in the hippocampus in mice (Bartolomucci et al., 2003). 
Thus, the effects of stress on central cytokine expression and activity are dependent 
upon the nature of stressor employed. Stress-induced changes in central cytokines are 
also both region and cytokine specific. For example, only IL-1β, and not TNF-α, was 




inescapable shock (O'Connor et al., 2003). However, regarding pregnancy, it is not 
yet established whether pregnancy alters brain cytokine expression or activity in 
response to stress, or whether central cytokines negativ ly impact directly on 
pregnancy maintenance.   
Consistent with stress-induced alteration in proinflammatory cytokine production, 
evidence indicates that central pro-inflammatory cytokines are involved in stress-
induced physiological and behavioural changes. Proinflammatory cytokines 
produced in response to a pathogen (mainly IL-1, IL-1β, IL-6 and TNF-α) trigger 
‘sickness behaviour’ (Dantzer, 2009) which is often associated with fever, fatigue, 
reduced appetite and depressed mood. The hypothalamus mediates the majority of 
these responses which seem to be due as a result of reprioritizing central factors to 
cope with the sickness (Schiepers et al., 2005). Both systemic and centrally 
administered cytokines are able to trigger ‘sickness behaviour’ response, indicating 
their causal involvement. Mounting evidence also indicates an association between 
proinflammatory cytokines and stress-related disorders e.g. pro-inflammatory 
cytokines administered both centrally and peripherally lead to behavioural alterations 
similar to depression (Capuron and Dantzer, 2003).  
Once again, although cytokines profoundly respond t stress, and stress is a source of 
pregnancy-related anxiety and depression, substantial evidence to provide a 




















































1.9 Thesis aims and hypotheses 
The experiments in this thesis were designed to investigate the effects of stress in 
early pregnant mice on prolactin regulation/activity and the maternal HPA axis. Due 
to the differing secretory profiles of women versus mice we aimed to focus on the 
effect of stress on basal prolactin levels in mice (as women also display steadily 
increasing levels of circulating prolactin during pregnancy but do not experience 
bidaily prolactin surges). Mice were used as a model to investigate the effects of 
stress in early pregnancy, in order to build upon previous studies in this area (e.g. 
(Arck et al., 1995, Joachim et al., 2003).  Day 5.5 of pregnancy was selected as a 
suitable time to study, as it represents very early pregnancy but is 1 day after 
implantation, therefore, it does not interfere with this process. Several 
approaches/experiments were conducted in order to investigate the effects of stress in 
early pregnant mice and the specific aims were: 
 
1. to investigate the effects of stress on prolactin secretion, TIDA neurone 
activation and dopamine activity in early pregnant mice.  
2. to measure the maternal HPA axis responses to stress in arly pregnancy. 
3. to determine the effect of stress in early pregnancy on foetal loss/survival. 
4. to determine the effects of stress in early pregnancy on prolactin negative feedback 
to the TIDA neurones. 
5. to investigate the impact of pregnancy-threatening pro-inflammatory cytokines 
(TNF-α and IL-6) on circulating prolactin and TIDA neurone activation in early 
pregnancy. 
6. to determine the effect of stress on anxiety in early pregnancy.  
 
Hypotheses: 
1. stress negatively impacts on prolactin secretion during early pregnancy and is 
associated with increased TIDA neurone activation and dopamine activity. 
2. HPA axis responses are heightened in early pregnancy vs. virgins. 
3. stress exposure in early pregnancy increases pregnancy f ilure. 
4. stress enhances prolactin negative feedback in early pregnancy. 
5. TNF-α and IL-6 reduce prolactin secretion during early pegnancy and 
increase TIDA neurone activation. 










Chapter 2: General Materials and Methods 
 
2.1 Animals 
Female C57BL/6J mice, weighing between 18-24g (8-10 weeks old), were used in all 
experiments. Mice were purchased from Harlan (Harlan L boratories UK Ltd., 
Leicestershire, UK) or they were obtained from an onsite colony derived from 
Harlan-purchased mice. Mice were housed in groups of 5-6 and maintained under 
standard laboratory conditions (temperature, 19-21oC; humidity, 50-55%) with food 
and water available ad libitum. The mice were under a 12:12hr light/dark cycle 
(lights on from 7am until 7pm). In order to obtain pregnant mice for studies, virgin 
female mice were mated overnight with C57BL/6J stud males. Female mice were 
examined the following morning for evidence of mating and the appearance of a 
vaginal plug was taken as day 0.5 of pregnancy. Mice identified as being plugged on 
the same day were housed together. All experiments were carried out in the early-
mid light phase of the circadian day (9.00-13.00h) in order to avoid the prolactin 
surge on the afternoon of proestrous in virgins and the bi-daily prolactin peaks in 
early pregnant mice. Virgin, day (d)5.5 pregnant (model of post-implantation early 
pregnancy) and d10.5 pregnant (model of mid pregnancy) mice were age-matched 
and selected at random for treatment groups in all experiments. Following the 
experiments and tissue/blood collection, pregnancy was confirmed by laparotomy 
and inspection of the uterine horns for the evidence of implantation sites. Animal 
care and experimental procedures were followed according to institutional guidelines 
and conformed to current requirements of UK Home Office regulations. All 
procedures were approved by the UK Home Office under the Animals (Scientific 
Procedures) Act 1986. 
 
2.2 Anaesthesia (non-recovery) 
Prior to transcardial perfuse fixation and collection of blood by cardiac puncture, 
mice were deeply anaesthetised with an overdose of odium pentobarbitone (short to 
intermediate acting barbiturate) i.p (0.3ml, 54.7mg/ l; Centravet, 22106 Didan, 
France). The needle was carefully inserted into the abdominal cavity, taking care to 






2.3.1 Subcutaneous (s.c) injections 
Subcutaneous injections were performed on the flank of the mouse. Mice were gently 
restrained in a holding bag (disposable icing bag; L keland, Cumbria, UK) and an 
injection (25G needle) made into the fold of loose skin on the flank.  
 
2.3.2 Intraperitoneal (i.p) injection 
Mice were gently restrained in a holding bag and the ventral side exposed. The 
needle (25G) was inserted into the lower abdomen of the mice.  
 
2.4 Stressors 
2.4.1 Immune stress protocol 
Virgin and pregnant (d5.5, d10.5) mice were gently restrained in a holding bag and 
injected with lipopolysaccharide (LPS; 10 or 12.5µg/100µl saline, i.p; E.coli 
E055:B5, Sigma, Poole, Dorset, UK), controls were giv n vehicle (isotonic saline, 
100µl, i.p). Mice were identified using marker pen scores on their tail. Mice were 
then returned to their home cage until sample colletion or further behavioural 
analysis before sample collection. 
 
2.4.2 24h fasting protocol 
Virgin and d5.5 pregnant were fasted for 24h, with food removed from their home 
cage at 10am (3h after lights on), controls were allowed to feed normally. After 24h 
mice were either sacrificed and tissues/blood colleted as required or they were used 
for further behavioural analysis before sample collection. 
 
2.5 Blood collection 
2.5.1 Cardiac puncture 
Once mice were deeply anaesthetised and showing no sig s of breathing (no chest 
movement) and loss of sensory/reflex response (no reaction to toe pinch), the 
abdominal cavity was opened up to expose the still beating heart. A 25G needle was 
inserted into the pointed tip of the heart and ~0.2ml blood extracted and added to a 
microcentrifuge tube (Greiner Bio-One Ltd, Gloucester hire, UK) containing ice-




Poole, UK; 5% solution, 15µl/100µl blood) and aprotinin (a protease inhibitor, 
Sigma-Aldrich Corp., Poole, UK; 0.04 trypsin inhibitor units in 10µl/tube). 
 
2.5.2 Trunk blood 
Mice were gently restrained in a holding bag and quickly decapitated using sharp 
surgical scissors. Trunk blood was collected from the site of decapitation in a 1.5ml 
microcentrifuge tube containing ice-cold EDTA (5% solution, 15µl/100µl blood) and 
aprotinin (0.04 trypsin inhibitor units in 5µl/tube).  
 
2.6 Radioimmunoassay (RIA) 
2.6.1 Progesterone RIA - Kit 1 
A commercial progesterone RIA kit was purchased (DSL-3900, Diagnostic Systems 
laboratories, Texas, USA) for measuring progesterone in mouse plasma. This kit was 
used for the majority of the experiments. However, in 2010 it became unavailable 
and therefore another kit had to be sourced and vali ated (kit 2) for use in the final 
experiment that required progesterone analysis. 
 
2.6.1.1 General principles 
This assay allows accurate measurement of plasma progesterone concentration (assay 
sensitivity 0.12ng/ml) by following the basic princples of RIA where there is 
competition between the radioactively-labelled antigen (I-125 progesterone) and the 
non-radioactively labelled antigen in the plasma, for antibody binding sites. 
Decanting the contents of the anti-progesterone-coated tubes allows separation of the 
bound from the free antigens and thus the amount of the radioactively-labelled 
antigen can be measured using a gamma counter. This is inversely proportional to the 
concentration of non-radioactive antigen that is present in the plasma sample. 
 
2.6.1.2 Method 
Prior to starting the assay, the kit contents were brought to room temperature and 
mixed gently by inversion. Controls and standards were reconstituted in 0.5ml 
deionised water (except 0ng/ml standard which requid 1ml deionised water) and 
were included in each assay run. Values obtained from standards were used to create 




could be derived (example of standard curve is shown in Figure 2.1). Controls were 
included to confirm the validity of the standard curve generated. 
Two uncoated tubes were labelled for total counts ad progesterone-coated tubes 
were labelled for standards, controls and the unknown samples (in duplicate). To the 
appropriate tube, 25µl of standards (0-60ng/ml), controls or samples were pipetted to 
the base. Immediately after this, 500 µl of progesterone I-125 reagent was added in 
the same manner to all tubes and the rack gently shaken to mix the tube contents. 
Following 70 min incubation in a waterbath at 37 oC, all tubes (except total counts) 
were decanted by simultaneous inversion in a foam rack. Tubes were struck sharply 
on absorbent paper and then left to drain for 2 min. Tubes were blotted to remove 
droplets and then counted using a gamma counter (Wizard 1470 Automatic Gamma 
Counter, Perkin Elmer) for one minute.  
 













Values used are taken from the data given by the manufacturer (Diagnostics Systems 
Laboratories) as typical active progesterone standard curve data (DSL-3900). The 
standard curve was generated by plotting % of zero bound (B/Bo) for each standard 
(B/Bo = mean absorbance for standard/mean absorbance for zero standard) against 




















2.6.2 Progesterone RIA - Kit 2 
A second progesterone kit (Progesterone ImmunChem Double Antibody RIA kit; 
MP Biomedicals, LLC, Orangeburg, USA) was purchased as the original kit (kit 1) 
was discontinued. This kit, therefore, required validation. In order to do this controls 
from the original kit, plasma samples previously measured with original kit and 
‘new’ progesterone controls (Control set I, MP Biomedicals, LLC, Orangeburg, 
USA) were included in a test assay.  
 
2.6.2.1 General principles 
This assay works along the same basic RIA principles as kit 1 (see section 2.5.1.1) 




Prior to starting the assay, the kit contents were brought to room temperature and 
tubes labelled appropriately in duplicate. ‘Kit 2’ progesterone standards (Control set 
I, MP Biomedicals) were reconstituted in 5ml distilled water (aliquoted and frozen at 
-20 oC) and ‘kit 1’ controls were reconstituted in 0.5ml deionised water. Plasma 
samples were diluted 1 in 10 with steroid diluent, provided in the kit. Values 
obtained from standards were used to create a standard curve from which the 
concentrations of the unknown plasma samples could be erived (example of 
standard curve is shown in Figure 2.2). Controls were included to confirm the 
validity of the standard curve generated. 
To two tubes, 500µl of steroid diluent and 100µl of the 0ng/ml standard were 
pipetted to the base (to check for non-specific binding, NSB). 100µl of standards (0-
50ng/ml), controls and unknown samples were then added to the appropriate tubes. 
To all tubes (excluding ones for total counts and NSB) 500µl of anti-progesterone 
was added. To all tubes 200µl of progesterone I-125 was added and the tubes 
vortexed before incubating for 60 min in a waterbath t 37 oC. Following incubation 
500µl of precipitant solution was added to all tubes (excluding total counts). Tubes 
were vortexed thoroughly and centrifuged at 1000 x g for 15 min at 4 oC. Tubes were 
then aspirated before precipitate was counted in a gamma counter (Wizard 1470 


















Values used are taken from the data given by the manufacturer (MP Biomedicals) as 
typical active progesterone standard curve data. The standard curve was generated by 
plotting % of zero bound (B/Bo) for each standard (B/Bo = mean absorbance for 
standard/mean absorbance for zero standard) against co centration and a simple 
spline curve/line was fitted using SigmaPlot.  
 
All control measurements from both ‘kit 1’ and ‘kit 2’ were within the limits 
expected for each control. The previously measured plasma samples (measured using 


























Table 2.1: Comparison of measured progesterone controls and plasma samples 








old kit Control I 0.782 1+/- 0.3 
  Control II 9.346 10+/-3 
new kit Control A 0.636 0.48-1.0 
  Control B 11.56 8.0-12.4 
  Control C 21.637 19.7-28.9 
Plasma  mouse 1 17.73 16.8 
  mouse 2 21.3 22.9 
 
Controls from kits 1 and 2 were measured using the new assay (kit 2). The values of 
all the controls (two from kit 1, three from kit 2)were within the expected control 
ranges, verifying the kit was accurately measuring samples. As an extra check, two 
plasma samples that had been measured using the original kit were also analysed. 
The newly read values were <7% different from the previously measured values. 
 
2.6.3 Corticosterone RIA 
2.6.3.1 General Principles 
This assay (Corticosterone ImmunChem Double Antibody RIA kit; MP Biomedicals, 
LLC, Orangeburg, USA) allows accurate measurement of plasma corticosterone 
concentration (assay sensitivity of 10ng/ml). In this assay, a limited amount of 
antibody is reacted with radioactively-labelled corticosterone. In the presence of a 
sample containing corticosterone a corresponding decrease in radioactively-labelled 
corticosterone bound to the antibody is observed, following the basic principle of 
RIA where there is competition between the radioactvely labelled antigen (I-125 
corticosterone) and the non-radioactively labelled antigen in the plasma, for antibody 
binding sites. Decanting the contents of the tubes allows separation of the bound 
from the free antigens and thus the amount of radioactively labelled antigen can be 
measured using a gamma counter (Wizard 1470 Automatic G mma Counter, Perkin 




standard curve). This is inversely proportional to the concentration of non-
radioactive antigen that is present in the plasma sample. 
 

















Values used are taken from the data given by the manufacturer (MP Biomedicals) as 
typical active corticosterone standard curve data. The standard curve was generated 
by plotting % of zero bound (B/Bo) for each standard (B/Bo = mean absorbance for 
standard/mean absorbance for zero standard) against co centration and a simple 
spline curve/line was fitted using SigmaPlot. 
 
2.6.3.2 Method 
Prior to starting the assay the kit components were brought to room temperature and 
tubes labelled as required. Controls (provided in the kit) were reconstituted with 2ml 
distilled water and allowed to stand at room temperature for at least 30 min before 
use. Plasma samples were diluted 1:200 with steroid diluent. 300µl of steroid diluent 
was added to two tubes (for NSB) and 100µl of steroid diluent added to a further two 
tubes (for 0ng/ml standard). 100µl of corticosterone standards (25-1000ng/ml), 
controls and diluted plasma samples were pipetted into the appropriate labelled 
tubes. 200µl of corticosterone I-125 was added to all tubes (excluding two tubes for 
total counts). 200µl of anti-corticosterone was added to all tubes (excluding tubes for 
total counts and NSB). Tubes were vortexed before incubation at room temperature 
Corticosterone (ng/ml)
















for 2 h. Following incubation, 500µl of precipitant solution was added to all tubes 
(excluding total count tubes), and tubes vortexed th n centrifuged at 1000 x g for 15 
min. Tubes were aspirated and rims blotted, before the precipitate was counted in a 
gamma counter (Wizard 1470 Automatic Gamma Counter, P rkin Elmer). 
 
2.7 ELISA 
2.7.1 General principles 
Enzyme-linked immunosorbent assay (ELISA) is a technique employed to detect the 
presence of either an antibody or an antigen in a sample. The basic principle is that 
an unknown amount of antigen is fixed to a surface (usually a 96 well plate) and a 
specific antibody is then added which binds to the antigen. This antibody is linked to 
an enzyme so that when a ‘substance’ is added the enzyme converts it to a detectable 
signal, typically a colour change. 
The two ELISAs used for measuring mouse prolactin and interleukin (IL)-6 (both 
R&D Systems, Inc., Minneapolis, US) were examples of “sandwich” ELISAs (see 
Figure 2.4 for diagram of assay steps).  
 
2.7.2 Prolactin ELISA 
2.7.2.1 Development and validation 
In order to measure prolactin in mouse plasma a DuoSet ELISA kit was purchased  
 (DY1445, R&D Systems, Inc., Minneapolis, US). The mouse prolactin ELISA was 
originally designed for the analysis of prolactin in cell culture supernates, thus it had 
to be adapted and developed for use with plasma. In order to do this a diluent for 
plasma was required as the concentrations of prolactin in plasma exceed the standard 
curve produced from the kit. To find and validate a suitable diluent standard curves 
were generated using phosphate buffered saline (PBS) supplemented with varying 
concentrations (10-50%) of heat-inactivated foetal bovine serum (FBS; Qualified, 
Heat-inactivated FBS; Invitrogen, California, USA) as suggested by R&D Systems. 
Standard curve samples for each diluent were all measur d in triplicate on the same 
96-well plate (Costar EIA plate, DY990, R&D Systems) and construction of standard 
curves (using a 4-parameter logistic curve fit) revealed PBS supplemented with 10% 
FBS gave the best curve fit: r2 was 0.9950 with 10% FBS, 0.9888 with 25% FBS and 






































to be encountered experimentally (see Figure 2.5 for 10% FBS standard curve and 
Figure 2.6). The 10% FBS diluent generated a standard curve with an r2 closest to 1 
(i.e. it fits the recommended standard curve best), therefore this dilution was selected 
for use with in all subsequent assays for standard cu ves and for diluting 
experimental mouse plasma. 
 
Figure 2.5: Example of standard curve for prolactin ELISA 
 
Standard curve generated using 10% FBS diluent. 4-parametric curve fitted as 
instructed by the manufacturer (R&D Systems) with optical density (OD) plotted 
against the concentration of prolactin. 
 
To determine whether the ELISA reported accurate readings for unknown plasma 
samples, spike and linearity experiments were performed. Plasma for validating the 
kit was obtained by sacrificing virgin female C57BL/6J mice (by conscious 
decapitation) and collecting trunk blood (0.4ml) into tubes containing ice-cold EDTA 
(Sigma-Aldrich Corp., Poole, UK; 5% solution, 15µl/100µl blood) and aprotinin 
(Sigma-Aldrich Corp., Poole, UK; 0.04 trypsin inhibitor units in 10µl/tube).  
Blood samples were centrifuged at 1000 x g for 5 min to separate the plasma from 
the other blood components, and the plasma collected and stored at -20oC until use in 




samples with 100ng/ml prolactin (supplied in kit) to test against the standard curve 
generated. In addition, spiked samples were also serially diluted (1 in 25, 1 in 50 and 
1 in 100) to test for linearity (Figure 2.6, Table 2.2). r2 was found to be 0.9925 
indicating a linear relationship with dilution. 
 
Table 2.2. Comparison of expected and measured prolactin concentrations at 









Mouse plasma was spiked with 100ng/ml prolactin and subsequently diluted by 
factors of 25, 50 or 100, in order to confirm that p rallel values are achieved with 
serial dilution. Measured values were found to be within 10% of the expected 
prolactin concentration (100ng/ml). 
 
Plasma samples collected from all subsequent experiments were typically diluted 25-
fold; if data provided for samples were not read from the linear part of the curve 
(falling lower on the standard curve) samples were r assayed at a dilution of 10-fold. 
Sensitivity for this assay was 1.57pg/ml. Inter-assay standards were included on  
every experimental plate to check assay consistency; the coefficient of variation 
between assays was 5.2%. For the ‘spiked’ control, plasma from control virgin mice 
were spiked with 100ng/ml prolactin, diluted x 25 and aliquoted and frozen (-20ºC) 
for use in future assays.  
As a final check of the ELISA, assay samples were coll ted from mice expected to 
have high plasma prolactin concentrations, a positive control. Virgin female 
C57BL/6J mice were injected i.p. with vehicle (isotonic saline; 100µl; n = 6 ) or a 









DF x measured 
prolactin (pg/ml) 





4000.00 4185.44 25 104635.92 104.64 104.64 
2000.00 1803.08 50 90154.12 90.15 90.15 







































n = 6) and were sacrificed by conscious decapitation 30 min later. Trunk blood was 
collected to provide plasma (as described above) and an assay carried out using the 
parameters determined previously for the ELISA kit. Metoclopramide significantly 
increased plasma prolactin concentration, as predicted, ompared to vehicle 
(Student’s t-test, p<0.01; Figure 2.7).  
 
2.7.2.2 Method 
Prior to carrying out the assay all components were brought to room temperature. 
Firstly, a 96-well plate was prepared for use in the assay by coating it with capture 
antibody. The capture antibody (144 µg of goat anti-mouse prolactin) was 
reconstituted in 1ml PBS to form a stock solution (137mM NaCl, 2.7mM KCl, 
8.1mM Na 2HPO4, 1.5mM KH 2PO4; pH 7.2 - 7.4; 0.2 mm filtered) and left for at  
least 15 min before use. Stock was then diluted to a w rking dilution of 0.8µg/ml in 
PBS, or aliquoted and frozen (-20ºC) for future assay . 100µl of diluted capture 
antibody was pipetted (using a multichannel pipette) into each well of the plate, 
plates then sealed (ELISA plate sealers, DY992, R&D Systems) and left to incubate 
at room temperature overnight (~18 h).  
The following day, well contents were decanted by inverting the plate abruptly and 
each well was then washed 3 times with around 0.4ml wash buffer (WA126, Wash 
Buffer Concentrate x25; solution of buffered surfactant with preservatives, 0.05% 
Tween 20 in PBS; R&D Systems; diluted in deionised water) using a squirt bottle. 
Following the last wash the plate was inverted and struck onto absorbent paper to 
remove any remaining wash buffer. The plate was then blocked by adding 300µl of 
Reagent Diluent (DY995, 1% bovine serum albumin (BSA) in PBS, 0.2µl filtered; 
R&D Systems) to each well and the plate incubated a room temperature for 
approximately 1 h 15 min.  During this time the prolactin standard was reconstituted 
with 0.5ml Reagent Diluent (1390 ng/ml prolactin) ad allowed to stand for a 
minimum of 15 min with gentle agitation prior to make dilutions (or aliquoting and 
freezing at -70ºC). A nine-point standard curve wascreated by using a 2-fold serial 
dilution (diluted in 10% FBS diluent as described above) starting with a top high 
standard of 20,000pg/ml. Plasma samples were dilute typically 25-fold using the 
10% FBS diluent also. Following the incubation with Reagent Diluent, the 







































“spiked” control were pipetted into the appropriate w lls of the plate in duplicate, 
plates were sealed and left to incubate at room temperature for 2 h. The 
decanting/washing step was then repeated, before incubation for a further 2 h with 
100µl/well of Detection Antibody (plates sealed). The detection antibody (36 µg 
biotinylated goat anti-mouse prolactin) was reconstituted with 1.0 ml of Reagent 
Diluent and left for at least 15 min before use. Stock was then diluted to a working 
dilution of 200ng/ml in Reagent Diluent, or aliquoted and frozen (-20ºC) for future 
assays. Decanting/wash step was repeated as before. 100µl of streptavidin-
horseradish peroxidase (HRP) was added to each well and plates covered to avoid 
direct light for 20 min at room temperature. Streptavidin-HRP was diluted to a 
working concentration as instructed on the bottle, ypically a 200-fold dilution, with 
Reagent Diluent. The aspiration and wash step was repeated for a final time before 
incubation for a further 20 min with 100µl/well of Substrate Solution (1:1 
combination of Colour Reagent A (H2O2) and Colour Reagent B 
(Tetramethylbenzidine); DY999, R&D Systems), again avoiding direct light (colour 
change from clear to blue). In order to terminate the assay, 50µl of 2N H2SO4 was 
added to each well (colour change from blue to yellow) and the plate read 
immediately to determine the optical density using a microplate reader (PowerWave 
XS, BioTek Instruments, Winooski, Vermont, USA) and software (KC junior, 
BioTek Instruments, Winooski, Vermont, USA) set to a primary wavelength 450nm 
and reference wavelength of 540nm. 
 
2.7.3 Interleukin (IL)-6 ELISA 
2.7.3.1 Development and validation 
The IL-6 DuoSet ELISA kit (DY406, R&D Systems, Inc., Minneapolis, US) was 
also designed for the analysis in cell culture supernat s and thus was developed and 
validated in the same manner as the prolactin ELISA (see section 2.6.2.1). To find 
and validate a suitable diluent, standard curves were g nerated using phosphate 
buffered saline (PBS) supplemented with varying concentrations (10-50%) of heat-
inactivated fetal bovine serum (FBS; Qualified, Heat-in ctivated FBS; Invitrogen, 
California, USA) as suggested by R&D Systems. Standard curve samples for each 
diluent were all measured in triplicate on the same 96-well plate (Costar EIA plate, 




logistic curve fit) revealed PBS supplemented with 10% FBS gave the best curve fit: 
r2 was 0.9999 with 10% FBS, 0.9977 with 25% FBS and 0.9996 with 50% FBS over 
the range of IL-6 concentrations that were expected to be encountered experimentally 
(see Figure 2.8 for 10% FBS standard curve and Figure 2.9).  The 10% FBS diluent 
generated a standard curve with an r2 closest to 1, thus, this dilution was selected for 
use with in all subsequent assays for standard curves and for diluting experimental 
mouse plasma.  
 
Figure 2.8: Example of standard curve for IL-6 ELISA 
 
Standard curve generated using 10% FBS diluent. 4-parametric curve fitted as 
instructed by the manufacturer (R&D Systems) with optical density (OD) plotted 
against IL-6 concentration. 
 
To determine whether the ELISA reported accurate readings for unknown plasma 
samples, spike and linearity experiments were perform as with the prolactin ELISA.  
Samples were created for the spike assays by “spiking” the plasma samples with 
2500pg/ml IL-6 (supplied in kit) to test against the standard curve generated. Spiked 
samples were also serially diluted (1 in 25, 1 in 50 and 1 in 100) to test for linearity 
(Figure 2.9, Table 2.3). r2 was found to be 0.9976 indicating a linear relationship 





Table 2.3. Comparison of expected and measured IL-6 concentrations at three 








Mouse plasma was spiked with 2500pg/ml IL-6 and subsequently diluted by factors 
of 25, 50 or 100, in order to confirm that parallel va ues are achieved with serial 
dilution. Measured values were found to be within 10% of the expected IL-6 
concentration (2500pg/ml). 
 
Plasma samples collected from all subsequent experiments were diluted between 10 
and 50-fold depending on the treatment group. Plasma from LPS-treated mice were 
typically diluted 50-fold (due to high IL-6 levels), while plasma from vehicle and 
fasting/control mice were diluted 10-fold (due to lower IL-6 levels). Sensitivity for 
this assay was 7.81pg/ml. Inter-assay standards were included on every experimental 
plate to check assay consistency; the coefficient of variation between assays was 
4.2%. For the ‘spiked’ control, plasma from control virgin mice was mixed with  
 2500ng/ml IL-6, diluted x 25, aliquoted and frozen (-20ºC) for use in future assays. 
As an additional check of the ELISA, assay samples w re collected from mice 
expected to have high plasma IL-6 concentrations, as a positive control. Spare 
plasma from pseudopregnant mice was used to test th ELISA. These mice had been 
injected with LPS (12.5µg/100µl saline, i.p; E.coli E055:B5, Sigma, Poole, Dorset, 
UK; n = 6) or vehicle (isotonic saline; 100µl; n = 7) and were sacrificed by conscious 
decapitation after 60, 120, or 240 min. Trunk blood was collected to provide plasma 
(as described above) and an assay carried out usingthe parameters determined 
previously for the ELISA kit. LPS treatment significantly increased plasma IL-6 
concentration, as predicted, compared to vehicle (pooled time point data; Student’s t-








DF x measured IL-6 
(pg/ml) 
% of  
Expected 
100.00 95.57 25 2389.21 95.57 
50.00 46.13 50 2306.31 92.25 












































































This assay was carried out in the same manner as the prolactin ELISA. Prior to 
carrying out the assay all components were brought to room temperature. A 96-well 
plate was prepared for use in the assay by coating it with capture antibody. The 
capture antibody (360 µg of rat anti-mouse IL-6) was reconstituted in 1ml PBS to 
form a stock solution (137mM  NaCl, 2.7mM KCl, 8.1mM Na 2HPO4, 1.5 mM KH 
2PO4; pH 7.2 - 7.4; 0.2 mm filtered) and left for at least 15 min before use. Stock was 
then diluted to a working dilution of 2µg/ml in PBS, or aliquoted and frozen (-20ºC) 
for future assays. 100µl of diluted capture antibody was pipetted (using a 
multichannel pipette) into each well of the plate, plates then sealed (ELISA plate 
sealers, DY992, R&D Systems) and left to incubate at room temperature overnight 
(~18 h).  
The following day, well contents were decanted by inverting the plate abruptly and 
each well then washed 3 times with around 0.4ml wash buffer (WA126, R&D 
Systems) using a squirt bottle. Following the last wash the plate was inverted and 
struck onto absorbent paper to remove any remaining wash buffer. The plate was 
then blocked by adding 300µl of Reagent Diluent (DY995, R&D Systems) to each 
well and the plate incubated at room temperature for approximately 1 h 15 min.  
During this time the IL-6 standard was reconstituted with 0.5ml Reagent Diluent 
(90ng/ml IL-6) and allowed to stand for a minimum of 15 min with gentle agitation 
prior to make dilutions (or aliquoting and freezing at -70ºC). A nine-point standard 
curve was created by using a 2-fold serial dilution (diluted in 10% FBS diluent as 
described above) starting with a top high standard of 1,000pg/ml. Plasma samples 
were diluted typically 10 to 50-fold using the 10% FBS diluent also. Following the 
incubation with Reagent Diluent, the decanting/washing step was repeated again. 
100µl of standards, samples and a “spiked” control were pipetted into the appropriate 
wells of the plate in duplicate, plates were sealed n  left to incubate at room 
temperature for 2 h. The decanting/washing step was then repeated, before 
incubation for a further 2 h with 100µl/well of Detec ion Antibody (plates sealed). 
The detection antibody (36 µg biotinylated goat anti-mouse IL-6) was reconstituted 
with 1.0 ml of Reagent Diluent and left for at least 15 min before use. Stock was then 




(-20ºC) for future assays. Decanting/wash step was repeated as before. 100µl of 
streptavidin-HRP was added to each well and plates covered to avoid direct light for 
20 min at room temperature. Streptavidin-HRP was diluted to a working 
concentration as instructed on the bottle, typically  200-fold dilution, with Reagent 
Diluent. The aspiration and wash step was repeated for a final time before incubation 
for a further 20 min with 100µl/well of Substrate Solution (1:1 combination of 
Colour Reagent A (H2O2) and Colour Reagent B (Tetramethylbenzidine); DY999, 
R&D Systems), again avoiding direct light (colour change from clear to blue). In 
order to terminate the assay, 50µl of 2N H2SO4 was added to each well (colour 
change from blue to yellow) and the plate read immediat ly to determine the optical 
density using a microplate reader (PowerWave XS, BioTek Instruments, Winooski, 
Vermont, USA) and software (KC junior, BioTek Instruments) set to a primary 
wavelength of 450nm and a reference wavelength of 540nm (according to 
manufacturer’s instructions).  
 
2.8 BD Cytometric bead array (CBA) 
CBAs were carried out by Evelin Hagen (Charité, Berlin, Germany; Petra Arck lab 
group) using a commercial CBA mouse Th1/Th2 cytokine kit (Catalogue No. 
551287; BD Biosciences, San Jose, CA, USA) for measuring tumour necrosis factor-
alpha (TNF-α) and interferon-gamma (IFN-γ) in mouse plasma.  
 
2.8.1 General principles 
This assay provides a sensitive and precise method of simultaneously detecting 
multiple cytokines from a single sample by capturing them with beads of known 
size/fluorescence (assay sensitivity/limit of detection is 4.5pg/ml for TNF-α and IFN-
γ, up to a maximum of 5,000pg/ml). This makes it possible to detect and measure 
several cytokines from a sample using flow cytometry. Each individual capture bead 
has been previously conjugated to an antibody specific for each cytokine. In addition, 
detection reagents (made up of phycoerythin (PE)-conjugated antibodies) are added 
to the unknown samples/standards, providing a specific fluorescent signal 
proportional to the amount of each bound cytokine (see Figure 2.11). Thus, the 
sandwich complexes formed (bead+cytokine+detection antibody) can be measured 







































bead and the detection antibody. The concentration of each cytokine can then be 
determined by reading off standard curves generated. 
 
2.8.2 Method 
Firstly, the cytokine standards were prepared by reconstituting one vial of lyophilised 
mouse standards with 2ml assay diluent (provided in kit). This top standard was 
allowed to incubate for at least 15min before a nine-point standard curve was created 
by using a 2-fold serial dilution (diluted in assay diluent). Capture beads were mixed 
in equal proportion for each cytokine to be tested, allowing enough for 10µl of each 
per assay tube (including standards and control). Mixed capture beads were then 
thoroughly vortexed and transferred to assay tubes. 50µl of standards and unknown 
samples were added to the relevant tubes. In addition, 50µl of assay diluent was 
added to one tube as a negative control. 50µl of PE detection reagent was applied to 
all reaction tubes, which were incubated at room tep rature for 2 h, protected from 
light. Following incubation, 1ml of wash buffer was dded to each tube and these 
were then centrifuged for 5 min at 200 x g. Tubes wre aspirated and the supernatant 
discarded. The pellets were resuspended in 300µl wash buffer. These samples were 
then passed through a flow cytometer and analysed uing FCAP Array software 
according to manufacturer’s instructions (BD Biosciences). 
 
2.9 Brain tissue processing 
2.9.1 Transcardial perfusion for fixation (for processing by immunocytochemistry) 
Transcardial perfuse fixation is a technique used to preserve tissue and prevent 
decay. The mouse was administered a lethal dose of odium pentobarbital (0.3ml i.p; 
Centravet, 22106 Didan, France). Once the mouse was deeply anaesthetised 
(exhibited no signs of breathing, non-responsive to toe pinch) the heart was exposed. 
The mouse was perfused with heparinised isotonic saline (129mg/L; ~100ml) and 
then fixed with 4% paraformaldehyde (~100ml) using a peristaltic pump. 
The brain was removed carefully from the skull using surgical scissors and 
transferred to a bijou vial containing a 4% paraformaldehyde and 15 % sucrose 
solution. The brain was then stored at 4ºC overnight (or until the brain had sunk to 
the base of the vial). The solution was then exchanged for a 30% sucrose solution in 




sunk). Following this, the brain was removed, rolled in absorbent paper to remove 
excess solution, frozen on foil in dry ice and wrapped in foil before storage in small 
labelled bag at -70ºC. 
 
2.9.2 Flash freezing (for processing by in situ hybridisation) 
Flash freezing is a technique used to freeze samples quickly so as to avoid the 
formation of ice crystals that can damage the tissue. Following brain removal, the 
brain (or other tissues) was placed onto foil sat upon dry ice. The brain was then 
quickly covered in powdered dry ice. Once frozen the brain was wrapped in foil, 
placed in a small labelled bag and stored at -70ºC until use. 
 
2.9.3 Brain sectioning  
2.9.3.1 Microtome sectioning 
Brains that had previously been perfused fixed were s ctioned using a freezing 
microtome (Leica CM 1325, Leica; set at -20 ºC). Coronal brain sections (containing 
paraventricular nucleus (PVN), arcuate nucleus, ventromedial hypothalamic nucleus 
(VMH), and supraoptic nucleus (SON); see Figure 2.12) and brainstem sections 
(containing the locus coeruleus (LC), nucleus tractus solitarius (NTS), and rostral 
ventrolateral medulla (RVLM); see Figure 2.13) were cut at 48µm and divided 
equally (with alternate sections) into 2 pots containing 0.1M phosphate buffer. If the 
sections were to be used straight away in immunocytochemistry they remained in 
0.1M phosphate buffer, however, if they were for use at a later date they were stored 
in cryoprotectant and kept at -70ºC until use. 
 
2.9.3.2 Cryostat sectioning 
Fresh frozen brains required for in situ hybridisation (ISH) were serially sectioned 
using a cryostat (at -16 ºC). Coronal brain sections (15µm) containing the 
hypothalamic PVN (see Figure 2.12 A) were mounted on P lysine microscope slides 
(coated with a permanent adhesive; VWR International, Leicestershire, UK) with 4 
sections per slide. Once 4 sections had been mounted o  the Polysine slide the slides 
were placed into a slide box (VWR) along with a silica bag (to reduce condensation 
ice damage). When the box was full of slides it wassealed with electrical tape and 












locations of areas of interest were confirmed with marker sections collected on 
gelatinised microscope slides (1 marker section for every 8 sections collected). 
Marker slides were dipped in Acetic Alcohol Fixative (AAF) for 10 seconds, rinsed 
with water, stained with 1% toluidine blue for 10 seconds, and rinsed with water 
before examination once dry under a light microscope. 
 
2.10 Immunocytochemistry 
2.10.1 General principles 
Immunocytochemistry (ICC) was first described by Coons et al. (1941) and is still 
used widely in research today. It is a technique used to neuro-anatomically identify a 
given antigen present in a tissue sample (or cytological preparation) by the binding to 
an antibody specific for that antigen. It can be usd to identify neuronal phenotype 
(e.g. tyrosine hydroxylase ICC identifies dopaminergic neurones, see section below) 
and can detect activity of neurones (e.g. Fos and pSTAT5 ICC, see sections below). 
Binding of the antibody to its corresponding antigen is followed by a labelling 
reaction to visualise the antigen-antibody complex, for example, by an enzymatic or 
fluorescently-labelled detection method (Renshaw, 2007). The quality of antibody 
reagents used is of fundamental importance for successful and reproducible staining. 
Antibodies are members of the immunoglobulin (Ig) family of proteins which play a 
central role in the adaptive immune response. Antibody molecules are fundamentally 
Y-shaped in structure, composed of two identical hevy polypeptide chains and two 
identical light polypeptide chains, supported by disulphide bonds (see Figure 2.14 for 
a schematic diagram). Both chain types contain variable and constant domains with 
the variable regions containing most amino acid sequence variation and are the site 
of antigen binding. 
The antibodies may be monoclonal (have an epitope and single antigen binding site) 
or polyclonal (have multiple epitopes and binding sites). The advantage of 
monoclonal antibodies are that they are highly specific for an antigen, however, they 
are difficult to generate successfully and low leves of labelling often occur due to 
low affinity or the fact that the antibody binds to an infrequent epitope on proteins. 
The use of polyclonal antibodies has the advantage of iving high levels of labelling 
for a single antigen due to it containing multiple c ones of antibodies to different 




Figure 2.14: Schematic of the immunoglobulin structure 
 
 
The basic Y-shaped antibody molecule is made up of four polypeptide chains (two 
heavy (H) and two light (L)), stabilised by disulphide bonds (indicated by the black 
circles joined together). The chains contain a number of immunoglobulin domains 
referred to as constant (C) and variable (V). The constant domain is responsible for 
dictating the antibody isotype and contains a conserved amino acid sequence. The 
variable domain contains sequence variation allowing specific antigen recognition 














be less specific as shared epitopes on different proteins (not the antigen of interest) 
may be labelled (Burry, 2010). Thus, it is important to have a suitable antibody that 




There are a number of methods for visualisation of the antigen-antibody complex 
such as the avidin-biotin peroxidase complex (ABC) technique (see Figure 2.15). 
Following exposure to the primary antibody, tissue ections are incubated with a 
biotinylated secondary antibody, followed by an avidin-biotin complex conjugated to 
an enzyme (e.g. horseradish peroxidase). This enzyme then converts the chromogen 
(e.g. diaminobenzidine-tetrahydrochloride (DAB)-nickel) to a coloured precipitate  
(black/dark brown for DAB) at the location of the enzyme, and thus, the antibody-
antigen complex, which can be visualised by light microscopy (Renshaw, 2007). Any 
endogenous peroxidase in the sample needs to be blocked in order to reduce non-
specific background staining (since endogenous peroxidase will also react with the 
chromogen). H2O2 is therefore added to suppress endogenous peroxidase activity, 
without damaging the epitopes present in the tissue. 
When double labelling is required the second primary antibody is visualised using a 
DAB reaction minus the nickel ammonium sulphate. This results in the formation of 
a brown precipitate that can be distinguished from the original black DAB nickel 
ammonium sulphate precipitant (generated for the first primary antibody). 
 
Fos 
c-fos is an immediate early gene and has been extensively used to identify activated 
neurosecretory neurones. It is generally thought that c-fos and its protein product Fos 
are good markers for identifying activated neurons that respond to a number of 
physiological and stress challenges (Kovács, 2008).  
Fos expression in experimental mouse brains and brainstems were typically 
evaluated  90 min after treatment as this is the report d time for peak neuronal Fos 
expression after stimulation (Sharp et al., 1991). By double labelling with tyrosine 
hydroxylase (see below) activation of tuberoinfundibular dopamine (TIDA) neurones 








































Tyrosine hydroxylase is the rate-limiting enzyme in dopamine biosynthesis 
(Anderson et al., 2006a). It is responsible for converting L-tyrosine to  
dihydroxyphenylalanine, which is the precursor for d pamine. Tyrosine hydroxylase 
can be used as a marker for dopaminergic neurones and thus for TIDA neurones, 
which are located in the dorsomedial and ventrolateral r gions of the arcuate nucleus 




Prolactin receptor-mediated signal transduction in TIDA neurons appears to 
exclusively use the transcription factor Signal Transducer and Activator of 
Transcription Proteins 5b (STAT5b) (Grattan et al., 2001b), to stimulate transcription 
of genes such as tyrosine hydroxylase (Ma et al., 2005a).  Prolactin binding to the 
long form of its receptor leads to the phosphorylation of STAT5. Phosphorylated 
(p)STAT5 can be used as a marker for prolactin signalling (negative feedback) in the 
TIDA neurons, when double labelled with tyrosine hydroxylase (Grattan, 2002). 
 
2.10.2 Fos immunocytochemistry protocol 
Brains were sectioned using a microtome (as described in section 2.9.3.1) at 48µm, 
typically stored in cryoprotectant at -20ºC and processed for Fos ICC (as previously 
described in our lab (Brunton et al., 2006)). For ICC, sections were transferred to 
small baskets and placed in petri dishes containing the solution required for each 
step. These were placed on a shaker at 70 rpm for washes. For incubations (e.g. with 
antibodies) sections were transferred to bijou vials and placed on the shaker at 80-
100 rpm. To start, sections were washed in 0.1M phos ate buffer (PB) with 0.3% 
Triton X-100 (PBT; 2 x 5 min, 2 x 10 min PBT) and once in 0.1M PB (5 min). 
Endogenous peroxidase was blocked with 0.3% H202 in 0.1M PB for 15 min. 
Sections were washed in 0.1M PBT (3 x 10 min) and 0.1M PB (1 x 5 min) before 
blocking for non-specific immunoreactivity with 3% normal sheep serum (NSS) in 
0.1M PBT, for 1 h at room temperature. Sections were then incubated in primary 




Cruz, CA; sc-52)(Cai et al., 2010) in 3% NSS in 0.1M PBT (1ml/vial) for 20 h at 
4ºC.   
After ~20 h, sections were washed in 0.1M PBT (4 x 5 min, 2 x 10 min) before 
incubation in biotinylated anti-rabbit immunoglobulin (1:100) and normal goat serum 
(3:100) in 0.1M PBT (Vectastain ABC Elite Kit PK610; Vector Laboratories, UK) 
for 1 h at room temperature. Sections were washed in 0.1M PBT (3 x 5mins) and 
incubated for a further 1 h in an Avidin DH and biotinylated horseradish peroxidase 
complex (1:50; Vector Laboratories; made up at least 30 min before use) in 0.1M 
PBT. Sections were washed in 0.1M PBT (2 x 10 min) and 0.1M sodium acetate (5 
min) before visualisation using diaminobenzidine (DAB; 0.25mg/ml), nickel II 
sulphate (0.025g/ml) and 0.3% H2O2 for approximately 2 min, resulting in black 
labelling of the cell nuclei. The reaction was terminated with 0.1M sodium acetate (5 
min) and the sections washed with 0.1M PB (4 x 5 min, 1 x 10 min) to reduce 
background staining. Sections were serially mounted onto gelatinised microscope 
slides and left to dry overnight. Slides were then passed through a series of ethanols 
(70%, 90%, 95%, 100% and 100%; 5 min each) followed by clearing in xylene (2 x 5 
min). Slides were covered with the mounting medium DPX (Merck-BDH, 
Lutterworth, UK) and glass coverslips (25mmx60mm; VWR). 
 
2.10.3 Fos and tyrosine hydroxylase immunocytochemistry 
Brains were sectioned and processed for Fos immunocytochemistry as described 
above (see section 2.10.2) and tyrosine hydroxylase (Meddle et al., 2000). Following 
the Fos visualisation step, sections were washed in 0.1M PB (6 x 5 min) and 0.1M 
PBT (2 x 5 min). Unreacted peroxidase was blocked with 0.3% H2O2 (15 min) and 
sections washed in 0.1M PBT (2 x 10 min) before incubation with  tyrosine 
hydroxylase primary antibody (anti-tyrosine hydroxylase Rabbit Polyclonal IgG, 
1:4000;  AB152;  Millipore, CA, USA)  in 3% NSS in 0.1M PBT (1ml/vial) for 40h 
at 4ºC.   
Following incubation sections were washed in 0.1M PBT (3 x 10 min) and then 
incubated in biotinylated anti-rabbit immunoglobulin (1:2000; Vector Laboratories, 
Bucks, UK) and normal goat serum (3:2000) in 0.1M PBT for 2 h at room 
temperature. After washes in 0.1M PBT (3 x 10 min), sections were incubated for a 




Vector Laboratories; made up at least 30 min before use) in 0.1M PBT. Sections 
were washed in 0.1M PBT (2 x 10 min) and 0.1M PB (5 min) before visualisation 
using DAB (0.25mg/ml) and 0.3% H2O2 for approximately 2 min, resulting in brown 
cytoplasmic labelling. The reaction was terminated with 0.1M PB (5 min) and the 
sections washed with 0.1M PB (6 x 5 min) to reduce background staining. Sections 
were serially mounted onto gelatinised microscope slid , left to dry overnight, and 
passed through a series of alcohols and xylene. Slides were covered with DPX 
mountant (Merck-BDH, Lutterworth, UK) and glass coverslips (25mmx60mm; 
VWR).  
 
Positive technical controls: spare sections from mice which had previously had other 
sections processed through the ICC protocol were included for individual Fos and 
tyrosine hydroxylase antibody staining and also for d uble staining. 
 
Negative technical controls: Omission of the primary Fos antibody resulted in no 
nuclear immunolabelling. Likewise, omission of tyrosine hydroxylase antibody led to 
no detection of cytoplasmic labelling (see Figure 2.16). 
 
2.10.4 pSTAT5 immunocytochemistry 
A protocol for pSTAT5 (phosphorylated Signal Transducer and Activator of 
Transcription 5) ICC was kindly supplied by Rosemary B own (Grattan Lab, 
University of Otago, NZ)(Brown et al., 2011). Brains were sectioned using the 
microtome (as described in section 2.9.2) at 48µm and typically stored in 
cryoprotectant at -20ºC. Sections were washed in 0.05M Tris-buffered saline (TBS; 3 
x 10 min). Antigen retrieval was carried out by incubating the sections in 0.01M 
Tris-HCL (pH 10) for 5 min at 90ºC (in a waterbath). Sections were left to cool for 5 
min at room temperature before washing for 10 min in ‘incubation solution’ (0.05M 
TBS supplemented with 0.3% Triton X and 0.25% bovine serum albumin (BSA; 
Sigma-Aldrich)). Sections were then washed with TBS (3 x 10 min) before blocking 
endogenous peroxidase with 40% methanol, 9% H2O2 in 0.1M TBS. Sections were 
then washed in 0.1M TBS (3 x 10 min) before incubation with primary antibody 
diluted in ‘incubation solution’ and 2% normal goat serum (1:400, Rabbit Polyclonal 
phosphor-STAT5 (Tyr 694); Cell Signalling Technology, Massachusetts, USA). 








Following incubation, sections were washed 3 times in 0.1M TBS (10 min) and 
incubated in biotinylated anti-rabbit immunoglobulin (1:200; Vector Laboratories; 
diluted in ‘incubation solution’) for 90 min. Sections were washed again in 0.1M 
TBS (3 x 10 min) and 0.1M sodium acetate (5 min) before visualisation using DAB 
(0.25mg/ml), nickel II sulphate (0.025g/ml) and 0.3% H2O2 for approximately 2 min, 
resulting in black labelling in the cell nuclei. Reaction was terminated with 0.1M 
sodium acetate (5 min) and sections washed in 0.1M TBS (3 x 10 min) before 
mounting, and drying. Slides were then covered withDPX mountant (Merck-BDH, 
Lutterworth, UK) and glass coverslips (25mmx60mm; VWR). 
  
2.10.5 pSTAT5 and tyrosine hydroxylase immunocytochemistry 
Brains were sectioned and processed for pSTAT5 ICC as described above (see 
section 2.10.4). Following the visualisation step, the reaction was terminated with 
0.1M sodium acetate (5 min) and sections washed in 0.1M TBS (3 x 10 min) as 
normal. Following this, sections were washed in 0.1M PB (4 x 5 min, 2 x 60 min) 
and 0.1M PBT (2x 5 min). Tyrosine hydroxylase ICC was then carried out as shown 
in section 2.10.3, starting with blocking of un-reacted peroxidase activity with 0.3% 
H2O2. 
 
Positive technical controls: sections of tissue previously processed through the ICC 
protocol were included for individual pSTAT5 and tyrosine hydroxylase antibody 
staining and also for double staining (if possible). 
 
Negative technical controls: Omission of the primary pSTAT5 antibody resulted in 
no nuclear immunolabelling. Likewise, omission of tyrosine hydroxylase antibody 
led to no detection of cytoplasmic labelling (see Figure 2.17). 
 
2.10.6 Immuno-labelled cell quantification 
Slides were coded so the experimenter was blind to treatment and examined under a 
light microscope (20x or 40x objective). Typically 4 sections were analysed per 
mouse for each area of interest (defined using (Franklin K, 1997)). For Fos or 
pSTAT5 single labelling, black or dark grey nuclei were counted as positively 
labelled cells. For double ICC with tyrosine hydroxylase, all cells with brown 







































and without a black/dark grey nucleus). The percentage of doubled labelled tyrosine 
hydroxylase-positive neurons were then calculated (s e Figures 2.16 and 2.17). 
 
2.11 HPLC analysis of DOPAC and dopamine content 
2.11.1 General Principles 
High-performance liquid chromatography (HPLC) is a powerful tool for analysis. It 
is used to separate compounds e.g. monoamines from a mixture to identify, quantify 
and purify specific components. This method can be utilized to determine dopamine 
activity by measuring the DOPAC and dopamine content of the median eminence 




A coronal section (~1mm thick) was cut rostrally from the optic chiasm using a 
mouse brain matrix for each mouse. The median eminence was then extracted from 
the section and immersed in 100µl of ice-cold 0.2 M perchloric acid. The tissue 
sample was homogenised using a polytetrafluoroethylne pestle and a cooled glass 
tissue grinder. This was then placed on ice for 30 min to denature, followed by 
centrifugation at 30,000xg for 15 min at 4oC.  75 µl of supernatant was adjusted to 
~pH 3 with 10 µl of 1M sodium acetate and frozen (-70°C) until the day of analysis. 
After centrifugation, pellets were resuspended in 30µl of distilled water and assayed 
in duplicate for total protein using a Coomassie protein assay kit (Thermo Fisher 
Scientific Inc, Waltham, MA, USA). (This monoamine work was carried out by Dr 
John Menzies, Centre for Integrative Physiology, The University of Edinburgh).  
 
HPLC analysis of DOPAC/Dopamine 
Samples were thawed and then diluted 1 in 2 with 0.02M acetic acid containing 
10µM EDTA. 40ng isoproterenol was added to each standard and unknown sample 
as an internal control. An Eicom HTEC-500 stand-alone HPLC system linked to an 
Eicom Insight autosampler (Eicom Europe, Ireland) was used to measure the 
monoamine content of each sample. Dopamine and DOPAC were separated using a 
reverse-phase Eicompak SC-3ODS 3x100mm analytical column in series with a 




at a flow rate of 400µl/min in a mobile phase composed of 80% 0.1M citrate-acetate 
buffer (pH 3.5) and 20% methanol containing 220mg/l sodium octane sulphonate 
(TCI Europe, Zwijndrecht, Belgium) and 5mg/l EDTA.  n electrochemical detector 
was used to detect voltage offset by applying a +750mV potential through a graphite 
WE-3G electrode at 25oC. Dopamine and DOPAC were eluted within 10min of 
injection and the eluted peaks separated by using mxed monoamine standards 
(dopamine, Tocris, UK; DOPAC, Sigma, UK). A four-point standard curve was run 
daily before and after sample injection as a control. P werChrom chromatography 
software (eDAQ, Poland) was used to record and integra  the signal from the 
detector, which was manually compared to retention times for each monoamine 
standard and converted to a concentration value (pg/ml). Finally, DOPAC:dopamine 
concentration ratios were also calculated. Intra-assay coefficient of variation was 
<10%. (The monoamine analysis was carried out by Dr John Menzies, Centre for 
Integrative Physiology, The University of Edinburgh).  
 
2.12 In situ hybridisation (ISH) 
2.12.1 General principles 
In situ hybridisation (ISH) delivers invaluable information concerning the 
localisation of gene expression in morphologically preserved tissue. It is a very 
sensitive technique and thus allows maximal use of tissues that may be in short 
supply (Wilcox, 1993). DNA is a double-stranded nucleic acid chain, with two 
complementary strands consisting of four deoxyneucleotides, linked by 
phosphodiester bonds. The four bases in DNA are adenine, cytosine, guanine and 
thymidine and these are linked via hydrogen bonds to bind the two strands together 
(adenosine binds to thymidine, cytosine binds to guanine). RNA is a single strand 
nucleotide with thymidine substituted for uradine.  
The principle of in situ hybridisation is specific annealing (hybridisation) of a 
labelled probe to complementary target DNA or RNA sequences present in tissue. A 
number of different types of probes can be used for example riboprobes or synthetic 
oligonucleotide probes.  Riboprobes are prepared by transcription in vitro using 
complementary DNA (cDNA) sequences as a template. Subcloning is used to insert 
the cDNA into a transcription vector and is flanked by two different RNA 




generated.  Oligonucleotide probes are single strands of DNA (20-50 bases) that are 
synthesised then labelled. They are less sensitive than longer riboprobes and thus are 
typically used for detection of relatively abundant gene expression e.g. hormone 
mRNAs.  To detect CRH, nur77 and vasopressin, oligonucleotide probes were used 
that were radioactively labelled (with 35S).  The stability of an oligonucleotide:RNA 
hybrid is dependent on length, composition (% guanosine:cytosine pairs vs. 
adenosine:thymidine pairs), temperature, salt concentration and the number of base-
pair mismatches. The strength of the hybrid is more destabilised with shorter probe 
lengths, lower % guanosine:cytosine content (as guanosine:cytosine pairs have 3 
hydrogen bonds compared to adenosine:thymidine which have 2 hydrogen bonds),  
higher temperatures (can dissociate (melt) probes depending of their stability), and 
increased numbers or mismatched base-pairs (Lewis ME, 1985). 
Following hybridisation with the probe, sections are washed at a temperature 
relevant to the length of the probe (usually 20ºC below the melting temperature of 
the probe used). Detection and visualisation of the nucleic acid hybrids is then 
carried out (see Figures 2.18 and 2.19). The hybrids can be detected by 
autoradiographic emulsion (for radioactively labelled probes) or by histochemical 
chromogen means (for non-isotopically labelled probes) (Jin and Lloyd, 1997).  
 
2.12.2 Method 
In situ hybridisation was carried out (as described in (Douglas et al., 2003, Pincus et 
al., 2010)) to visualise and semi quantify mRNA for the immediate early gene nur77, 
corticotrophin releasing hormone (CRH) and vasopressin. The protocol below was 
used for all three of these, with the temperature of post-hybridisation washes and 

























Making stock and working solutions of unlabelled olig nucleotide probe 
Oligonucleotide probes were synthesised (MWG Biotech AG, Ebersberg, Germany) 
corresponding to mouse CRH mRNA, nur77 mRNA and vasopressin mRNA. The 
probe sequences were complementary to: mouse CRH mRNA (bases 496-537) 5’-
CCT GTT GCT GTG AGC TTG CTG AGC TAA CTG CTC TGC CCT GGC -3’; 
mouse nur77 (bases 201-236) 5’- GTC TCG GGG CTG GCC AGG TCC ATG GTA 
GGC TTG CCG -3’; and vasopressin mRNA (bases 466-501) ’- GAC CCG GGG 
CTT GGC AGA ATC CAC GGA CTC TTG TGT -3’. 
The lyophilised oligonucleotide probes was diluted to 100pmolµl-1using sterile H2O 
(autoclave ddH2O) with stock solution and stored in 10µl aliquots at -20ºC until 
required. On the day of labelling, the stock solutin was diluted to give a working 
solution of 10pmolµl-1 with ddH2O. 
 
3’ end labelling of oligonucleotide probe 
The 3' end of oligonucleotide probes (MWG Biotech AG, Ebersberg, Germany) were 
labelled with 35S-dATP (NEN, PerkinElmer Life Sciences (UK) Ltd, Cambridge, 
UK) using terminal deoxynucleotidyl transferase (TdT; Promega, Southampton, UK; 
25 units per 20pmole of probe). TdT is an enzyme which catalyses the addition of 
nucleotides to the 3’ terminus of a DNA strand without requiring a template and was 
used to label the oligonucleotide probes with radioctivity labelled nucleotides.  
 
The following were put into a sterile microcentrifuge tube, vortexed and incubated 
for 2 h at 37ºC (waterbath): 
35µl sterile ddH2O 
10µl buffer 
2 µl 35S dATP 
2 µl probe 
1µl TdT enzyme (added last to start the reaction) 
 
After 1 h a further 1 µl 35S dATP and1µl TdT were added. Once the incubation was 







Purification Using Spin Columns 
A QIAGEN quick nucleotide removal kit was used to ‘clean-up’ the radioactive 
probe by removing unincorporated nucleotides, salts, nd other contaminants and 
oligonucleotides (>17 nt) and DNA are purified using a bind-wash-elute procedure. 
1µl of each labelling reaction was removed before purification and put it into a 
scintillation tube together with a 3.5ml of scintillation fluid (Ultima Gold) to be 
counted using a β-counter (Packard Tri-Carb, 2500 TR liquid scintilla on analyzer). 
Buffers provided in the QIAGEN quick nucleotide removal kit was used purify the 
probes. 500µl of buffer PN was added to the reaction sample (50µl) and the contents 
transferred into a spin column. The sample was centrifuged for 1 min at 6000rpm and 
the spin column placed into a new collection tube (radioactive flow-through 
discarded). 500µl of buffer PE (containing ethanol) was added to the column and 
centrifuged for 1 min at 6000rpm (radioactive flow-through discarded). This wash 
was repeated with another 500µl buffer PE and the tub (empty) centrifuged for an 
additional 1 min at13,000 rpm. The spin column was pl ced into a clean 1.5ml 
microcentrifuge tube and DNA eluted by adding 50µl buffer EB (elution buffer = 
10mM TrisCl, pH 8.5) or sterile ddH2O to the centre of the spin column. This was 
left to stand for 1 min before centrifuging for 1 min at13,000 rpm, which eluted the 
labelled probe into the micro-centrifuge tube.  Another 1µl sample was removed and 
put it into a scintillation tube together with a 3.5ml of scintillation fluid (Ultima 
Gold). Using scintillation fluid as a blank, both the before and after purification 
samples were counted using the β-counter to calculate the percentage incorporation 
of the radiation. The tubes containing labelled probes with the highest percentage 
incorporation were used for hybridisation later (stored at -20ºC).  
 
Tissue Fixation (section preparation for hybridisaton) 
Slides were removed from freezer and allowed to warm to room temperature before 
slide selection (with the aid of marker slides). Slides were transferred to slide racks 
and placed in 4% paraformaldehyde in 0.1M PBS for 10 min and then washed twice 
in 1x PBS for 5 min. Slides were then incubated in Triethanolamine (TEA; Sigma) 
and acetic anhydride (Sigma) for a further 10 min to help reduce background. Slides 




alcohols: 70% ethanol, 95% ethanol, 100% ethanol, 100% chloroform, 100% ethanol 
and 95% ethanol, all for 3 min. Slides were then thoroughly air dried. 
 
RNase predigestion controls 
Two RNase-treated slides were included to act as negative controls for the ISH. 
RNase (ribonuclease) is an enzyme that catalyses the breakdown and degradation of 
RNA. 2µl of RNase A (Sigma-Aldrich, UK) was added to 2.9ml RNase buffer 
(10mM Tris, 0.5M NaCl, 1mM EDTA). 40µl of the solution was spread onto each 
section (160µl/slide) and slides were incubated for 1 h at 37ºC in a humid chamber. 
Humid incubation chambers were prepared by lining a plastic box (labelled RNase 
only) with moist (ddH2O) filter paper. Slides were arranged on glass platforms. 
Following incubation, the solution was tipped off the slides and they were placed in a 
coplin jar filled with ddH2O for 5 min, before drying. 
 
No probe controls 
As another negative control two slides were included that were not it contact with the 
radioactively-labelled probe (no probe controls). 
 
Hybridisation 
Hybridisation solution was prepared with 45µl required for each slide (based on four 
mouse sections/slide). The sections were hybridised u ing hybridisation solution 
(hybridisation buffer + formamide + diothioreitol) containing the labelled 
oligonucleotide probe (210,000cpm per slide; 45µl per 4 sections). 
The required volume of hybridisation buffer (contaiing formamide) was added to a 
sterile tube. 15µl of DTT per 1ml of Hybridisation Solution was adde along with the 
necessary volume of probe. Specific radioactivity: for nur77 = 923017cpm/pmole 
probe (26.5fmole/µl hybridisation buffer); CRH = 983395cpm/pmole probe 
(29.7fmole/µl hybridisation buffer); and vasopressin = 914412cpm/pmole probe 









Probe Calculations:  
- Total volume of hybridisation mixture required = 45 µl x no. of slides = X µl 
- Hybridisation mixture requires 4615 cpm/µl, therefore,  
Total radioactivity (cpm) required = total volume (X) x 4615 = Y cpm 
- Volume of probe required = Y/labelled probe count = Zµl of probe in X µl of 
hybridisation mixture. 
 
Using a pipette 45µl of hybridisation mixture was added to one end of each slide and 
evenly distributed across the sections using a Nescofilm ‘coverslip’. Two no probe 
slides were coated with hybridisation buffer/DTT only. Slides were then placed into 
the moist chambers and left to hybridise at 37ºC overnight (20hours). 
 
Post-Hybridisation Washes 
Slides were removed from the oven and ‘swept’ back and forth through 1 x SSC to 
remove the Nescofilm coverslip, at room temperature. Th  slides were then ran 
through 2 more rinses (at room temperature) with 1 x SSC before being placed into 
slide racks. A water bath was heated to the appropriate temperature: 58ºC for CRH 
probe and 55ºC for vasopressin and nur77 probes. 1 x SSC was heated and the slides 
in racks rinsed for 4 x 15 min. After the warm washe  slides were rinsed in room 
temperature 1 x SSC for 2 x 30 min washes and finally in ddH2O before slides were 
left to dry. 
 
Dipping slides in autoradiographic emulsion 
Emulsion (Kodak NTB-3) was removed from the fridge and allowed to warm to 
room temperature (~2 h). In a dark room (under light-safe conditions) the emulsion 
bottle was placed into a black plastic pot in a waterbath (40ºC) to melt (~1.5 h). Once 
melted, the emulsion was diluted (3 emulsion: 1 sterile ddH2O) and transferred to a 
coplin jar in the water bath (under safe-light conditions).  Slides were arranged in 
plastic grips and dipped in the emulsion (each for the same length of time). Slides 
were allowed to drip on tissue before transfer to light-tight drying boxes (left 
overnight). Once the emulsion was dry, slides were transferred into slide boxes 
(under safe-light conditions) containing silica bags. Boxes were then sealed with 




either at room temperature (CRH and nur77) or at 4ºC (vasopressin) for the desired 
exposure time (CRH about 6 weeks, nur77 about 4 weeks and vasopressin about 7 
days). 
 
Developing emulsion dipped slides 
Developer (Kodak D19; 157g added to 500ml ddH2O) and fixer (Ilford Hypam rapid; 
diluted 100ml in 400ml ddH2O) were prepared. In the dark room under safe-light 
conditions slides were transferred to plastic racks and placed in fresh developer for 5 
min. Slides were then dipped in ddH2O for 2 sec and placed in fixer (2 x 5min), 
followed by ddH2O (2 x 5 min). Slides were allowed to dry thoroughly before 
counter-staining 
 
Haematoxylin and eosin counterstaining  
Slides were placed in 0.4% haematoxylin (filtered) for 2 min and rinsed in water. 
They were then dipped in acid alcohol, rinsed in water then placed in Scott’s Tap 
Water Substitute for 3 min. Slides were washed in water for 3 min, placed in 1% 
Eosin (filtered) for 2.5 min and rinsed again in water before dipping in potassium 
alum for 2 min. Slides were then rinsed in water and passed through graded alcohols 
(70%, 80%, 95%, 100%, 100% ethanol) for 5 min each before clearing with xylene 
(2 x 5 min). Slides were covered with DPX mountant (Merck-BDH, Lutterworth, 
UK) and glass coverslips (25mmx60mm; VWR). 
 
Negative Controls 
 RNase treated and no probe controls (see Figure 2.20 for example of vasopressin 
controls) showed very little background labelling and no positive cells. 
 
Positive cell counting 
Slides were coded so the experimenter was blind to treatment group. The number of 
positive cells in the area of interest were counted un er a light microscope (40x 
objective). A positive cell was typically identified as one that contained more than 
three times the number of silver grains than the background (area with low signal 
close to the area of interest). The number of positive cells was counted in the area of 
interest (e.g. PVN) in each section (~4 sections per mouse) and mean number of cells 







































Grain Area Analysis 
 The grain area of cells identified as positive were measured using a computer image 
analysis system Open Lab (Improvision Inc, Lexingto, MA, USA). The grain area  
of 20 positive cells (or fewer if <20 positive cells present) per section was measured, 
along with 4 background cells. The average background measurements were 
subtracted from the average positive cell measurements for each mouse to calculate 
the true mean grain density of a positive cell. 
 
2.13 Behavioural testing 
In order to test for anxiety behaviour, two commonly used behavioural tests were 
carried out: the elevated plus maze and the open field test. These both exploit the 
natural aversion of rodents to open areas. 
 
2.13.1 Elevated plus maze 
The elevated plus maze (EPM) is commonly used as an ssay for anxiety-related 
behaviour in rodents. The maze is made up of 2 openarms and 2 closed arms 
(enclosed by a wall). Behaviour in this test reflects the conflict between the 
preference for enclosed protected areas (closed arm) and the motivation to explore 
novel environments (open arm). In contrast to other behavioural anxiety tests which 
rely on noxious stimuli (e.g. electric shock) and normally produce a conditioned 
response, the maze relies on the rodent’s penchant for dark and enclosed spaces and 
an unconditioned fear of open spaces and heights (Walf and Frye, 2007). Anti-
anxiety behaviour can be observed by increased time/activity in the open arm. Motor 
activity can also be determined by recording the number of entries to open and 
closed arms. Discrepancies often arise between conclusions made from studies using 
the EPM, likely reflecting differences in analysis parameters. Therefore, in an 
attempt to better characterise the anxiety behaviour a number different criteria can be 
used including classic temporal and spatial parameters as well as other ethological 
parameters, such behaviours aimed at assessing the presence of danger, risk 
assessment behaviours (e.g. stretched attended posture) (Carola et al., 2002).  
An EPM was constructed for use with mice. It comprised of four arms (2 open, 2 
closed) coming out from a central area (5x5cm square) on a 1m high cross-stand. The 
closed arms were enclosed by walls (15cm high x 30cm long x 5cm wide), while the 




Figure 2.21). Mice were placed into the centre square (neutral area) of EPM and 
allowed to freely move whilst being video recorded from above for 5 min  
(experimenter switched on video and left the behavioural room for 5 min). It has 
been previously demonstrated by Montgomery (1955) that rats display a more robust 
avoidance response in the first 5 min of the test. The behavioural recording was later 
analysed manually for typical anxiety behaviour criteria (Carola et al., 2002), the 
latency to first open arm entry, number of open armentries, total entries (to open and 
closed arms), percentage time spent in each arm (open arm, closed arm), and the 
number of stretch attends performed. Stretch attends represent risk assessment 
involving the mouse stretching its body, from a more p otected area (closed 
arm/neutral zone) towards a less protected area (open arm). 
 
2.13.2 Open field test 
The open field test (OFT) is frequently used to measure anxiety-related behaviour in 
rodents and consists of an empty and bright square/arena, surrounded by walls. The 
OFT task reflects the conflict between the rodent’s i nate fear of the central area 
(open, unknown and potentially dangerous) versus their desire to explore novel 
environments. When anxious, the natural tendency of the rodent is to stay in close 
proximately to the walls of the arena (thigmotaxis). In this context, anxiety-related 
behaviour is measured by the degree to which the rod nt avoids the central area 
(inner zone) of the arena (Choleris et al., 2001). 
The open field test is carried out on an arena: board divided into 25 squares (5 x 5 
squares; 10cm2) with a 15cm high wall (Kimura et al., 2009); see Figure 2.22). The 
central 9 squares are considered to be the inner zone (more anxiogenic) and the outer 
16 squares the outer zones (less anxiogenic). The area was made out of thick 
cardboard and coated in sticky-back plastic to allow cleaning between each mouse 
tested. The mouse was placed onto the central square (in the inner zone) and allowed 
to move freely over the arena whilst being video reco ded for 5 min (experimenter 
switched on video and left the behavioural room for 5 min). The behavioural 
recording was later analysed manually for percentage of time spent in the inner zone, 
number of inner zone entries, the number of crossing  over the grid lines in the inner 
zone, total crossings (to give indication of locomoter activity) and the number wall 










































































2.14 General statistics 
All data is presented as means ± SEM. The statistical tests used are mentioned in 
each chapter. These were typically 1-way ANOVAs, 2-way ANOVAs, and 3-way 
ANOVAs, along with Holm-Sidak post hoc tests. Unpaired Students t-tests or Chi-
squared tests were also used in some cases. P values <0.05 were considered 
significant. Statistical tests were carried out using the programme 































Effects of stress on the hypothalamo-pituitary-adrenal axis 








3.1.1 Control of prolactin secretion 
Prolactin, produced predominantly in the anterior pituitary, is normally under the 
inhibitory control of dopamine, released from neurosecretory hypothalamic 
neurones. TIDA neurones provide the major source of dopamine and are located in 
the arcuate nucleus. They release dopamine from their nerve terminals in the median 
eminence, which diffuses into capillaries of the pituitary portal blood vessels where it 
is then transported to anterior pituitary. Here dopamine inhibits the release of 
prolactin via activating its receptors on lactotrophs (Demarest et al., 1985). 
Dopamine activates its D2 receptors located here to tonically inhibit secretion of 
prolactin (Freeman et al., 2000). A circadian rhythm is apparent in both women 
(Freeman et al., 2000, Ben-Jonathan et al., 2008) and rodents at proestrous (Freeman 
et al., 2000). A preovulatory prolactin surge occurs during the afternoon of 
proestrous in rodents, coinciding with the luteinising hormone (LH) surge (Egli et al., 
2010). Rodents have a different secretory profile to women: during early pregnancy 
in mice it has been shown that serum prolactin increases in a pattern of bi-daily 
prolactin surges. Mating in rats and mice induces a neurogenic reflex consisting a 
large nocturnal and a smaller diurnal a prolactin surge (Grattan and Kokay, 2008, 
Larsen and Grattan, 2010), although studies have reported only a single diurnal surge 
in pseudopregnant mice (Yang et al., 2009).  
As secretory prolactin profiles are known to alter in early pregnancy, we aimed to 
determine if the prolactin response to dopamine diff red from virgins by 
administering a D2 dopamine antagonist to reduce activation of D2 receptors. We 
hypothesised that the prolactin response to the antago ist would be more exaggerated 
in early pregnancy, showing an alteration to the prolactin control system enabling the 
elevated levels of prolactin observed in early pregnancy. In addition, blood samples 
from extra mice administered a dopamine antagonist were also collected to allow 





3.1.2 Effect of stress in early-mid pregnancy on the HPA 
Prolonged exposure to stress in early pregnancy is known to have profound adverse 
effects on reproduction and has been associated with pregnancy failure (Nakamura et 
al., 2008, Parker and Douglas, 2010) and foetal programming (Seckl and Meaney, 
2004). Mice do not experience “abortions”, however, the presence of resorption sites 
in the uterine horns indicate foetal loss. High stre s situations cause the secretion of 
corticotrophin-releasing hormone (CRH) and vasopressin (AVP) from the 
hypothalamus. These two neuropeptides then act synergistically to stimulate the 
secretion of adrenocorticotrophic hormone (ACTH) from the pituitary corticotrophs 
and consequently the release of the stress hormone cortisol (corticosterone in 
rodents) from the adrenal cortex. It is known that t e HPA response to stress is 
attenuated in late pregnancy (Brunton and Russell, 2008, Brunton et al., 2008), 
however, responses are poorly understood in early pregnancy.  
We aimed to investigate the HPA responses in early-mid gestation and to do this we 
used two ethologically relevant stressors, chosen to mimic situations that may 
potentially be experienced by pregnant women: infection/fever or hunger possibly 
arising from malnutrition or hyperemesis. Thus, if experienced during gestation they 
may have detrimental effects on pregnancy maintenance, similar to other stressors 
(e.g. psychological or noise stress (Joachim et al., 2003)). In order to determine the 
effects of stress on the HPA axis in early pregnancy, mice were injected with 
lipopolysaccharide (LPS; immune stress) and mRNA expr ssion was measured for 
hypothalamic CRH, nur77 (immediate early gene and regulator of CRH) and 
vasopressin in the paraventricular nucleus, along with plasma corticosterone and 
progesterone. Progesterone was measured to investigat  he acute effects of stress in 
early pregnancy on the secretory function of the corpus luteum. 
 
3.1.3 Effect of stress in early pregnancy on the prolactin system 
A major candidate to mediate brain-to-body responses to stress is prolactin and its 
hypothalamic control mechanisms. Prolactin is essential for rodents and facilitatory 
in women to enhance the secretion of progesterone, acting as a luteotrophic hormone 
by maintaining the integrity of the corpus luteum following mating. It has been 
reported to be a potent survival factor for human granulosa cells, while reduced 




2003). Prolactin, is involved in a number of other important processes including 
initiation and maintenance of lactation, reproductive behaviour and immune 
modulation (Freeman et al., 2000).  
Typically stress increases prolactin secretion in virgin or male rodents (Freeman et 
al., 2000). However, it has been proposed that stress stimulates prolactin release if 
pre-stress levels are low, but inhibits its secretion if pre-stress levels are high, for 
example, during the proestrous afternoon surge (Gala, 1990). However, Poletini et al. 
(Poletini et al., 2006) have shown that the pattern of prolactin secretion in response 
to stress in female rats depends upon the plasma levels of ovarian steroids rather than 
prestress levels. From the literature it seems that very little work has been carried out 
investigating the effects of stress on the prolactin system in early pregnancy.  
The aim of this study was to determine whether immune stress and/or 24h fast in 
mice decreases prolactin concentration in early pregnancy, corresponding with 
reported stress-reduced progesterone secretion (Joachim et al., 2003), and 
furthermore, whether stress-reduced prolactin is associated with an increase in TIDA 
neurone activation. Stress-reduced prolactin in early pregnancy may represent an 
exciting new target for potential prolactin therapy in early pregnant women 
displaying low prolactin concentrations as this hasbeen linked with an increased 
incidence of miscarriage in women (Douglas, 2010). 
Immunocytochemistry for nuclear Fos, the protein product of the immediate early 
gene c-fos, has long been used to measure neuronal activation (Sagar et al., 1988). 
For the neuroendocrine systems it has provided vital information regarding when and 
where stimuli are processed (Hoffman and Lyo, 2002).  By double-labelling with 
another protein marker it allows activation of specific neuronal cell types to be 
measured. Tyrosine hydroxylase (rate-limiting enzyme in dopamine biosynthesis) 
can be used as a marker for TIDA neurones in the arcuate nucleus (Anderson et al., 
2006a), therefore, Fos-positive tyrosine hydroxylase stained cells indicate neuronal 
activation of these TIDA neurones in the arcuate nucleus. We aimed to use double 
labelling with tyrosine hydroxylase and Fos to determine whether there was an 
increase in activation of TIDA neurones following stre s (LPS and 24h fast) in early 
pregnancy, associated with reduced prolactin. Despit  Fos expression in the TIDA 




secretion (Hollis et al., 2005), Fos is reported to not always provide a good prediction 
of TIDA activation (Hoffman et al., 1994). Therefore, we also measured the 
dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC; dopamine metabolite) 
content in the median eminence and used these and the DOPAC:Dopamine ratio to 
provide more insight into dopamine activity.  
 
3.1.4 Aims and Hypotheses 
 
Aims: 
1. To determine if the prolactin response to dopamine is altered in early 
pregnancy compared to virgins, demonstrating a change in the prolactin 
control system to permit the increased prolactin cocentrations typically 
observed in early pregnancy. 
2. To investigate the HPA axis responses to stress (immune stress) in early-mid 
pregnancy and compare these to virgin mice. 
3. To determine the effect of immune or 24h fast stres on circulating prolactin 
levels in early pregnancy. 
 
 Hypotheses: 
1. The prolactin response to dopamine is attenuated in arly pregnancy vs. 
virgins.  
2. The HPA axis responses to stress will be elevated in early pregnancy 
compared to virgin mice. 
3. Exposure to stress will cause a reduction in prolactin secretion in early 
pregnant mice compared to control and this will be associated with reduced 
progesterone levels and an increase in activation of TIDA neurones.  












3.2.1 Control of prolactin in early pregnancy  
3.2.1.1 Treatment 
A. time responses. Preliminary trials were carried out on virgin mice to test the time-
course of prolactin response to the dopamine antagoist metoclopramide. 
Metoclopramide was dissolved in 0.9% saline (25µg/100µl saline) and a dose of 
1µg/g body weight (or 100µl saline) was administered subcutaneously (s.c.) This
dose has been reported to significantly increased plasma prolactin in mice (Knoferl et 
al., 2000). Mice were returned to their home cage and then sacrificed by conscious 
decapitation after 10, 30, 60 or 120 min (n = 4/group). Trunk blood was collected, 
processed for plasma and stored at -20ºC until assay using the prolactin ELISA. 
 
B. dose responses. Dose-response curves (prolactin response) were generated for 
virgin and d5.5 pregnant mice. Virgin and d5.5 mice were administered various 
doses of metoclopramide (0.1, 0.5, 1, 5, or 15µg/g body weight; s.c; n = 6) and 
returned to their home cages. After 10 min mice were quickly moved to an adjacent 
room and sacrificed by conscious decapitation (10 min ti e-point found to generate 
the largest prolactin peak in the preliminary trial above). Trunk blood was collected, 
processed for plasma and stored at -20ºC until assay with the prolactin ELISA. 
Following blood collection pregnancy status was checked by laparotomy and 
inspection of the uterine horns for evidence of implantation sites. 
 
3.2.1.2 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see general methods section 2.7.2.2) for the mouse prolactin DuoSet 
ELISA (DY1445, R&D Systems, Inc., Minneapolis, US).  
 
3.2.2 Effect of immune stress on plasma hormones, IL-6 and  neuronal activation in 
early pregnancy  
3.2.2.1 Treatment 
Virgin and d5.5 pregnant mice were gently restrained i  a holding bag and injected 
with lipopolysaccharide (LPS; 12.5µg/100µl saline, i.p; E.coli E055:B5, Sigma, 




respectively) and mice returned to their home cages (these mice were used for 
hypothalamic neuronal activation analysis). A second cohort of mice (virgin and d5.5 
pregnant) were treated in exactly the same way to provide plasma and brainstems for 
hormone assays and neuronal activation analysis in the brainstem (these samples 
were not collected from the original set of mice; n = 6). A third cohort of mice 
(virgin and d5.5 pregnant) were treated as before with LPS (n = 8) or vehicle (n = 8, 
9 respectively) and were used to provide median emin nce samples for measuring 
the content of the monoamines dopamine and its metabolite DOPAC. The 
DOPAC:dopamine ratio was used as an additional measur  of dopamine activity 
(Andrews and Grattan, 2003).  
 
3.2.2.2 Blood/tissue collection and perfuse fixation 
After 90 min, mice (from the first two cohorts) were quickly moved to an adjacent 
room and injected with an overdose of sodium pentobarbitone (0.3ml i.p; Centravet, 
22106 Didan, France). Once the mouse was deeply anaesthetised the heart was 
exposed. Blood was removed by cardiac puncture before the mouse was perfused 
with heparinised saline, then fixed with 4% paraformaldehyde (see General Methods 
section 2.9.1) The brain and brainstems were carefully removed and stored overnight 
(4ºC) in 4% paraformaldehyde and 15 % sucrose solution. They were then 
cryoprotected in a 30% sucrose solution at 4ºC overnight and frozen (-70°C). Blood 
was processed for plasma and frozen (-20°C) before assays. Mice from the final 
cohort were killed after 90 min by conscious decapitation and the brains removed 
and processed for HPLC analysis of DOPAC and dopamine content in the median 
eminence (see General Methods section 2.11; monoamie work was carried out by 
Dr John Menzies, Centre for Integrative Physiology, The University of Edinburgh). 
Following blood/tissue collection in the above experim nts pregnancy status was 
checked by laparotomy and inspection of the uterine horns for evidence of 
implantation sites. 
 
3.2.2.3 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.2.2) for the mouse prolactin DuoSet 





3.2.2.4 Progesterone RIA 
Plasma samples (undiluted) were assayed in duplicate using a progesterone RIA kit 
(DSL-3900; kit 1; see General Methods section 2.6.1.2). 
 
3.2.2.5 IL-6 ELISA 
Plasma samples were diluted 1 in 50 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.3.2) for the mouse IL-6 DuoSet ELISA kit 
(DY406, R&D Systems, Inc., Minneapolis, US).  
 
3.2.2.6 Corticosterone RIA 
Plasma samples were diluted 1 in 200 and assayed in duplicate using a 
cortocosterone RIA kit (Corticosterone ImmunChem Double Antibody RIA kit; MP 
Biomedicals) (see General Methods section 2.6.3.2).  
 
3.2.2.7 Brain sectioning, tyrosine hydroxylase/Fos ICC and analysis 
Brains and brainstems (from first two cohorts) were sectioned using a freezing 
microtome (48µm). Coronal brain sections containing paraventricular nucleus 
(PVN), arcuate nucleus, ventromedial hypothalamic nu leus (VMH), supraoptic 
nucleus (SON),  and brainstem sections containing the locus coeruleus (LC), nucleus 
tractus solitarius (NTS), rostral ventrolateral medulla (RVLM) were stored in 
cryoprotectant before double immunocytochemistry (ICC) was carried out for Fos 
and tyrosine hydroxylase (TH) (see General Methods section 2.10.3).  
Using a light microscope (20x or 40x objective) on c ded slides, Fos-positive cells 
(dark grey/black nucleus) were counted in roughly 4 sections per mouse for each area 
of interest (defined using (Franklin K, 1997)). For the PVN, Fos-positive cells were 
quantified for the magnocellular (m) and parvocellular (p) PVN separately. In 
addition to Fos only counts, the arcuate nucleus and the brainstem, were analysed for 
the number of tyrosine hydroxylase-positive cells colo alized with Fos (expressed as 








3.2.2.8 HPLC analysis of DOPAC/Dopamine 
The DOPAC and dopamine content of the median eminence was measured using 
HPLC (see General Methods section 2.11; monoamine analysis was carried out by 
Dr John Menzies, Centre for Integrative Physiology, The University of Edinburgh).  
 
3.2.3 Effect of immune stress in early and mid-pregnancy on HPA axis and pro-
inflammatory cytokine activity  
3.2.3.1 Treatment 
Virgin and pregnant (d5.5, d10.5) mice were gently restrained and injected i.p. with 
either LPS (10µg/100µl saline; E.coli E055:B5, Sigma; n = 9,6,5, respectively) or 
vehicle (100µl saline; n = 9,7,4 respectively) and mice were replaced into their home 
cage. Following 90 min mice were moved to an adjacent room and were immediately 
decapitated (<1 min after removal from home cage). Trunk blood was collected, 
processed for plasma and frozen ( -20 oC). The brains were collected, quickly frozen 
in crushed dry ice and stored at -70oC. Another cohort of virgin and day 5.5 pregnant 
mice were injected i.p with LPS (12.5µg/100µl) (n = 7, 5 respectively) or vehicle 
(saline; n = 5, 5 respectively) and sacrificed 4h later. Brains were collected as before. 
Following sample collection pregnancy status was checked by laparotomy and 
inspection of the uterine horns for evidence of implantation sites. 
 
3.2.3.2 Plasma hormone levels  
Plasma from the 90 min experiment was assayed for corticosterone and progesterone, 
using the same dilutions as described above (see Gen ral Methods section 3.2.2).  
 
3.2.3.3 Proinflammatory cytokine levels 
Plasma from the 90 min experiment was assayed for TNF-α and IFN-γ by cytometric 
bead array (see General Methods section 2.8.2). 
 
3.2.3.4 In situ hybridisation and analysis 
Brains were sectioned (15µm) on a cryostat prior to in situ hybridisation for 
quantitative analysis of CRH and nur77 (stress-induce  immediate early gene) 
mRNA expression in the pPVN (see General Methods section 2.12.2). The second 




Vasopression drives ACTH secretion synergistically with CRH and its response to 
stress is typically seen in vasopressin mRNA after 4h. Coded slides were analysed 
for the number of positive cells and the grain cellarea. The total grain area (µm2) 
was calculated by multiplying the mean number of positive cells by the mean grain 
area.  
 
3.2.4 Effect of immune stress in early pregnancy on pregnancy rate 
3.2.4.1 Treatment 
d5.5 ‘pregnant’ mice (mice where a plug was found o d0.5) were gently restrained 
and injected with either LPS (12.5µg/100µl saline, i.p; n = 11) or vehicle (100µl 
saline, i.p; n = 10). Mice were returned to their home cages. On gestation day 13.5 
mice were quickly moved to an adjacent room and killed by conscious decapitation. 
Trunk blood was collected, processed for plasma and frozen (-20ºC) until use in 
hormones assays.  
 
3.2.4.2 Pregnancy status analysis 
The pregnancy status was established on d13.5 by laparotomy and inspection of the 
uterine horns for healthy foetal development and signs of resorption. Mice were 
considered ‘pregnant’ if they had ≥4 developing foetuses and ‘not pregnant’ if they 
had ≤3 developing foetuses and signs of resorption (see Figure 3.1). 
 
3.2.4.3 Plasma hormone levels 
Plasma samples were measured for prolactin and progesterone using the same 
dilutions as described previously (section 3.2.2). 
 
3.2.5 Effect of 24h fast stress on plasma hormones, IL-6 and neuronal activation in 
early pregnancy  
3.2.5.1 Treatment 
Virgin and d5.5 pregnant mice were fasted for 24h (n = 6, 8 respectively), with food 
removed from their home cage at 10am (lights on at 7am), controls were allowed to 
feed normally (n = 6, 8 respectively). After 24h mice were quickly moved to an 
adjacent room and were sacrificed by conscious decapitation (to provide trunk blood 








































fixed following 24h treatment to provide tissue foranalysis of neuronal activation 
(virgin fast and control, n = 6; d5.5 fast and contr l n = 5, 6 respectively).  
 
3.2.5.2 Blood/tissue collection and perfuse fixation 
For blood collection one cohort of mice were killed by decapitation and their trunk 
blood collected, processed for plasma and frozen (-20ºC) until use in assays. For 
brain collection the second cohort of mice were perfused fixed as described in 
section 3.2.2.2 and brains were frozen before sectioning on a microtome. Following 
blood/tissue collection pregnancy status was checked by laparotomy and inspection 
of the uterine horns for evidence of implantation sites. 
 
3.2.5.3 Plasma hormone and IL-6 levels.  
Plasma samples were measured for prolactin, progesterone and corticosterone as 
previously described (section 3.2.2). Samples were also diluted 1 in 10 and assayed 
in duplicate for IL-6 using the adapted mouse IL-6 DuoSet ELISA (DY406, R&D 
Systems, Inc., Minneapolis, US; see General Methods section 2.7.3.2). 
 
3.2.5.4 Brain sectioning, tyrosine hydroxylase/Fos ICC and analysis 
As described in section 3.2.2, tyrosine hydroxylase nd Fos ICC was carried out on 
coronal brain sections containing the PVN, arcuate nucleus, VMH, and SON, and the 
expression of Fos and tyrosine hydroxylase was analysed. 
 
3.2.6 Effect of 24h fast stress in early pregnancy on pregnancy rate 
3.2.6.1 Treatment 
d5.5 pregnant mice were fasted for 24h (n = 11), with food removed from their home 
cage at 10am (lights on at 7am), controls were allowed to feed normally (n = 10).  
On gestation day 13.5 mice were quickly moved to an adjacent room and killed by 
conscious decapitation. Trunk blood was collected, processed for plasma and frozen 
(-20ºC) until use in hormones assays and the pregnancy status was established. 
 
3.2.6.2 Pregnancy status analysis 
The pregnancy status was established by laparotomy and inspection of the uterine 




‘pregnant’ if they had ≥4 developing foetuses and ‘not pregnant’ if they had <3 
developing foetuses and signs of resorption. 
 
3.2.6.3 Plasma hormone levels  
Plasma samples were assayed for prolactin and progesterone as previously described, 
using the same dilutions (section 3.2.2). 
 
3.2.7 Statistics 
Statistical evaluation of the mean hormone concentrations (prolactin, progesterone 
and corticosterone), IL-6 concentration, neuronal activ tion and mRNA gene 
expression for each group were typically determined by 2-way ANOVAs with a 
Holm-Sidak post-hoc test. Data for DOPAC and dopamine content in the median 
eminence were analysed by 2-way ANOVAs on rank-transformed data, as the 
unranked data failed normaility testing. Prolactin and progesterone data from d13.5 
LPS and vehicle treated mice could not be analysed u ing a 2-way ANOVA (as there 
were no mice in the ‘pregnant’ LPS group) and Student t-tests were carried out on 
the remaining groups. Pregnancy rate was evaluated using a chi square test. p<0.05 
was considered significant. Data are presented as group means±SEM (excluding 




















3.3.1 Control of prolactin secretion in early pregnancy 
3.3.1.1 Effect of metoclopramide on prolactin concentration 
Basal prolactin concentrations did not differ over time after injection of saline. 
Metoclopramide treatment significantly increased plasma prolactin and this varied 
depending on how long after administration mice were sacrificed (2-way ANOVA, 
interaction treatment x group p= 0.025). Mice sacrificed 10 min after 
metoclopramide administration had plasma prolactin levels that were significantly 
higher than the vehicle treated group at the same ti e (Holm-Sidak post hoc test, 
p<0.05 vs. vehicle) (Figure 3.2 A).  
 
3.3.1.2 Effect of pregnancy on dopaminergic inhibition of prolactin secretion 
Administration of increasing doses of metoclopramide elevated plasma prolactin 
concentrations in both virgin and d5.5 pregnant mice (2-way ANOVA, p<0.001 
across dose (treatment), p=0.002 across group; Figure 3.2 B). Prolactin secretion was 
significantly higher in d5.5 pregnant mice, compared to virgins, following 
metoclopramide treatment at the 0.5 and 1.0µg/g doses (Holm-Sidak post hoc test, 
p<0.05 vs. vehicle). Therefore, the dose-response curve was shifted to the left in 
pregnant mice.  
 
3.3.2 Effect of immune stress on plasma hormones, IL-6 and neuronal activation in 
early pregnancy  
3.3.2.1 Prolactin concentration 
Basal prolactin concentration was significantly higher in d5.5 pregnant vs. virgin 
mice (vehicle-treated). LPS treatment had no significant effect on plasma prolactin 
concentration in virgin mice but significantly decrased it in d5.5 pregnant mice (2-
way ANOVA, interaction treatment x group p<0.001; Figure 3.3 A). 
 
3.3.2.2 Progesterone concentration 
Basal plasma progesterone was significantly greater in p egnant vs. virgin mice. LPS 
significantly increased plasma progesterone in the virgin group compared to control. 
In contrast, LPS treatment in d5.5 pregnant mice significantly decreased plasma 








 3.3.2.3 IL-6 concentration 
Basal levels of IL-6 in the plasma were low and similar in both virgin and early 
pregnant mice. LPS treatment significantly increased plasma IL-6 in both groups (2-
way ANOVA, interaction treatment x group p<0.001) although to a higher degree in 
early pregnancy (Holm-Sidak post hoc test, p<0.05 vs. virgin; Figure 3.3 C). 
 
3.3.2.4 Corticosterone concentration  
In both virgin and early pregnant mice the basal corti sterone concentrations were 
similar. LPS treatment significantly elevated plasm corticosterone compared to 
vehicle-treated mice and there was no difference between virgin and pregnant mice 
(2-way ANOVA, p<0.001 across treatment; Figure 3.3 D). 
 
3.3.2.5 Activation of TIDA neurones 
TIDA neurones are located in dorsomedial and ventrolateral regions of the arcuate 
nucleus (see Figures 3.4A and 3.4B). The basal number of Fos-positive neurones per 
arcuate profile was similar in both virgin and pregnant mice and was not significantly 
altered following LPS treatment (2-way ANOVA, ns; Figure 3.4C). The basal level 
of double labelled neurones (presented as  % Fos-positive tyrosine hydroxylase 
neurones) in the arcuate nucleus (TIDA neurones) were also similar in both virgin 
and d5.5 pregnant mice (Figure 3.4D). However, TIDA activation (indicated by 
double-labelling) was significantly increased after LPS in d5.5 pregnant mice only 
compared to control groups (2-way ANOVA, interaction treatment x group p=0.017).  
 
3.3.2.6 Median eminence monoamine content 
DOPAC: The basal levels of normalised DOPAC content (i.e. pg/ml/µg protein) in 
the median eminence appeared to be higher in virgin mice vs. pregnant but this was 
not significant (2-way ANOVA on rank transformed data, ns; Figure 3.5 A). LPS 
treatment appeared to reduce DOPAC content in virgin mice but not significantly so. 
Dopamine: The basal levels of normalised dopamine co tent in the median eminence 
appeared to be slightly higher in virgin mice vs. pregnant but this was not significant 
(2-way ANOVA on rank transformed data, ns; Figure 3.5 B). LPS treatment had no 














































DOPAC:dopamine ratio: The basal DOPAC:dopamine ratio in virgin vehicle-treated 
mice tended to be lower than in early pregnancy, but  this was not significant (2-way 
ANOVA on rank transformed data, ns, Figure 3.5 C). LPS treatment seemed to 
reduce the ratio in virgin mice vs. vehicle (not significant) but it remained unchanged 
in early pregnant mice. 
 
3.3.2.7. Activation of other hypothalamic cell groups 
Supraoptic nucleus (SON): In the SON basal expression of Fos was similar in virgin 
and pregnant mice. LPS treatment significantly increased the number of Fos-positive 
neurones in both virgin and d5.5 pregnant mice withno difference between the two 
groups (2-way ANOVA, p<0.01 across treatment; Figure 3.6). 
Paraventricular nucleus (PVN): Basal Fos expression in the mPVN was higher in 
pregnant vs. virgin mice.  LPS treatment elevated Fos expression in virgin and 
pregnant mice but the increase was not significant in pregnancy (2-way ANOVA, 
p<0.05 interaction treatment x group; Figure 3.7). Basal Fos expression in the pPVN 
was increased in pregnant vs. virgin mice also. LPSincreased the number of Fos-
positive neurones in both groups, with no significant difference between virgin and 
pregnant mice (2-way ANOVA, p<0.01 interaction treament x group; Figure 3.7).  
Ventromedial hypothalamus (VMH): Basal Fos expression in the VMH was similar 
in both virgin and early pregnant mice. Following LPS treatment Fos expression was 
significantly increased in virgin mice but not in d5.5 pregnant mice, although there 
being no significant difference between LPS-treated virgin and pregnant mice (2-way 






























3.3.2.8. Activation of tyrosine hydroxylase-positive cell groups in the brainstem 
Locus coeruleus (LC): Basal expression of Fos-positive nuclei was similar in both 
virgin and early pregnant mice. LPS treatment increased the number of Fos-positive 
cells in both groups but was only significant in the virgin mice vs. vehicle (2-way 
ANOVA, p<0.001 across treatment; Figure 3.9). Basal expression of Fos-positive 
tyrosine hydroxylase (TH) neurones (%) in the LC was similar between virgin and 
pregnant mice. Following LPS treatment expression was significantly increased in 
both groups (2-way ANOVA, p<0.001 across treatment) with no significant 
difference between the two groups.  
Nucleus tractus solitarius (NTS): In the NTS, basal expression of Fos was similar in 
both virgin and pregnant mice. LPS treatment signifcantly increased the number of 
Fos-positive cells similarly in virgin and early pregnant mice (2-way ANOVA, 
p<0.001 across treatment; Figure 3.10). Basal expression of Fos-positive TH 
neurones (%) was not significantly different between pregnant and virgin mice. After 
LPS, expression was increased in both groups with the response greater in pregnant 
mice vs. virgins (2-way ANOVA, p<0.05 across group, p<0.001 across treatment).  
Rostral ventrolateral medulla (RVLM): In the RVLM, basal expression of Fos was 
similar in both virgin and pregnant mice. LPS treatment significantly increased the 
number of Fos-positive cells similarly in both virgin and pregnant mice (2-way 
ANOVA, p<0.001 across treatment; Figure 3.11). Basal expression of Fos-positive 
TH neurones (%) was also not significantly different between pregnant and virgin 
mice. After LPS, expression was elevated in both groups with a greater response in 





































3.3.3 Effects of stress in early and mid-pregnancy on HPA axis and proinflammatory 
cytokine activity  
3.3.3.1 Corticosterone concentration 
At 90 min basal corticosterone concentrations were similar in virgin and pregnant 
groups and LPS-injected mice exhibited significantly increased corticosterone 
concentration vs. vehicle controls in all groups (2-way ANOVA, p<0.001 across 
treatment; Holm-Sidak post hoc, p<0.05 vs. virgin and d5.5 LPS; Figure 3.12 A).  
 
3.3.3.2 Progesterone concentration 
Basal plasma progesterone concentration was significa tly greater in pregnant groups 
(d5.5 and d10.5) vs. virgin. Plasma progesterone lev ls were significantly increased 
by LPS treatment in virgin mice but significantly decreased by LPS in pregnant mice 
compared to vehicle (2-way ANOVA, interaction treatment x group p<0.01; Figure 
3.12 B). There was not a significant difference between LPS-treated groups. 
 
3.3.3.3 TNF-α and IFN-γ concentration 
At 90 min basal TNF-α levels in the plasma were similar between virgin and
pregnant groups. LPS-injected mice exhibited significantly increased TNF-α levels 
vs. vehicle in virgin and pregnant groups, although the stress-induced levels were 
higher in virgin compared to both pregnant groups (2-way ANOVA, interaction 
treatment x group p<0.001; Holm-Sidak post hoc, p<0.05 vs. virgin; Figure 3.12 C). 
Basal interferon-gamma (IFN-γ) levels were similar between all groups and LPS 
treatment had no significant effect on circulating IFN-γ concentrations (2-way 
ANOVA, ns; Figure 3.12 D). 
 
3.3.3.4 PVN gene expression 
nur77: In the pPVN, the basal number of nur77-positive cells (Figure 3.13 A-D) was 
similar in virgin and pregnant mice and LPS significantly increased the number of 
nur77-positive cells in all groups (2-way ANOVA, p<0.001 across treatment; Figure 
3.13 E). Grain area per cell was higher in virgin vs. pregnant vehicle treated mice 
and was increased by LPS treatment in all groups, however, this response was 








p<0.001 across treatment; Holm-Sidak post hoc test, p<0.05 vs. virgin LPS; Figure 
3.13 F). Basal nur77 mRNA total expression was slightly higher in vehicle-treated 
virgins compared to pregnant (d5.5 and d10.5) mice. LPS significantly increased 
expression in all groups compared to vehicle, however, the response in pregnancy 
was attenuated compared to virgins (2-way ANOVA p<0.05 across group, p<0.001 
across treatment; post hoc p<0.05 vs. virgin LPS ; Figure 3.13 G), primarily due to 
attenuated grain area per cell.  
CRH: In the same group of mice, following vehicle treament, the number of CRH-
positive cells and grain cell area in the pPVN (Figure 3.14 A-D) were similar 
between virgin and pregnant mice. LPS treatment did not significantly alter the 
number of CRH-positive cells in the pPVN of any group (2-way ANOVA, p=0.056 
across treatment; Figure 3.14 E) or the grain area per positive cell (2-way ANOVA, 
ns; Figure 3.14 F). Basal CRH mRNA total expression in the pPVN did not differ 
between pregnant and virgin groups. However, LPS significantly elevated the total 
CRH mRNA expression in virgins whilst having no significant effect on expression 
in early-mid pregnancy. Therefore, LPS-induced CRH expression in early-mid 
pregnancy (like nur77) was significantly attenuated compared to virgin mice (2-way 
ANOVA, p<0.05 across treatment, p<0.05 across group; Figure 3.14 G).  
Vasopressin: In mice from the 4h study, basal levels of vasopressin-positive cells and 
grain area (Figure 3.15 A-B) were similar between virgin and d5.5 pregnant mice. 
LPS significantly increased the number of vasopressin-positive cells in the pPVN of 
both virgin and d5.5 pregnant mice (2-way ANOVA, p<0.001 across treatment; 
Figure 3.15 C). The grain area per positive cell was also increased following LPS in 
both groups, although the response was attenuated in pregnant compared to virgin 
mice (2-way ANOVA, p<0.001 across treatment; Figure 3.15 D). The basal total 
vasopressin mRNA in the pPVN was similar between vehicl -treated d5.5 pregnant 
mice and virgin mice. LPS significantly elevated vasopressin mRNA expression in 
virgin and pregnant mice (2-way ANOVA, p<0.001 across treatment; Holm-Sidak 































3.3.4 Effect of LPS stress in early pregnancy on pregnancy rate 
3.3.4.1 Pregnancy rate analysis on d13.5 
LPS treatment significantly decreased the pregnancy rate from 70% (vehicle-treated) 
to 0 % by gestation day 13.5 (Chi-square p<0.01 vs. vehicle; Figure 3.16A).  
 
3.3.4.2 Prolactin concentration on d13.5 
As there were no mice in the pregnant LPS group (due to occult foetal loss) a 2-way 
ANOVA was not carried out. Student t-tests showed that here was no significant 
difference in plasma prolactin levels between the vehicle-treated pregnant and ‘non-
pregnant’ mice (identified as plugged but have ≤3 developing foetuses at d13.5) and 
no difference with treatment in the ‘non-pregnant’ mice at d13.5 (Figure 3.16 B). 
 
3.3.4.3 Progesterone concentration on d13.5 
Vehicle-treated mice had significantly reduced progesterone in non-pregnant mice 
vs. pregnant (p=0.001, students t-test). There was no significant difference with 
treatment in the non-pregnant at d13.5 (Figure 3.16C). 
 
3.3.5 Effect of 24h fast stress on plasma hormones a d neuronal activation in early 
pregnancy  
3.3.5.1 Prolactin concentration  
Basal prolactin concentration was significantly higher in d5.5 pregnant vs. virgin 
mice (controls). 24h fast treatment had no significant effect on plasma prolactin 
levels in virgin mice but it significantly decreased prolactin secretion in d5.5 
pregnant mice (2-way ANOVA, interaction treatment x group p<0.01; Figure 3.17 
A). 
 
3.3.5.2 Progesterone concentration 
Basal plasma progesterone was significantly greater in d5.5 pregnant vs. virgin mice. 
24h fast did not alter the concentration of progesterone in virgins vs. control, 
however, fasting significantly decreased plasma progesterone in d5.5 pregnant mice 








3.3.5.3 IL-6 concentration 
IL-6 concentrations of control mice were similar betw en virgin and pregnant mice. 
24h fast treatment had no significant effect on plasm  IL-6 concentration in virgins, 
however, it significantly increased plasma IL-6 in d5.5 mice (2-way ANOVA, 
p<0.05 interaction treatment x group; Figure 3.17 C). 
 
3.3.5.4 Corticosterone concentration 
In both virgin and d5.5 pregnant mice the basal cortic sterone concentrations were 
similar. 24h fast treatment significantly elevated corticosterone secretion compared 
to control mice (2-way ANOVA, p<0.001 across treatment; Figure 3.17 D). 
 
3.3.5.5 Activation of TIDA neurones 
The basal number of Fos-positive neurones per arcuate profile (Figure 3.18 A-B) was 
similar in both virgin and pregnant mice and increased following 24 fast similarly in 
both groups, confirming the expected response to hunger (Johnstone et al., 2006) (2-
way ANOVA, p<0.001 across treatment; Figure 3.18 C). The basal levels of 
neurones double labelled for Fos and tyrosine hydroxylase (expressed as % Fos-
positive tyrosine hydroxylase cells) in the arcuate nucleus (TIDA neurones) were 
similar in both virgin and d5.5 pregnant mice. However, % double-labelled cells 
(activated TIDA neurones) were significantly increas d by 24h fast treatment in d5.5 
pregnant mice only compared to controls (2-way ANOVA, p<0.05 across treatment; 
Holm-Sidak post hoc test p<0.05 across treatment in pregnant group; Figure 3.18 D).  
 
3.3.5.6. Activation of other hypothalamic cell groups 
Supraoptic nucleus (SON): In the SON basal expression of Fos was similar in virgin 
and pregnant mice and 24h fast had no significant effect on either group (2-way 
ANOVA, ns; Figure 3.19). 
Paraventricular nucleus (PVN): Basal Fos expression in the mPVN and pPVN were 
not altered by either pregnancy or 24h fast treatmen  (2-way ANOVA, ns; Figure 
3.20).  
Ventromedial hypothalamus (VMH): Basal Fos expression in the VMH was similar 
in both virgins and early pregnant mice and 24h fast did not significantly alter 


































































3.3.6 Effect of 24h fast stress in early pregnancy on pregnancy rate 
3.3.6.1 Pregnancy rate analysis on d13.5 
24 h fast decreased the pregnancy rate from 70% (control) to 36% by day 13.5, this 
was however not a significant reduction (Chi square, not significant; Figure 3.22A).  
 
3.3.6.2 Prolactin concentration on d13.5 
Basal levels of plasma prolactin at d13.5 were similar between pregnant and ‘non-
pregnant’ mice. 24h fast increased plasma prolactin in the ‘non-pregnant’ group vs. 
vehicle. The ‘non-pregnant’ fast group also had higher prolactin levels than the 
pregnant fasted mice (2-way ANOVA, p<0.01 interaction treatment x group; Holm-
Sidak p<0.05 non-pregnant fast vs. non-pregnant vehicle and vs. pregnant fast; 
Figure 3.22B). However, statistics should be interpr ted with caution as no 
significant difference was found in the 2-way ANOVA between groups or between 
treatments alone.  
 
3.3.6.3 Progesterone concentration on d13.5 
Pregnant mice had significantly higher plasma progesterone at d13.5 vs. ‘non-
pregnant’ mice, while there was no difference with LPS treatment (2-way ANOVA, 
























3.4.1 Control of prolactin secretion in early pregnancy 
Post-implantation, dopamine antagonist treatment result d in a shift to the left of the 
prolactin dose-response curve. Thus, blocking dopaminergic D2 receptors evoked a 
higher response in prolactin release in early pregnant compared to virgin mice. This 
hyper-responsiveness to metoclopramide in early pregnancy may suggest a lower 
dopamine tone, decreased tyrosine hydroxylase expression, or a reduced 
DOPAC:dopamine ratio. However, a reduction in basal dopamine activity may be 
unlikely given the continued stimulation/feedback by prolactin in early pregnancy. It 
may be that the TIDA neurones themselves are less responsive to prolactin, as they 
are in late pregnancy, when this allows a nocturnal prolactin surge the day before 
parturition  (Grattan et al., 2008), thus contributng towards the higher basal prolactin 
observed in early pregnancy compared to virgins (Freeman et al., 2000, Ben-
Jonathan et al., 2008). Other potential explanations nclude altered dopaminergic D2/ 
prolactin receptor number or sensitivity at the lactotrophs/TIDA neurones. However, 
this experiment can neither confirm nor reject these possibilities. In situ hybridisation 
could be used to determine whether there is down regulation of D2 or PRL-R gene 
expression due to stress in early pregnancy, however this may not be likely as this is 
not what causes the reduced sensitivity to prolactin observed in late pregnancy 
(Kokay and Grattan, 2005). 
It is only at lower doses that we see a difference between early pregnant and virgin 
mice. This is possibly because at higher doses a much larger proportion of D2 
receptors are blocked in both virgin and pregnant groups and therefore, regardless of 
the number of receptors, sensitivity or basal dopamine present, the maximum 
prolactin response has been attained.  
This experiment did not include a ‘no dopamine antagonist’ control for pregnant 
mice, which means it is difficult to make a comparison between the basal levels of 







3.4.2 Effects of stress on HPA axis and proinflammatory cytokine responses in early 
pregnancy 
The stressors used were selected as being ethological y relevant to women, 
mimicking potential situations that could arise in pregnancy, including infection or 
hunger. Both immune stress and 24h fasting stress activated the HPA axis, increasing 
corticosterone secretion, as expected, in both virgins and early-mid pregnancy 
(Neumann et al., 1998, Brunton et al., 2008). Therefore, it is not until later in 
gestation that HPA axis responses to stressors are attenuated, as previously shown in 
mice (Douglas et al., 2003), rats (Nakamura et al., 1997, Douglas et al., 2003, 
Brunton et al., 2005, Brunton et al., 2008) and women (de Weerth and Buitelaar, 
2005). In addition, we show that circulating levels of the proinflammatory cytokines 
IL-6 and TNF-α were significantly increased by treatment with LPS. TNF-α has been 
implicated to act as a mediator of stress-induced fo tal death in early pregnancy. It 
has been proposed that TNF-α boosts death signalling to kill an embryo if initial 
stress/events may result in structural anomalies to the foetus, in turn it may stimulate 
protective mechanisms if the repair of these damages may prevent maldevelopment  
(Toder et al., 2003, Torchinsky et al., 2005). It has been recently found that LPS 
treatment in early pregnant mice caused haemorrhages in the placenta and increased 
the risk of pregnancy loss. In addition, foetuses that did survive show evidence of 
hypoxia in the brain and impaired foetal neurogenesis, which was found to be 
dependent upon TNF-α  receptor 1 (TNFR1). TNF-α antagonist treatment prevented 
the placental pathology and foetal loss suggesting that in early gestation the placenta 
is highly sensitive to proinflammatory signalling. Furthermore, TNF-α inhibition 
may be an effective prophylactic measure to avoid maternal infection-induced 
placental defects and associated risks to the developing foetus, including miscarriage 
and foetal brain development (Carpentier et al., 2011). 
IFN-γ, another proinflammatory cytokine, is released in the uterus from natural killer 
cells in the maternal endometrium, in early pregnancy. In mouse pregnancies it is 
reported to play an important role in initiation of endometrial vascular remodelling, 
angiogenesis at implantation sites and maintenance of the placenta. In humans, 
alterations of these events are believed to contribute to serious complications e.g. 




pregnancy did not alter the levels of IFN-γ. TNF-α (and IL-6) are not the only 
cytokines that have altered secretion following immune stress in early gestation. LPS 
is known to stimulate production of many cytokines by macrophages (Andersson et 
al., 1992). For example, LPS administration to rodents has been reported to increase 
IL-1β,  IL-6 and TNF-α, although in late gestation elevated IL-1β and IL-6 are not 
apparent following LPS treatment (Fofie et al., 2005). 
Glucocorticoids are reported to exert adverse effects in late pregnancy on the 
placenta and foetus, however, their effect in early p egnancy is less well defined. In 
early gestation, it has been suggested that the actions of glucocorticoids are balanced 
between positive pregnancy-protective effects (e.g. suppression of natural killer cells 
(Krukowski et al., 2011)) and adverse pregnancy-threatening effects (e.g. restriction 
of trophoblast invasion) (Michael and Papageorghiou, 2008). This experiment does 
not clarify the role of glucocorticoids but implies that high levels are possible at this 
stage in pregnancy and they may be detrimental to reproductive success. 
In women acute psychosocial stress elicits a robust HPA response in early-mid 
pregnancy  (Nierop et al., 2006). Acute physical (water immersion), immune (LPS) 
or emotional (restraint) stress induces a strong HPA axis secretary response in early-
mid pregnant rodents although this response is attenua d in late pregnancy 
(Nakamura et al., 1997, Neumann et al., 1998). Prolonged or chronic stress is thought 
to cause long-term detrimental effects on the mother and/or offspring (Douglas, 
2010). This has not been directly tested on women due to ethical concerns, although, 
a correlation between stress perception and cortisol levels show blunted salivary 
cortisol levels in early pregnant women reporting to have experienced chronic 
stressful life events (Obel et al., 2005). In contras , rats exposed to repeated chronic 
social stress prior to mating, display elevated corti sterone levels during the first 
half of pregnancy (Stefanski et al., 2005). Unfortunately neither of these papers 
report pregnancy outcome statistics. 
Analysis of the hypothalamic responses of the HPA axis to immune stress in early 
pregnancy was carried out. Unexpectedly, nur77 and CRH mRNA responses in the 
pPVN to LPS were significantly attenuated in early-mid gestation compared to 
virgins, extending previous reports of attenuated responses in late pregnancy 




from increased opioid inhibition and allopregnanolone levels (Brunton and Russell, 
2008). However, raised opioid inhibition and allopregnenalone is only apparent later 
in pregnancy and thus cannot be held accountable for our response in early 
pregnancy (Douglas et al., 1995, Brunton et al., 2009). Although, allopregnanalone 
levels in the blood/ brain may increase in early pregnancy as a result of mating 
behaviours (Frye et al., 2007), treatment with  progesterone is unable to reduce stress 
responses of ovary-intact virgin rats (Douglas et al., 2000). On the other hand, the 
attenuated response may be related to the post-mating neurogenic reflex experienced 
in female rodents which induces peaks of gonadotrophin secretion by altering 
noradrenaline release from the  brainstem (Cameron t al., 2004, Szawka et al., 
2005). Immune stress is relayed to the HPA axis predominantly via brainstem 
noradrenaline pathways, therefore, pregnancy-induced changes in pathway signalling 
may compromise the response to immune stress, includi g PVN CRH neuronal 
response. 
A dissociation between hypothalamic nur77/CRH mRNA and secretory 
corticosterone (via pituitary ACTH) responses to immune stress in the peri-
implantation period was demonstrated. This confirms and extends previous studies in 
late pregnant rats showing similar corticosterone secretory responses but reduced 
CRH release (Nakamura et al., 1998, Neumann et al., 1998). It also supports previous 
findings that median eminence CRH content remains unchanged following stress in 
early pregnant rats, implying that stress did not ev k  a CRH response/release 
(Nakamura et al., 1997). As CRH responses were shown t  be attenuated very early 
in pregnancy it is plausible to deduce that the CRH neurone responses are adapted 
by/under the influence of early pregnancy factors such as the mating-induced 
neurogenic reflex, pregnancy hormones and cytokines. Conversely, vasopressin 
responses to the immune stress remained robust, with LPS inducing increased 
vasopressin mRNA expression in both early pregnancy d virgins, to a similar level. 
This is intriguing as vasopressin has been found to be synthesised in some of the 
same pPVN neurones as CRH and appears to be co-released with CRH at the median 
eminence (Wang and Majzoub, 2011). Vasopressin alone in the absence of CRH 
appears to drive the high corticosterone responses observed.  In addition, it is thought 




to act directly at the pituitary and adrenals to induce hormone secretion directly, thus 
bypassing the PVN (John and Buckingham, 2003).  
nur77 is a putative regulator of CRH (Douglas et al., 2003),  has been shown to bind 
and regulate the expression of the promoters for both CRH and POMC and is thought 
to play an important role in the neuroendocrine regulation of HPA axis activity 
(Murphy and Conneely, 1997). In addition, CRH is alo known to regulate and 
induce  nur77 expression (Kovalovsky et al., 2002). Vasopressin’s relationship with 
nur77 is less clear. The vasopressin gene promoter sequence contains a putative 
nur77 element (also present in the CRH gene), however, in vitro studies found that 
removal of this did not affect regulation of the vasopressin promoter (Iwasaki et al., 
1997), implying nur77 is not involved in vasopressin control. 
Vasopressin processing/analysis in d10.5 pregnant mice was not carried out and it 
may have been useful to further support similar gene r sponses in early and mid-
pregnancy. Also the vasopressin analysis was carried out on a different cohort of 
mice than for CRH/nur77 which is not ideal for direct comparison. However, mice 
were purchased from the same supplier, housed in a similar environment and age 
matched. As in situ hybridisation analysis may be interpreted differently between 
experimenters, only one person carried out all analysis for every gene in order to 
reduce variability and allow more precise group/gene comparisons. In situ 
hybridisation provides information regarding the prsence of mRNA markers for a 
gene of interest. However, this is not a measure of the actual peptide content or of its 
release and it is possible that it does not directly reflect these. In addition, slightly 
different LPS doses were given (10 vs. 12.5µg/mouse) in ach experiment. However, 
both are high doses and have previously been shown to induce murine foetal loss 
(Silver et al., 1994, Parker and Douglas, 2010).  
 
3.4.3 Effect of stress on pregnancy hormones and TIDA neuronal activation 
In contrast to HPA axis hormones, key pregnancy hormones were dramatically 
reduced by both immune and 24h fast stress in earlypregnancy. Plasma progesterone 
was significantly decreased by stress on gestation d5.5, confirming previous reports 
(Joachim et al., 2003), and for the first time we demonstrated that basal prolactin was 
strongly and rapidly inhibited by stress in early pregnancy as hypothesised. It is not 




decreased by stress in early pregnancy and further experiments are required to 
address this question. Previous reports reveal an important role for the bi-daily 
prolactin peak secretory pattern in maintaining early pregnancy in rodents and 
therefore it would be of interest to know the effect of stress on the prolactin system at 
this time. Basal progesterone and prolactin levels w re elevated in early pregnancy as 
expected, extending previous reports that prolactin increases prior to implantation in 
pseudopregnancy in mice (Yang et al., 2009, Larsen and Grattan, 2010).  
The reduction in prolactin secretion shown following stress may contribute towards 
the stress-induced decrease in progesterone simultaneously observed, as prolactin is 
known to enhance progesterone secretion (Freeman et al., 2000). During early 
pregnancy in rodents, progesterone production in the ovaries is mainly driven by 
prolactin binding to its receptor expressed in corpus luteal cells and activating the 
JAK2/STAT5 pathway (Erlebacher et al., 2004). Although we do not provide 
evidence of prolactin’s role in driving progesterone directly in our studies, injecting 
early pregnant mice with prolactin has been shown to i crease progesterone secretion 
and abrogate stress-induced resorption in mice (Erlbacher et al., 2004). Whether 
prolactin is able to rapidly effect progesterone secretion via altered gene transcription 
is unknown. 
It should be noted that basal levels of prolactin differ between the two stress 
experiments. Although the reason behind this is not clear, brief anaesthesia (~3min) 
before blood sampling after the LPS stress and not after fasting stress may be 
accountable. The use of pentobarbitone anaesthesia a  been reported to increase 
plasma prolactin in rodents (Turpen and Dunn, 1978) within 15 minutes and thus the 
brief anaesthetic used may have been sufficient to i crease prolactin levels 
accordingly. We can rule out the possibility that bsal levels were different due to the 
influence of the prolactin surges on the afternoon f proestrus in virgins and the bi-
daily peaks in early pregnant mice (Grattan and Kokay, 2008), as in order to avoid 
these all experiments were conducted in the early-mid light phase of the circadian 
day (9.00-13.00h). 
The stress-induced decrease in plasma prolactin was shown to be associated with a 
parallel mild, but significant, increase in TIDA neuronal activation following 24h 




rapidly respond to stress-induced factors. In virgin mice TIDA neurone activation 
remain unaltered by either stressor, thus, altered responsiveness in early gestation is 
acquired post-mating. Interestingly, only the TIDA subpopulation was responsive to 
stress as no general Fos activation in the arcuate nucl us was apparent following 
stress in early pregnancy. TIDA neurones have already adapted to mediate the 
neurogenic reflex in early pregnancy and the bi-daily prolactin peak secretory 
profile, therefore, these alterations may confer th c anges observed with stress.  
Although expression of Fos in TIDA neurones following an immune challenge has 
previously been reported to reflect changes in prolactin secretion (Hollis et al., 2005), 
it should be noted that Fos is not the best indicator of TIDA neurone activation.  Fos 
staining is absent in these neurones under basal conditions despite the fact they are 
tonically activated and are able to express Fos-related antigens (Hoffman et al., 1994, 
Hoffman and Lyo, 2002). Therefore, it appears that Fos in TIDA neurones may only 
serve as a weak marker of TIDA neurone activation following acute stimulation e.g. 
LPS, which may help explain why we only see a mild increase in Fos-positive TIDA 
neurones (increase from 2.9% to 12.9% following LPS in early pregnancy; 2-way 
ANOVA, p<0.001 across treatment).  
The DOPAC content and DOPAC:dopamine ratio in the median eminence were used 
as additional measures of dopamine activity (Shieh and Pan, 2001, Andrews and 
Grattan, 2003). DOPAC levels appeared to be higher in control virgin mice 
compared to early pregnant mice (not significant), which could partially explain the 
increased basal prolactin secretion observed in early pregnancy. DOPAC levels also 
seemed to be higher in control virgin mice compared to LPS-treated virgins. 
However, the DOPAC levels, and therefore dopamine activity, do not seem to 
underlie prolactin secretion since this was unchanged by LPS in virgin mice and 
there is no change in DOPAC to reflect the stress-rduced prolactin levels observed 
in early pregnancy. DOPAC:dopamine ratios revealed  similar pattern to DOPAC 
content and it was found that basal levels tended to be higher in virgins vs. pregnant 
mice. LPS did not significantly alter the DOPAC:dopamine ratio in virgin or 
pregnant mice. However, LPS-treated virgin mice had a ratio 63% lower than 
vehicle-treated mice, although this was not significant due to the high variability 




for). Thus, dopamine activity in the TIDA neurone terminals is not analogous to Fos 
expression in TIDA neurones in pregnant mice nor does it reflect prolactin levels.  
Thus, stress does not alter prolactin via dopamine activity and other factors must be 
considered. One such possible explanation is that LPS, and/or the associated 
cytokines released, is/are able to directly affect the pituitary lactotrophs to inhibit 
prolactin secretion (Theas MS, 1998, de Laurentiis A, 2002, O'Connor et al., 2003).  
Although TIDA neurones are considered to be the main controllers of prolactin, 
dopamine activity could be altered in other dopaminergic neurones e.g. 
tuberohypophyseal (THDA) and periventricular hypophyseal dopamine (PHDA) 
neurones. Dopamine released from all three subpopulations has been demonstrated to 
topically suppress lactotrophs (DeMaria et al., 1998). THDA neurones release 
dopamine from their terminals in the anterior pituitary and this has been shown to 
inhibit oxytocin release (Freeman et al., 2000). This may contribute to reducing 
prolactin secretion as oxytocin is reported to be a prolactin-releasing factor in 
pregnancy (McKee et al., 2007). THDA neurones have also been shown to be 
responsive to LPS and cytokines to control prolactin (de Laurentiis A, 2002).  
In contrast to the responses to LPS, fasting generally activated the arcuate neurones 
in both virgin and early pregnant mice. The fasting-i duced Fos observed in virgins 
verifies previous publications, reflecting activation of other neurones such as 
neuropeptide Y neurones (NPY) (Becskei et al., 2009). Although food intake is 
increased during pregnancy (Douglas et al., 2007), with prolactin and placental 
lactogen contributing to hyperphagia (Ladyman et al., 2010), Fos expression was 
similar between early pregnant and virgin mice. It is not yet known how these or 
other appetite-signalling hormone (e.g. leptin, ghrelin), which also rise throughout 
gestation, may interact with arcuate neurone responses to stress.  
These findings support the conclusion that immune and f sting stress, along with 
other stressors (eg. psychological stress (Joachim et al., 2003)) have detrimental 
effects on pregnancy maintenance, inducing inhibition of vital pregnancy hormones 
and thus potentially compromising optimal implantation and pregnancy success.  
 
3.4.4 Effect of stress on neural activation in other ypothalamic nuclei 
Other hypothalamic nuclei seem to behave in a different manner to those in the 




LPS stimulated Fos expression in the SON, PVN and VMH of virgins. This may be a 
consequence of upstream brainstem activity. The SONis known to be innervated by 
direct monosynaptic neurones projecting from the brainstem (LC, NTS and VLM) 
(Michaloudi et al., 1997, Northrop et al., 2006). These hypothalamic neurones 
normally respond to stress with immediate early gene xpression/activity and release 
neuroendocrine factors involved in producing and controlling responses of the HPA 
axis (Douglas, 2005b). Basal Fos expression in the PVN was elevated in early 
pregnancy compared to virgins which is interesting as this has not been previously 
reported at other gestation periods (Luckman, 1995). The basal activity in the PVN 
may be changed due to early pregnancy-related alterations in hormones and/or 
cytokines. The LPS-induced increase in Fos expression in early pregnant mice was 
attenuated compared to virgins mirroring the blunted response of CRH and nur77 
mRNA to immune challenge. The pPVN, which displayed a substantially lower 
response to LPS in early pregnancy, is known to contain oxytocin neurones, and this 
may contribute to the decreased prolactin response b rved. 
Oxytocin has been reported to be a crucial prolactin-releasing factor, playing a role 
in the regulation of prolactin secretion. Anatomically this seems likely as oxytocin 
(synthesised in the PVN and SON) is transported via axons to the neural lobe where 
it is released from its terminals and also from the external zone of the median 
eminence. Oxytocin is then transported to the anterior pituitary via the portal vessels 
where it has access to the lactotrophs (Freeman et l., 2000). A sub-population of 
these lactotrophs have been shown to possess oxytocin receptors  (Breton et al., 
1995). Prolactin release is modulated by oestradiol, which increases between 
diestrous and proestrous inducing the prolactin surge on the afternoon of proestrous. 
It has been reported that oxytocin actions at the lactotrophs are elevated at this time 
with an increase in secretary responses to oxytocin due to an increase in the number 
of oxytocin-responding lactotrophs and magnitude of their Ca2+i responses. It is, thus, 
suggested rising oestrogen levels facilitate oxytocin stimulatory actions on 
lactotrophs and prolactin release (Tabak et al., 2010). The action of oxytocin on 
controlling the prolactin rhythm has also been suggested to be coordinated by 
vasoactive intestinal polypeptide (VIP). VIP originates from the suprachiasmatic 




nucleus and oxytocin neurones in the PVN (Egli et al., 2010). Oxytocin 
neurosecretory cells of the PVN, which have VIP receptors, have been identified 
using ICC along with retrograde tracing with Fluoro-G ld (method for labelling 
neurosecretory cells). The injection of a VIP antisense oligonucleotide into the SCN 
eradicates the afternoon oxytocin and prolactin peaks normally observed in 
cervically-stimulated ovariectomised rats, suggesting VIP has a role in contributing 
to oxytocin and prolactin secretion (Egli et al., 2004).  
Thyrotropin-releasing hormone (TRH) is also thought to stimulate prolactin release 
and is known to increase in human pregnancy (Amino et al., 1981), therefore TRH 
responses may also be altered following stress in early pregnancy, impacting on 
prolactin secretion.  TRH-deficient mice during lactation display significantly 
reduced serum prolactin compared to the wild type mice. The prolactin mRNA and 
content were also reduced in the pituitary of these mice, all of which were reversed 
by TRH treatment, indicating TRH is needed for regulation of pituitary mRNA 
regulation. Despite the low prolactin levels in theTRH deficient dams they are still 
fertile, suggesting TRH is not crucial for pregnancy and lactation but is needed for 
complete function of the lactotrophs, especially during lactation (Yamada et al., 
2006). Administration of TRH to rats can induce prolactin secretion, however the 
temporal release of TRH is not strongly correlated to prolactin secretion (Freeman et 
al., 2000). The prolactin-stimulating effects of TRH were thought to occur in the 
pituitary; however, a study in rats has found that TRH works at the hypothalamic 
level, leading to modulation of the functional outpt of TIDA neurones (altering 
firing patterns) and thus reducing its inhibitory effect on prolactin (Lyons et al., 
2010, van den Pol, 2010).  
Therefore, it would be of interest to determine the eff ct of stress in early pregnancy 
on these potential prolactin releasing factors e.g. oxytocin, to see if stress induces 
changes in their secretion/expression/activity in early pregnancy that could account 
for the depleted prolactin secretion observed at this time. 
Prolactin has also been implicated to be involved in the regulation of oxytocin, 
supported by the finding that mRNA for the long form of the prolactin receptor 
(PRL-RL) is predominantly colocalised with oxytocin mRNA in the SON (over 80% 




predominantly located in oxytocin neurones and the proportion of oxytocin neurones 
exhibiting PRL-RL mRNA increased with pregnancy (Kokay et al., 2006). Prolactin 
administration i.c.v increases Fos expression in the SON (Cave et al., 2001) and can 
increase the electrically stimulated oxytocin release nd mRNA content in the 
hypothalamus (Ghosh and Sladek, 1995). Together these data strongly suggest that 
prolactin directly regulates the activity of oxytocin neurones. However, no change 
was observed in the basal Fos response in the SON of early pregnancy mice 
compared to virgins despite radically different prolactin concentrations. Although, 
basal Fos expression in the PVN was significantly higher in early pregnant versus 
virgin mice which may reflect increased activation of oxytocin neurones, and 
subsequently contribute towards the increased plasma prolactin levels.  
In contrast to the general arcuate nucleus response, 24h fasting had no significant 
effect on SON, PVN or VMH Fos expression, confirming previous reports 
(Johnstone et al., 2006). Therefore, although both stressors reduce prolactin and 
progesterone secretion, and increase Fos expression in the arcuate nucleus, they 
affect other hypothalamic nuclei activity differently. Potential roles for hypothalamic 
factors, other than dopamine, on prolactin secretion are unclear following fasting.  
Therefore, the two stressors used display only similar patterns of hypothalamic 
activation in TIDA neurones, implying that stress re ponses may generally converge 
at this neuroendocrine system in early pregnancy.  
 
3.4.5 Effect of stress on tyrosine hydroxylase-positive cell groups in the brainstem  
LPS and consequently its cytokine load can access the arcuate nucleus e.g. via the 
leaky blood brain barrier (BBB) in the median eminenc . In addition, cytokines can 
activate the noradrenergic pathways to the hypothalamus (Brunton and Russell, 
2008).  The central noradrenergic system originates in the medulla and pons and 
extensively innervates areas of the brain that are involved in stress response 
regulation. It is activated by a wide variety of stre sful stimuli, both psychological 
and physical (e.g. cytokine administration) (Pacak et al., 1995a, Pacak et al., 1995b). 
For example, IL-1 activates neurones in the NTS and VLM when given peripherally 
to rats. These represent sources of catecholaminergic cells that project to and 
innervate the PVN (Ericsson A et al., 1994) and result in increased noradrenaline 




responses to IL-1β, reducing PVN CRH and oxytocin neurone activation 
(Weidenfeld et al., 1989, Melik Parsadaniantz et al., 1995, Buller et al., 2001). The 
above indicate that noradrenergic projections play a crucial role in mediating HPA 
responses to IL-1β. IL-1β does not directly act on these neurones: most do not 
express IL-1β receptors and systemically administered IL-1β  is unlikely to cross the 
BBB (Rivest et al., 2000). IL-1β, like LPS and other cytokines drive prostaglandin 
synthesise (via cyclo-oxygenase (COX) expression induction) which activates these 
noradrenergic neurones (Rivest, 2001, Brunton and Russell, 2008). This idea is 
supported by studies using COX inhibitors, for example, central administration of a 
COX-1 inhibitor attenuates LPS-induced increase in ACTH and corticosterone 
secretion (Garcia-Bueno et al., 2009). In late pregnancy, the activity of the 
noradrenergic system in the PVN is reduced compared to virgin rats, and therefore, 
may contribute to the attenuated HPA response to stress observed at this time 
(Douglas, 2005a, Russell et al., 2008). 
We show that LPS administration increases neuronal activation in the LC, NTS and 
RVLM in the brainstem in both virgins and d5.5 pregnant mice. Neurones in the LC 
show a generally lower response in early pregnancy compared to virgins, potentially 
leading to the attenuated response of the pPVN. The PVN receives noradrenergic 
innervations from the A6 cell bodies of the LC, as well as from A1 and A2 cell 
bodies of the VLM and NTS, respectively (Cunningham nd Sawchenko, 1988, 
Saphier and Feldman, 1989, Hwang et al., 1998).The LC also has a role in activation 
of the HPA axis (Ziegler and Herman, 2002), supported by the report lesion of the 
LC suppresses restraint stress-induced ACTH and corticosterone secretion (Ziegler et 
al., 1999). 
Although LC response to stress appeared lower in early pregnancy compared to 
virgins, the number neurones activated overall in the LC was low. However, 
neuronal activation in the NTS and RVLM was significantly higher following stress 
in early pregnancy compared to virgins, suggesting these neurones have adapted with 
increased sensitivity to stimuli and may contribute towards to the exaggerated 
response observed by the TIDA neurones. A temporal association was reported 
between noradrenaline release (in the medial preoptic area) and prolactin secretion 




surge regulation (Szawka et al., 2007). Evidence indicates both physiological 
adrenergic and noradrenergic involvement in the neuronal regulation of the TIDA 
system. Synaptic interactions reported between the adrenergic and TIDA neuronal 
systems indicate that adrenergic neurones may also be involved in the regulation of 
the TIDA system and provide a potential pathway for central adrenergic effects on 
prolactin secretion (Hrabovszky and Liposits, 1994). 
The noradrenergic nucleus LC participates in both proestrous and steroid-induced 
surges of prolactin. LC lesion decreases noradrenaline release in the preoptic area, 
PVN and mediobasal hypothalamus, reducing prolactin and luteinising hormone 
secretion (Szawka et al., 2005). However,  LC has not been implicated to be involved 
in stress-induced prolactin changes (Poletini et al., 2006). The NTS is known to be 
activated by LPS and cytokines (Brunton et al., 2005, Sparkman et al., 2006) but an 
association with prolactin secretion has yet to be described. Likewise RVLM  
neurones are known to be activated by cytokines (Zhang et al., 2003). Although a 
direct link to prolactin secretion remains unknown at present, arcuate neurones have 
been observed to be activated by stimulating the RVLM, and the arcuate perikarya 
showed labelling with a retrograde tracer that was originally microinjected into the 
RVLM (Li et al., 2009).  
We also show an increase in TIDA neurone activation with fasting stress, like LPS, 
in early pregnancy but we do not know whether this is accompanied by 
noradrenergic activation in the brainstem as this wa not analysed.  It has, however, 
been shown that food ingestion was critical for the expression of Fos in the 
noradrenergic cells of the LC and NTS in rodents (Johnstone et al., 2006) and 
therefore we may not expect to observe an increase in Fos activation in the brainstem 
of fasted mice. 
 
3.4.6 Effect of stress on pregnancy rate and hormones at d13.5 
We have shown that LPS stress in early pregnancy dramatically induced complete 
pregnancy failure, reducing pregnancy rate from 70% (vehicle-treated) to 0% 
(p<0.01). 24h fasting in early pregnancy lead to a milder phenotype, reducing 
pregnancy rate from 70% to 36%.  Although this loss wa  not significant following 
24h fasting this may be due to the way in which the pregnancy rate was calculated. 




sites (average of 7 implantation sites). However, a more insightful measure of 
pregnancy rate/foetal loss can be gained by counting the number of implantation sites 
and the number of resorption sites in the uterine horns and calculating the percentage 
of viable implantation sites (Joachim et al., 2003). Never the less, we showed stress 
(on gestation d5.5) had detrimental effects on pregnancy outcome which supports 
previous reports of stress-induced abortion in mice (Wiebold et al., 1986, Joachim 
RA, 2001, Joachim et al., 2003) and increased miscarr age associated with elevated 
cortisol in early pregnant women (Nepomnaschy et al., 2006). The importance of 
stress-reduced prolactin on pregnancy outcome is yet to be determined. It would be 
an interesting experiment to replace the prolactin lost due to stress in early pregnancy 
(i.e. to keep prolactin levels high) to see if the pr gnancy outcome in response to 
stress can be reversed. This type of hormone replacment study has previously been 
carried out for progesterone in which a progesteron derivative, dydrogesterone, was 
found to abrogate murine stress-triggered abortion (J achim et al., 2003). Low serum 
progesterone has also been associated with miscarriage in women, as well as 
increased perceived stress levels (supported by higher circulating CRH 
concentrations). In very early gestation (women recruited between 4-7 weeks) these 
risk factors were more pronounced (Arck et al., 2008). LPS has previously been 
shown to induce occult pregnancy loss in mice (Foerster et al., 2007) , while 
neutralisation of LPS (using a bacterial permeability increasing protein) or blockage 
of Toll-like receptor (TLR)-4 for LPS abrogate (sonic) stress-triggered foetal loss in 
mice (Friebe et al., 2011). Studies into the effects of fever and infection on 
pregnancy maintenance in animals have reported that hyperthermia in early gestation 
is associated with resorption, foetal death, and serious malformations e.g. 
cardiovascular malformations (Edwards, 1969, Poswillo et al., 1974, Smith et al., 
1978, Edwards et al., 1995). In humans the data/evidence for whether fever causes 
foetal loss and complications is not quite so clear. A number of studies show 
compelling evidence for the increased risk of adverse pregnancy outcomes following 
fever. For example, Q fever has been shown to increase the incidence of spontaneous 
abortion, intrauterine growth retardation and preterm labour (Carcopino et al., 2009). 
In contrast, another group has reported that there is not an association between fever 




revealed that 18.5% of the recruited women (total 24,000) suffered a fever in the first 
16 weeks of pregnancy, indicating that fever is commonly experienced during early 
pregnancy. However, this study is not able to reflect the group of women who 
spontaneously aborted in very early pregnancy, before the usual enrolment time. In 
addition, episodes of fever were only recorded in the first 16 weeks and therefore we 
do not know about the effects of fever occurring later in pregnancy on foetal loss. 
Thus, this study cannot absolutely conclude that there is no link between fever and 
miscarriage. 
Mounting evidence indicates that events occurring early in life/in utero are critical 
determinants for problems later in life. Where pregnancy failure does not arise, foetal 
programming may. Exposure to chronic stress or glucocorticoids during both early 
and late gestation and the neonatal period induces long-lasting adverse effects in the 
offspring, for example, cardiovascular disease and depression (Seckl et al., 2000, 
Seckl and Meaney, 2004). Administration of LPS to mice during mid pregnancy 
results in a number of physiological and behavioural ch nges to their male offspring. 
These males displayed attenuated anxiety behaviour, reduced food/water intake and a 
lower body weight up until postnatal day 40, indicating prenatal stress can lead to 
complex and long-term effects on the offspring (Asiaei et al., 2011). It is thought that 
local glucocorticoid action in the decidua or developing placenta is involved in 
stress-induced programming during pregnancy and is accompanied by detrimental 
alterations in 11β-hydroxysteroid dehydrogenases (11β-HSDs) in the 
decidua/placenta (Seckl and Meaney, 2004, Holmes et al., 2006, Holmes and Seckl, 
2006). 11β-HSDs are glucocorticoid metabolising enzymes which modify 
glucocorticoid actions in a tissue-specific manner. 11β-HSD1 regenerates active 
glucocorticoids, thus increasing corticosterone/cortis l levels. 11β-HSD2 expression 
acts as a dehydrogenase, inactivating corticosterone or cortisol through conversion to 
11-dehydrocorticosterone and cortisone respectively. Its expression is high in the 
foetal brain but less so in the adult brain where it is confined to specific areas, 
indicating its importance in development. Loss of this enzyme from foetal tissues 
leads to altered cerebellum development and long-term heightened anxiety, 
consistent with programming (Holmes and Seckl, 2006). Decreased activity of 




foetus for hypertension and metabolic disease laterin life. In addition prenatal 
exposure to cytokines has been shown to result in obesity and gender-specific 
programming in the offspring (Dahlgren et al., 2001) 
Following 24h fasting in early pregnant mice, plasm prolactin levels at d13.5 were 
significantly elevated in non-pregnant fasted mice compared to both non-pregnant 
control and pregnant fasted mice. It is unclear by what means levels are significantly 
higher at this later date following fasting and no such change was found on d13.5 
following LPS injection on d5.5 or immediately follwing 24h fast. Fasted mice that 
remained pregnant exhibited slightly lower circulating prolactin levels on d13.5 
compared to pregnant controls, indicating a pronged effect on prolactin. Conversely, 
progesterone secretory responses on d13.5 following 24h fast and were similar to 
control mice (pregnant and non-pregnant) suggesting the fasting treatment did not 
have a lasting effect on progesterone secretion in pregnancy.  
During intrauterine development, one of the principal environmental factors 
influencing the growth/development of the embryo/foetus, is the maternal diet and 
subsequent nutrient supply. Epidemiological studies have found that undernutrition 
during foetal life is associated with increased risk of complex diseases 
(Chmurzynska, 2010); the incidence of metabolic syndrome, cardiovascular diseases, 
hypertension, diabetes and obesity have all been fou d to be higher (McMillen and 
Robinson, 2005) and appear to be independent of lifestyle risk factors (Drake and 
Walker, 2004). Maternal protein restriction during foetal development and lactation 
in rats causes decreased birth weight, delayed sexual maturation and leads to 
premature aging of reproductive function in female offspring (only data on female 
progeny reported) (Guzman et al., 2006). The “thrifty phenotype” hypothesis was 
proposed almost two decades ago (Hales and Barker, 1992) and describes an 
association between poor nutrition/foetal growth and increased risk of impaired 
glucose intolerance/diabetes and metabolic syndrome. These finding have been 
reproduced in many studies since then in different populations and ethnic groups  
(Hales and Barker, 2001). It suggests that an adaptive response occurs due to poor 
foetal nutrition, leading to altered metabolism. This could be beneficial if born into a 
low/poor nutrition environment; however, problems ari e when the pre and post-natal 




In summary, we found that circulating prolactin was profoundly inhibited by either 
LPS immune stress or 24h fasting in early pregnancy. As prolactin is mainly under 
the inhibitory control of dopamine released from TIDA neurones we hypothesised 
that stress would increase TIDA neurone activity. In support of this, both stressors 
significantly increased Fos expression in TIDA neurones in early pregnant mice. 
However, LPS did not enhance TIDA dopamine activity in the median eminence (as 
measured by DOPAC content and DOPAC:dopamine ratio). These data imply that 
increased TIDA neurone activation plays a role in stress-reduced prolactin levels in 
early pregnant mice but is not souly responsible. Attenuated pPVN neurone 
recruitment and increased activation of noradrenergic nuclei following stress in early 
pregnancy indicate that other mechanisms may also contribute to reduced prolactin 


























Mechanisms controlling prolactin secretion/responses  




Chapter 4: Mechanisms controlling prolactin secretion/responses following 
stress in early pregnancy 
 




4.1.1 Prolactin signal transduction 
Different isoforms of the prolactin receptor are expressed in mice, namely the short 
and long form, with the long form predominantly located in the hypothalamus and 
more highly expressed in the arcuate nucleus than te short form (Pi and Grattan, 
1998, Bakowska and Morrell, 2003).While both forms display identical extracellular 
portions (and so both bind prolactin), they differ in their ability to activate 
intracellular pathways (Grattan, 2002). The membrane proximal region of the 
intracellular domain in the long form of the prolactin receptor is associated with 
Janus kinase 2 (JAK2). Prolactin binding to its receptor leads to dimerization of the 
receptor molecules and phosphorylation of JAK2 rapidly (<1min) follows (Freeman 
et al., 2000). JAK2 recruits and phosphorylates latent cytoplasmic proteins termed 
signal transducers and activator of transcription (STATs). Phosphorylated (p)STAT 
molecules then form homo- and hetero-dimers which translocate to the nucleus and 
bind to specific promoter sequences of target genes (Grattan, 2002). A number of 
STATs are reported to be involved in prolactin signal transduction in various tissues, 
including STAT1, STAT3, STAT5a and STAT5b (Bole-Feysot et al., 1998).  
The short form of the prolactin receptor does not activ te the JAK-STAT pathway 
but mediates some actions of prolactin through mitogen-activated protein kinase 
(MAPK) pathways.  
 
4.1.2 Prolactin negative feedback 
Pituitary produced prolactin is mainly under the inhibitory control of dopamine 
released from hypothalamic TIDA neurones in the arcu te nucleus (Grattan, 2002). 
Prolactin also activates a short-loop feedback system to regulate its own secretion by 
stimulating TIDA neurones. Prolactin receptors are expressed on these neurones 
(Kokay and Grattan, 2005) and prolactin has been shown to increase hypothalamic 




TIDA neurones via prolactin binding to the long form of its receptor requires 
activation of the JAK2/ STAT5 signalling transduction pathway (Grattan et al., 
2001b, Ma et al., 2005a) and is thought to contribue to the stimulation of tyrosine 
hydroxylase mRNA expression (Grattan and Kokay, 2008).  pSTAT5b has been 
demonstrated to specifically mediate prolactin negative feedback on the TIDA 
neurones, with prolactin treatment inducing nuclear tr nslocation of pSTAT5 (Lerant 
et al., 2001). STAT5b deficient mice express very high serum prolactin levels, 
although mRNA levels and immunoreactivity of tyrosine hydroxylase are low, 
indicating signal transduction is impaired and demonstrating that pSTAT5 is 
essential for mediating prolactin negative feedback in TIDA neurones (Grattan et al., 
2001b). In addition, STAT5 deficient mice also display characteristics of prolactin 
insensitivity, including compromised luteotropic support with attenuated serum 
progesterone in pregnancy, spontaneous abortion, impair ent of mammary gland 
development and insufficient milk production (Udy et al., 1997). 
 
4.1.2.1 Prolactin negative feedback in early and late pregnancy 
During late pregnancy and lactation, TIDA neurones b come less able to secrete 
dopamine in response to prolactin, consequently leading to a state of 
hyperprolactinemia. There are a number of physiologcal changes in the regulatory 
pathways that control prolactin secretion at this time. Firstly, the placenta provides 
lactogenic hormones, the placental lactogens, in a number of species including 
rodents (Lee and Voogt, 1999). These are able to bind to and activate prolactin 
receptors without being subject to the normal inhibitory control by dopamine. 
Subsequently, the short-feedback loop is bypassed in late pregnancy and lactation 
allowing continued activation of the prolactin receptors, leading to increased 
progesterone secretion while simultaneously decreasing prolactin release itself 
(Grattan, 2002). Secondly, TIDA neurones have a reduc  ability to respond to 
prolactin, with lower TIDA activation compared to early pregnancy (Grattan and 
Averill, 1995, Andrews et al., 2001), and prolactin secretion resumes despite the 
continued placental lactogen presence. Thirdly, suckling of the nipple is a potent 
prolactin stimulus involving a suckling-induced reduction in the activation of TIDA 




At the end of gestation and during lactation, prolactin loses the ability to induce 
STAT5b phosphorylation and nuclear translocation, when compared with diestrous 
rats. This was reported to be associated with an increase in suppressors of cytokine 
signalling (SOCS) mRNA and may underlie the diminished TIDA neurone dopamine 
output and hyperprolactinemia observed at this time(Anderson et al., 2006a).  
SOCS act as feedback inhibitors of signalling for a number of cytokines that utilize 
the JAK/STAT pathways. They appear to act as part of an intracellular feedback loop 
to suppress STAT phosphorylation and consequently to dampen signal transduction 
(Starr and Hilton, 1999). SOCS proteins contain a central Src homology 2 (SH2) 
binding domain through which they bind to phosphotyr sine residues located in 
cytokine receptors (eg. for SOCS2 and 3 and cytokine-inducible SH2-containing 
protein, CIS) or JAKs (e.g. for SOCS1). They are then able to suppress cytokine 
signalling in number of ways: by binding to and inhibiting the activity of JAKs; 
competing for phosphorylated binding sites on receptors with STATs; or by targeting 
bound signalling proteins for proteasomal degradation (Wormald and Hilton, 2004). 
Thus, they may play a role in inhibiting prolactin stimulation of STAT5b in late 
pregnancy and lactation. 
On d22 of pregnancy, rats have been found to have incr ased SOCS1 and SOCS3 in 
the arcuate nucleus compared to diestrous rats, and on d7 of lactation CIS mRNA 
levels were significantly elevated, which suppressed prolactin levels to that of basal 
(Anderson et al., 2006a).  These data are consistent with the hypothesis that 
SOCS/CIS mediate the loss of prolactin-induced activ tion of STAT5b in TIDA 
neurones. Administration of prolactin has been shown induce expression of SOCS1, 
2 and 3 along with CIS mRNA in the ovary and adrenals (but not mammary glands) 
of lactating rats deprived for 24h of circulating prolactin. Furthermore, suckling 
induces SOCS mRNA in the ovary (but not mammary glands) of these rats. After 
48h pup-deprivation the mammary gland increases SOCS gene expression in 
response to prolactin (Tam et al., 2001).  
oPRL administration ordinarily increases the STAT5 nuclear:cytoplasmic ratio in 
lactating mothers whose pups are removed. However, in the presence of the pups 
prolactin signal transduction through STAT5 in the TIDA neurones is suppressed. It 




along with up-regulation of CIS transcripts, while SOCS1 and 2 mRNA are not. 
These data imply that loss of sensitivity to prolactin negative feedback is due to 
heightened CIS expression/action in the TIDA neurones (Anderson et al., 2006b). 
Prolactin negative feedback is known to be maintained throughout early-pregnancy 
prolactin surges (Demarest et al., 1983, Grattan et al., 2008). In accordance with 
prolactin negative feedback during early pregnancy, TIDA neurones display a 
semicircadian pattern of activity, with reduced dopamine release during the prolactin 
surges and increased release between them, allowing initiation and termination of the 
surges (McKay et al., 1982). In early pregnancy, studies have been carried out to see 
if the nocturnal prolactin surge increases SOCS (SOC 1, SOCS2, SOCS3, CIS) 
expression in the arcuate nucleus. In contrast to late pregnancy and lactation 
responses to exogenous prolactin, high (endogenous) prolactin levels in early 
pregnancy do not induce SOCS expression (Anderson et al., 2006a). It is thought that 
declining progesterone and high oestrogen during late pregnancy induce SOCS in 
TIDA neurones. Oestrogen and prolactin were shown to i duce SOCS1, SOCS3 and 
CIS mRNA levels in the arcuate nucleus of ovariectomised late pregnant rats, while 
progesterone reversed the effect of oestrogen (Steyn et al., 2008). In early pregnancy 
although negative feedback is apparent during prolactin surges and SOCS is not 
induced, the effects during basal levels of prolactin are yet to be investigated. In 
addition, no reports have been published into stres effects on negative feedback in 
early pregnancy. It is known that stress in early gestation increases circulating 
cytokine levels, affects TIDA activity and alters prolactin secretion, thus, stress could 
impact on prolactin negative feedback systems. 
Therefore, in order to investigate the effect of stre s in early pregnancy on prolactin 
negative feedback to TIDA neurones, mice were stresed (LPS or 24h fast) and then 
administered ovine prolactin (oPRL) to drive negative feedback. We aimed to use 
immunocytochemistry, double labelling for tyrosine hydroxylase and pSTAT5, to 
determine whether there is an alteration in pSTAT5 signalling in TIDA neurones 









4.1.3 Aim and Hypothesis 
 
Aim: 
1. To discover if stress (either alone or in conjunction with oPRL treatment) 
alters prolactin negative feedback in early pregnancy. 
 
Hypothesis: 






























4.2.1 Effect of LPS stress on prolactin negative feedback 
4.2.1.1 Treatment 
d5.5 pregnant mice were gently restrained in a holding bag and either injected with 
lipopolysaccharide (LPS; 12.5µg/100µl saline, i.p; E.coli E055:B5, Sigma, Poole, 
Dorset, UK; n = 14) (Hollis et al., 2005) or vehicle (100µl, i.p; n = 14), at around 
10am (3h after lights on). Mice were then returned to their home cages. After 3h 
mice were injected with ovine prolactin (oPRL; 1µg/g bodyweight i.p; Sigma-
Aldrich; vehicle and LPS treated n = 7) (Anderson et al., 2006b) or prolactin buffer 
(30mM NaHCO3, 150mM NaCl, pH 10.8; n = 7) mixed with saline (1:1) as a 
control, before being killed 1h later (4h after LPS injection). This time point was 
selected following a literature search (Anderson et al., 2006b, Anderson et al., 2008). 
 
4.2.1.2 Blood/tissue collection and perfuse fixation 
One hour after oPRL injection, mice were quickly moved to an adjacent room and 
injected with an overdose of sodium pentobarbitone (0.3ml i.p; Centravet, 22106 
Didan, France). Once the mouse was deeply anaesthetised a blood sample was taken 
by cardiac puncture before the mouse was perfused with heparinised saline and fixed 
with 4% paraformaldehyde (as described in General Methods section 2.9.1). The 
brain was carefully removed and stored overnight (4ºC) in 4% paraformaldehyde and 
15 % sucrose solution. The brain was then stored in a 30% sucrose solution at 4ºC 
overnight. Following this the brains were frozen befor  sectioning. Blood was 
processed for plasma and frozen (-20°C) prior use in assays. Following blood/tissue 
collection pregnancy status was checked by laparotomy and inspection of the uterine 
horns for evidence of implantation sites. 
  
4.2.1.3 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.2.2) for the mouse prolactin DuoSet 
ELISA (DY1445, R&D Systems, Inc., Minneapolis, US). To test that there was no 
cross-reactivity between the murine and ovine prolactin when measuring mouse 




pseudopregnant control mice (saline only, not administered oPRL; n = 4) was pooled 
and then spiked with (1) 100ng/ml murine prolactin; (2) 20µg/ml ovine prolactin, or 
(3) 100ng/ml murine prolactin and 20µg/ml ovine prolactin. The plasma samples 
were then diluted and assayed (n = 4 per treatment) as above. 20µg/ml oPRL was 
used to spike the plasma as 20µg was the dose given to the mice and it has been 
estimated that 20g mice contains around 1.2-1.6 ml blood (~1ml plasma). oPRL was 
dissolved in prolactin buffer (30mM NaHCO3, 150mM NaCl, pH 10.8) before being 
used to spike plasma samples. 
 
4.2.1.4 Brain sectioning, tyrosine hydroxylase/pSTAT5 ICC and analysis 
Brains were sectioned using a freezing microtome (48µm) to provide coronal brain 
sections containing paraventricular nucleus (PVN), arcuate nucleus, ventromedial 
hypothalamic nucleus (VMH) and supraoptic nucleus (SON). Sections were stored in 
cryoprotectant before immunocytochemistry (ICC) was c rried out for pSTAT5 and 
tyrosine hydroxylase (see section 2.10.5). Using a li ht microscope (20x or 40x 
objective) on coded slides, pSTAT5-positive cells (those with a dark grey/black 
nucleus) were counted in roughly 4 sections per mouse for each area of interest 
(defined using (Franklin K, 1997)). For the PVN, pSTAT5-positive cells were 
quantified for the magnocellular (m) and parvocellular (p) regions separately. In 
addition to pSTAT5 only counts, the arcuate nucleus wa  also analysed for the 
number of tyrosine hydroxylase-positive cells colocalized with pSTAT5 (expressed 
as a percentage of the total number of tyrosine hydroxylase cells).  
 
4.2.2 Effect of 24h fast on prolactin negative feedback 
4.2.2.1 Treatment 
Virgin and d5.5 pregnant were fasted for 24h (n =18, 20 respectively), with food 
removed from their home cage at 10am (lights on at 7am), controls were allowed to 
feed normally (n = 16, 21 respectively). After 23h mice were injected with oPRL 
(1µg/g bodyweight i.p; Sigma-Aldrich; virgin control and fasted n = 8, 10 
respectively; d5.5 control and fasted n =11) or prolactin buffer (virgin control and 






4.2.2.2 Blood/tissue collection and perfuse fixation 
On hour after oPRL injection blood was collected by cardiac perfusion and mice 
perfused fixed as described above to provide brains for immunocytochemistry (see 
section 4.2.1.2). Following blood/tissue collection pregnancy status was checked by 
laparotomy and inspection of the uterine horns for evidence of implantation sites. 
 
4.2.2.3 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.2.2) for the mouse prolactin DuoSet 
ELISA (DY1445, R&D Systems, Inc., Minneapolis, US).  
 
4.2.2.4 Brain sectioning, tyrosine hydroxylase/pSTAT5 ICC and analysis 
Brains were sectioned and processed for pSTAT5 and tyrosine hydroxylase 
immunocytochemistry as described above (see section 4.2.1.4). The arcuate nucleus 
was analysed for the number of pSTAT5-positive tyrosine hydroxylase cells 
(expressed as a percentage of the total number of ty osine hydroxylase cells).  
 
4.2.3 Statistics 
Statistical analysis of the mean prolactin concentrations, pSTAT5 counts and % 
pSTAT5-positive tyrosine hydroxylase cells, from LPS-treated d5.5 pregnant mice, 
were determined by 2-way ANOVAs, with Holm-Sidak post-hoc tests. Data from 
virgin and d5.5 pregnant mice from the fasting stress xperiment were analysed using 
a combination of 2-way and 3-way ANOVAs with a Holm-Sidak post-hoc tests. Data 















4.3.1 Effect of LPS stress on prolactin negative feedback 
4.3.1.1 Prolactin concentration 
LPS significantly reduced plasma prolactin vs. vehicle n d5.5 pregnant mice treated 
with prolactin-buffer. Murine plasma prolactin conce trations were significantly 
lower in oPRL treated mice vs. control (prolactin buffer) (2-way ANOVA, 
interaction LPS x prolactin treatments p<0.001; Figure 4.1). However, LPS treatment 
in mice given oPRL did not significantly decrease murine plasma prolactin further.  
Control checks on oPRL cross-reactivity showed that t ere was a significant 
difference between prolactin treatments (1 way ANOVA, p<0.001 across treatment). 
Murine prolactin spiking to plasma significantly increased prolactin levels to the 
same degree as plasma spiked with both ovine and murine prolactin (Holm-Sidak 
post hoc test, ns). Ovine prolactin alone did not alter the levels of prolactin vs. 
plasma alone (Holm-Sidak post hoc test, ns; data not shown) measured using the 
murine prolactin ELISA. Therefore, ovine prolactin levels are not read by the murine 
prolactin ELISA, nor do they interfere with reading of murine prolactin levels when 
co-administered with murine prolactin. 
 
4.3.1.2 % pSTAT5-positive TIDA neurones 
Very few neurones expressed nuclear pSTAT5 in the arcuate nucleus of mice treated 
with prolactin buffer (Figure 4.2 A and B) and the number of pSTAT5-positive 
neurones per arcuate profile was similar in both veicl  and LPS treated mice. This 
was significantly increased following oPRL treatment in both groups (2-way 
ANOVA, p<0.001 across prolactin treatment; Figure 4.2 C). LPS treatment alone did 
not alter the percentage of pSTAT5-positive TIDA neurones, however, oPRL 
treatment increased the proportion of double labelled neurones (presented as % of 
tyrosine hydroxylase neurones that were pSTAT5-positive) in LPS treated mice (2-
way ANOVA, interaction LPS x prolactin treatments p=0.025; Figure 4.2 D). When 
the percentage of double labelled neurones was plotted against mean plasma 
prolactin data, there appears to be an inverse relationship in all groups except the 
pregnant stressed mice treated with prolactin buffer, which shows low prolactin and 


















































































4.3.1.3 pSTAT5 expression on other hypothalamic cell groups  
Supraoptic nucleus (SON):  
In the SON, expression of pSTAT5 was similar in all groups regardless of LPS or 
oPRL treatment (2-way ANOVA, ns; Figure 4.4). 
Paraventricular nucleus (PVN): 
pSTAT5 expression in the mPVN and pPVN was similar in all groups and not 
altered by LPS or oPRL treatment (2-way ANOVA, ns; Figure 4.5). 
Ventromedial hypothalamus (VMH):  
LPS treatment alone did not alter the number pSTAT5-positive nuclei in the VMH, 
however, oPRL treatment increased the pSTAT5-positive cells (2-way ANOVA, 













































4.3.2 Effect of 24h fast on prolactin negative feedback 
4.3.2.1 Prolactin concentration 
Neither 24h fast nor oPRL treatment significantly altered plasma prolactin in virgin 
mice. Murine plasma prolactin concentrations were significantly reduced by fast 
treatment in d5.5 pregnant mice vs. non-fasted (in both oPRL and prolactin buffer 
treated groups (3-way ANOVA, interaction fast treatment x group p<0.001; 2-way 
ANOVA for pregnant groups only, p<0.001 across treatment; Figure 4.7). oPRL 
treatment reduced plasma prolactin in non-fasted prgnant mice. However, it did not 
reduce prolactin further in fasted d5.5 mice.  
 
4.3.2.2 % pSTAT- positive TIDA neurones 
The number of pSTAT5-positive neurones per arcuate profile was similar in both 
virgin and pregnant non-fasted mice treated with prolactin buffer (Figure 4.8 A-D). 
However, when treated with oPRL the number of pSTAT5 nuclei increased 
significantly in the non-fasted pregnant mice. Although pSTAT5 expression in non-
fasted virgins appears to also mildly increase with oPRL treatment this was not 
significant (3-way ANOVA, interaction prolactin treatment x group p<0.01; Figure 
4.8 E). The number of pSTAT5-positive neurones per arcuate profile was similar in 
both virgin and pregnant fasted mice treated with prolactin buffer and the number of 
pSTAT5 nuclei increased in both virgin and pregnant mice that were treated with 
oPRL (3-way ANOVA, interaction fast x prolactin treatments p=0.001). Individual 
2-way ANOVAs for virgin and pregnant mice alone revealed that 24h fasting 
increases the pSTAT5 expression in oPRL treated virgin and pregnant mice (2-way 
ANOVAs, interaction fast x prolactin treatments p<0.05; Holm-Sidak post hoc tests, 
p<0.05 across prolactin treatment within fasted mice,  p<0.05 fast vs. control in 
prolactin treated mice).  
The percentage of pSTAT5-positive tyrosine hydroxylase-positive cells (TIDA 
neurones) was similar in virgin and pregnant non-fasted mice treated with prolactin 
buffer. When treated with oPRL the %-pSTAT5 positive TIDA neurones increased 
slightly in the non-fasted pregnant mice (3-way ANOVA, interaction prolactin 
treatment x group p< 0.01; Figure 4.8 F). The % of pSTAT5-positive tyrosine 
hydroxylase neurones was low in both virgin and pregnant fasted mice treated with 




treatments p<0.001, fast x prolactin treatments x group p=0.001). Individual 2-way 
ANOVAs for virgin and pregnant mice alone revealed that 24h fast increased the % 
pSTAT5-positive TIDA neurones only in oPRL treated pregnant mice (2-way 
ANOVA, interaction fast x prolactin treatment p<0.05; Holm-Sidak post hoc tests, 
p<0.05 fast vs. control in d5.5 prolactin treated mice). 
When the % pSTAT5-positive TIDA neurones are plotted against the mean plasma 
prolactin data there appears to be an inverse relationship in 7 out of the 8 groups, the 
obvious outlier being the pregnant stressed mice treated with prolactin buffer. They 
display both low plasma prolactin and low pSTAT5-positive tyrosine hydroxylase 












































4.4.1 Effect of LPS stress on prolactin negative feedback 
In support of previous data (see section 3.3.2), LPS administration in early pregnancy 
robustly diminished circulating prolactin in mice tr ated with prolactin buffer. 
Additional treatment with oPRL decreased murine plasm  prolactin in non-stressed 
early pregnant mice as expected, demonstrating that prolactin negative feedback had 
been driven (DeMaria et al., 1999, Anderson et al., 2006a). However, although LPS 
reduced plasma prolactin, oPRL supplementation did not further decrease it in early 
pregnancy. This may be because levels have already been substantially reduced and 
further changes are minimal and thus not significant.  
Although stress alone reduces circulating prolactin this is not the case with pSTAT5 
signalling. The percentage of pSTAT5-positive TIDA neurones in stressed early 
pregnant mice was low and comparable to non-stressed mice, showing negative 
feedback via the pSTAT5 signalling pathway is not altered by stress alone (at basal 
prolactin levels). However, the addition of oPRL significantly increased the % 
pSTAT5-positive TIDA of stressed pregnant mice only, demonstrating stress 
enhances negative feedback in these mice.  
Stress and prolactin treatment had no notable effect on pSTAT5 expression in the 
hypothalamic SON and PVN despite prolactin receptors being expressed in these 
nuclei (Kokay et al., 2006). In non-pregnant rats prolactin treatment is reported to 
decrease firing rates of oxytocin neurones, while having no effect on vasopressin 
neurone activity. Therefore, prolactin seems to directly and specifically regulate 
oxytocin neurone activity (Kokay et al., 2006). A study in male rats has reported that 
prolactin has an inhibitory effect on oxytocin releas , influencing activation of the 
JAK-STAT signalling pathway as well as neuronal excitability of oxytocin neurons. 
Although the functional significance of this is yet to be fully elucidated it has been 
proposed that it may be important in  coordinating secretion of oxytocin with events 
that alter prolactin secretion, reflecting a feedback pathway to regulate the prolactin-
releasing role of oxytocin (Townsend et al., 2005). However, our data show that LPS 





Expression of pSTAT5 nuclei in the VMH was increased with prolactin treatment 
but was not altered by LPS stress although significance of this unclear. Previous 
studies have reported limited STAT5 expression in VMH and DMH (dorsomedial 
hypothalamic nuclei), areas of the hypothalamus known to regulate energy balance 
and feeding (Lee et al., 2008). This suggests a role for STAT5 and prolactin in 
energy balance. Appetite and food intake are increased in pregnancy in order to meet 
the high metabolic demands of the developing offspring and increase fat storage for 
lactation. For this to occur and be maintained pregnant females become resistant to 
the anorectic actions of leptin (Ladyman et al., 2010). Prolactin is reported to be 
orexigenic, acting centrally to increase food intake by inducing leptin resistance and 
suppressing intracellular signals of leptin receptor activation in the VMH and PVN 
(Naef and Woodside, 2007). Consistent with these reports, prolactin receptor-
deficient mice (male and female) display reduced boy weight and fat mass 
compared to wild-type, supporting the role for prolactin in weight regulation 
(Freemark et al., 2001). 
Therefore, enhanced prolactin negative feedback, via prolactin receptor-induced 
signalling at the TIDA neurones, does not appear to underlie LPS-induced prolactin 
suppression in early pregnant mice  
 
4.4.2 Effect of 24h fast stress on prolactin negative feedback 
As shown previously (see section 3.3.5), 24h fasting in early pregnancy decreased 
circulating prolactin whilst having no considerable effect on virgin mice (treated with 
prolactin buffer). As with LPS stress, additional treatment with oPRL decreased 
murine plasma prolactin in non-stressed early pregnant mice as expected, 
demonstrating prolactin negative feedback. In virgin mice there appears to be a 
general trend of reduction in plasma prolactin with oPRL treatment, however, this is 
not significant. It may be the case that the dose of oPRL given was too low to see a 
significant decrease in the already relatively low plasma prolactin levels (compared 
to pregnant mice). Other studies looking at prolactin negative feedback in mice have 
observed an increase in negative feedback using much higher doses of oPRL e.g. 
Brown et al., 2011, used a dose five times higher (5µg/g body weight). The dose 
chosen for our experiments has been previously shown t  increase pSTAT5 nuclear 




(Anderson et al., 2006b). However, in our mice the increase in pSTAT5 expression, 
due to oPRL treatment, may not be high enough to significantly impact on plasma 
prolactin levels at the time point observed. In addition, the data generated is quite 
variable and thus may be masking a subtle reduction in plasma prolactin with oPRL 
treatment. In early pregnancy, although fasting stres  reduced plasma prolactin, 
oPRL supplementation did not further decrease it, suggesting prolactin negative 
feedback is not enhanced further by stress.  
As with immune stress, 24h fast alone did not alter pSTAT5 signalling in either 
virgin or early pregnant mice. The expression of pSTAT5 in the TIDA neurones was 
equally low in control and fasted mice administered prolactin buffer only. oPRL 
increased pSTAT5 expression in the arcuate of virgin and early pregnant mice. The 
percentage of pSTAT5-positive TIDA neurones in stressed early pregnant mice 
(treated with prolactin buffer) was low and comparable to non-stressed mice, 
showing negative feedback was not enhanced by stress alone (at basal prolactin 
levels). However, the addition of oPRL significantly increased the % pSTAT5-
positive TIDA neurones in fasted virgin and pregnant mice, once again 
demonstrating stress enhances negative feedback in these mice.  
The overall expression of pSTAT5-postive neurones i these data is relatively low 
compared to other studies, this is likely due to using a lower dose of oPRL to drive 
feedback (Brown et al., 2011, Sjoeholm et al., 2011). However, the dose we chose 
has been previously used before e.g. in lactating rats whose pups were removed for 
16h, oPRL injection significantly increased the STAT5 nuclear: cytoplasmic ratio 
compared to vehicle (Anderson et al., 2006b).  
Prolactin receptor expression is known to increase during pregnancy and lactation in 
the choroid plexus and a number of hypothalamic nuclei including the arcuate 
nucleus, PVN and SON (Grattan et al., 2001a). There is mounting evidence that 
raised prolactin levels increase food intake, with i.c.v. administration of prolactin 
inducing hyperphagia in virgin female mice in a dose-dependent manner (Sauve´ and 
Woodside, 1996). In addition, prolactin via i.c.v. increases food intake without 
influencing oestrous cyclicity, and irrespective of whether administered bi-daily or 
chronically via infusions (Noel and Woodside, 1993, Sauve´ and Woodside, 1996, 




activation leads to increased food intake, independently of steroid hormone levels, 
and therefore raised prolactin levels during early p egnancy may contribute to 
hyperphagia (Ladyman et al., 2010). 
 
4.4.3 Relationship between plasma prolactin and STAT5 activity 
In general, an inverse relationship seems to exist between prolactin and % pSTAT5 
in TIDA neurones in both the LPS and fast studies. However, there is an obvious 
outlier to this theory in that stress in early pregnancy (no prolactin) suppresses 
prolactin despite low pSTAT5 expression. This implies that although pSTAT5 
expression can be driven following stress in early p egnant mice (with oPRL), it is 
not exclusively responsible for the stress-reduced prolactin. Data show stress alone 
causes prolactin suppression but not via increased pSTAT5 expression, thus it is not 
utilizing the prolactin short-loop feedback system. This cannot explain the mild 
stress-induced increase in TIDA activation previously observed or the decrease in 
prolactin secretion in early pregnancy so other stres -related hypothalamic 
mechanisms must be responsible. 
 
4.4.4 Potential pregnancy or stress-related factors a geting TIDA neurones  
4.4.4.1 The CRH system 
TIDA neurones are thought to be targets for the CRH system and are known to 
express CRH receptors. CRH R1 receptor-like immunoreactivity (CRH R1-ir) is 
apparent in rat TIDA neurones, however, CRH-ir fibre innervation is very sparse in 
the arcuate nucleus suggesting it is does not have a major role in TIDA regulation 
(Campbell et al., 2003). CRH could also have an indirect effect on the TIDA 
response via activation of the LC which is innervated by CRH-like immunoreactive 
fibres (Ehlers et al., 1983, Valentino et al., 1992, Jedema and Grace, 2004) and 
expresses receptors for CRH (Sánchez et al., 1999). The LC is robustly activated 
following stressful stimuli in experimental animals (e.g. see section 3.3.2.8) and 
leads to increased noradrenaline (NA) levels in the CNS (Itoi and Sugimoto, 2010). 
Noradrenaline from the LC plays a role in LH pulse inhibition in response to stress 
and noradrenaline neurones are known to project to the arcuate nucleus or medial 
preoptic area (MPOA) (Campbell and Herbison, 2007) directly or indirectly e.g. via 




following stress, may impact directly on the arcuate nucleus, altering TIDA 
activation. 
 
4.4.4.2 Sex steroids and SOCs 
TIDA neurones also have receptors for steroids suchas progesterone and oestrogen 
which change with reproduction state (Steyn et al., 2007).  High levels of 
progesterone are present from the day of mating and, along with the enhanced 
presence of steroid receptors during pregnancy, supports the idea that steroid 
hormones may directly alter TIDA neurone activation t  regulate prolactin secretion 
(Steyn et al., 2007, Leite et al., 2008). How this affects TIDA neurone 
responsiveness to stress stimuli during early pregnancy is unclear from the literature 
at present. Oestradiol has been shown to greatly augment prolactin-induced STAT5 
activation, and increase prolactin receptor, SOCS-3 and CIS mRNA levels in the 
arcuate nucleus and choroid plexus (Anderson et al., 2008).  
As mentioned previously, during late gestation and l ctation prolactin loses its ability 
to drive phosphorylation of STAT5b and this was found to be associated with 
enhanced SOCS mRNA which may underlie reduced TIDA neurone dopamine 
output  (Anderson et al., 2006a). During stress in early pregnancy, the opposite effect 
may occur and expression of SOCS may be diminished, t us allowing increased 
pSTAT5b signalling and suppressed prolactin secretion. However, this seems 
unlikely as LPS treated mice have been shown to have increased expression of 
SOCS-3 in the pituitary (Chesnokova et al., 2002) and we found that stress reduces 
prolactin despite low pSTAT5 levels.  
 
4.4.4.3 Stress-induced cytokines 
Another possible stress-related mechanism driving TIDA activation and/or prolactin 
suppression is activity of cytokines associated with stress/LPS. IL-6 and TNF-α are 
potential candidates for involvement as they are both released following LPS 
treatment in early pregnancy (see section 3.3.2.3 and 3.3.3.1, respectively) and are 
known to be detrimental to pregnancy maintenance (Carpentier et al., 2011).  
STAT5 A and B are widely expressed and activated by a plethora of cytokines 




al., 2007), IL-10 (Wehinger et al., 1996), and IL-4, and  growth hormones (Han et 
al., 1996, Herrington et al., 2000), in addition to pr lactin.  
In order to investigate the role of proinflammatory cytokines further we selected two 
cytokines: TNF-α and IL-6, which were administered to early pregnant mice to 



































4.5.1 The cellular T system 
One of the most important components of the cellular immunosystem which adapt in 
early pregnancy are the helper T (Th) cells (reviewed in (Guerin et al., 2009)). Naive 
CD4+ T cells differentiate into two polarised forms, Th1 and Th2 cells, which exhibit 
different effector responses. Th 1 cytokines (e.g.TNF-α) trigger numerous cell-
mediated cytotoxic and inflammatory responses, while Th 2 cytokines (e.g. IL-10) 
are involved with B cell anti-body production and are required for the secretion of 
hPL and hCG (Druckmann and Druckmann, 2005). 
 
4.5.1.2 The cellular T system in pregnancy 
It has been suggested that successful pregnancy is characterised by a Th2 
phenomenon, with higher Th2 cytokine production andrelease involved in foetal 
allograft survival and pregnancy maintenance (Piccinni et al., 1995, Piccinni, 2006).  
Recently the Th1:Th2 paradigm has been extended to nc mpass Th17 cells (which 
produce the pro-inflammatory cytokine IL-17) and regulatory T (Treg) cells (which 
regulate Th cells). Th17 cells play a role in induction of inflammation and in the 
pathogenesis of rejection, while Treg are involved in immunoregulation as well as 
peripheral tolerance (Saito et al., 2010). In early p egnancy Treg cells are highly 
expressed in the decidua. Decreased numbers of peripheral and decidual Treg cells 
have been observed in spontaneous miscarriage cases, suggesting Treg cells 
contribute to maternal immune tolerance of conceptus antigens and support 
pregnancy maintenance (Sasaki et al., 2004). 
 
4.5.2 Progesterone as an immunosteroid 
We have shown that stress in early pregnancy decreases circulating progesterone and 
prolactin, both of which may also disrupt the cytokine milieu. Progesterone is known 
to act as an immunosteroid, aiding maternal tolerance to the foetal ‘semi-allograft’. 
In this capacity, progesterone inhibits very early T-cell lymphopoiesis (generation of 
lymphocytes) and provides a pregnancy protective immune environment favouring 




Progesterone exerts an anti-abortive effect by triggering progesterone induced 
blocking factor (PIBF) release (Arck et al., 2007). In mice, PIBF reduces NK cell 
activity (which correlates with resorption rate) (Szekeres-Bartho et al., 1997a) and 
alters the cytokine profile of activated lymphocytes, favouring production of Th2 
cytokines over Th1 cytokines (Szekeres-Bartho and Wegmann, 1996). Stress in early 
pregnancy decreases circulating progesterone, reduces PIBF and increases resorption 
rates in mice, all of which have been shown to be abrogated with progesterone 
treatment (Joachim et al., 2003, Parker and Douglas, 2010).  These data highlight the 
importance of progesterone in establishing and maintaini g a suitable cytokine 
balance in the peri-implantation period.  
 
4.5.3 Prolactin and immune regulation 
Prolactin is known to be immunomodulatory, not just through its role in driving 
progesterone secretion in mice (Freeman et al., 2000). Prolactin has been shown to 
regulate the cytokine profile and enhance the production of IFN-γ, IL-10 and IL-12 
in a stimulus specific manner (Matalka, 2003, Matalka and Ali, 2005). In addition, 
decidual prolactin silences expression of genes thoug t to be detrimental to 
pregnancy, including IL-6 and 20α-HSD in decidua (Bao et al., 2007). 
 
4.5.4 Effects of stress on cytokine balance in pregnancy 
Cytokines are reported to be key mediators in the bi-directional interaction between 
the maternal immune system and the reproductive syst m throughout pregnancy 
(Wegmann et al., 1993). Cytokines are not only released following infection or 
inflammation but have been shown to be secreted following physical and 
psychological stress (Turnbull and Rivier, 1999). The cytokine profile displayed in 
early gestation is delicate and can be disturbed by a number of stressors, including 
immune challenges such as LPS or physical stressors uch as hunger (Parker and 
Douglas, 2010). Psychoemotional stress also disrupt the cytokine balance in mice, 
resulting in foetal loss (Blois et al., 2004). A study into psychological stress in 
pregnant women reported a positive correlation betwe n high perceived stress scores 
and elevated serum proinflammatory cytokines (IL-6 and TNF-α) and lower anti-




al., 2005). An increased Th1 profile is also apparent in blood and decidual cells of
pregnant mice following stress (Blois et al., 2005b, Blois et al., 2007). 
 
4.5.5 Effects of IL-6 and TNF-α on the HPA axis  
Two proteins known to be detrimental for the normal progress of pregnancy are the 
cytokines IL-6 and TNF-α, both of which are elevated in the serum of women with
preeclampsia (Szarka et al., 2010). It has long been known that cytokines are potent 
activators of the central stress response, constituting part of the feedback loop 
through which the immune system communicates with the CNS (Chrousos, 1995). 
LPS administration activates the HPA axis and induces the synthesis and release of 
cytokines including IL-6 and TNF-α (Turnbull and Rivier, 1999, McCann et al., 
2000). TNF-α and IL-6 are able to stimulate activation of the HPA axis either alone, 
or in synergy with each other (Chrousos, 1995, Tsigos and Chrousos, 2002). The 
principal action of these cytokines is probably on the release of CRH and vasopressin 
from the hypothalamus, but they can also have effects at the pituitary level. IL-6 and 
TNFα have both been shown to stimulate ACTH release from the anterior pituitary in 
vitro and in vivo (McCann et al., 1994).  
 
4.5.6 The role of IL-6 in immune regulation  
IL-6 is a multifunctional cytokine that is produced from immune cells (e.g. 
macrophages and dendritic cells) as well as a variety of other cells including 
endothelial and epithelial cells (Diehl and Rincón, 2002). IL-6 binding to its receptor 
induces activation of JAK/STAT signalling pathways as well as the 
CCAAT/enhancer binding protein (C/EBP) pathway (Diehl and Rincón, 2002). 
Activation of JAK1and JAK 2 by IL-6 causes activation of STAT 3 and mildly 
activates STAT1.  
IL-6 is involved in the control of Th1:Th2 differentiation, promoting Th2 
differentiation (dependent upon endogenous IL-4) whilst inhibiting Th1 polarization. 
IL-4 is the most potent factor that stimulates naive CD4+ T cells to differentiate to 
the Th2 phenotype and IL-6 has been demonstrated to in uce IL-4 production in 
CD4+ T cells, that then polarizes naive CD4+ T cells to effector Th2 cells (Rincón et 
al., 1997). IL-6 also upregulates SOCS1 expression in activated CD4+ T cells, 




IFN-γ receptor-mediated signals suppresses autoregulation of IFN-γ gene expression 
during activation of CD4+ T cells. Consequently, Th1 differentiation is prevented 
(Diehl et al., 2000). Therefore, IL-6 has a dual role in Th1/Th2 differentiation, 
promoting Th2 and inhibiting Th1 differentiation. 
 
4.5.7 Effects of IL-6 and TNF-α in pregnancy 
4.5.7.1 Effects of IL-6 in pregnancy 
Mounting evidence indicates that IL-6 can directly modulate gonadal functions. In 
the ovary IL-6 is produced by rat granulosa cells and can suppress progesterone 
secretion in vitro in rat and porcine granulosa cells (Gorospe et al., 1992, Machelon 
et al., 1994). IL-6 is not normally expressed in the decidua and both IL-6 and its 
receptor have been shown to be downregulated in the rat decidua by prolactin and 
oestradiol (Deb et al., 1999b).  Decidual prolactin is a robust repressor of IL-6 
expression in the mouse decidua (Bao et al., 2007). Although decidual IL-6 is 
normally suppressed it is produced in response to inflammation and is thought to 
have an important role in the pathophysiology of infection-induced preterm labour 
(Romero et al., 1990, El-Bastawissi et al., 2000, Bao et al., 2007). Production of IL-6 
during pregnancy may trigger an inflammatory respone and compromise pregnancy 
success, thus prolactin-induced inhibition of its expr ssion in the decidua could be of 
major physiological importance. 
IL-6 mRNA is also not expressed in the corpus luteum throughout the majority of 
pregnancy in the rat (only apparent in very early pegnancy and immediately 
following parturition) but it too has been shown to be induced by LPS. Progesterone 
inhibits IL-6 expression and therefore it is likely the high levels of this hormone 
during pregnancy prevent the expression of IL-6 which may have a deleterious effect 
on corpus luteum function (Telleria et al., 1998). 
 
4.5.7.2 Effects of TNF-α in pregnancy 
TNF-α is a pleiotropic cytokine and has been identified throughout the female 
reproductive tract, placenta and embryonic tissue (Terranova et al., 1995). Elevated 
levels of TNF-α are thought to be adverse to reproduction and numerous studies have 
revealed that TNF-α administration to pregnant mice results in foetal loss (Toder et 




embryonic death) have found that these mice exhibit an ncreased level of TNF-α in 
decidual cell cultures (reviewed in (Toder et al., 2003)) and also have elevated 
expression in the placenta (Tangri and Raghupathy, 1993). In rats, LPS-induced 
foetal loss can be abrogated by blocking of maternal TNF-α activity (Renaud et al., 
2011). In mice, various stressors have been reported to activate TNF-α producing 
cells at the foetal-maternal interface and increase production of TNF-α. Ultrasonic 
stress significantly elevates resorption rate with a maximal effect on gestation day 
5.5 and increased decidual TNF-α release (Arck et al., 1995). These observations 
have implicated TNF-α in triggering immunological-induced pregnancy loss (embryo 
death due to failure to prevent rejection) (Clark et al., 1999, Raghupathy, 2001). 
TNF-α is thought to act as a mediator in stress-induced embryonic death, possibly 
through dysfunction of mechanisms required for the uterus to become receptive to 
blastocysts, thus preventing implantation (Torchinsky et al., 2005). In women the 
level of TNF-α in the amniotic fluid is significantly higher with uterine infections 
and is associated with preterm birth incidence (Romer  et al., 1990). TNF-α has also 
been implicated in other pregnancy complications such as preeclampsia in baboons 
(Sunderland et al., 2011)  and humans, where it has been suggested as useful marker 
for preeclampsia in the first trimester (Serin et al., 2002, Leblanc et al., Epub ahead 
of print). 
TNF-α has been characterised over recent years as a powerful apoptotic activator as 
well as an activator of anti-apoptotic signalling cas ades. It has been described to 
boost death signalling in order to kill the embryo if an initial adverse situation causes 
structural abnormalities, while triggering protective mechanisms if damage repair is 
possible and may avoid maldevelopment (Toder et al., 2003).  
 
4.5.8 IL-6, TNF-α and prolactin 
The rat pituitary cell line, MtT/SM, secretes prolactin and has the characteristics of 
somatomammotrophs. IL-6 has been found to stimulate proliferation of these cells 
and inhibit the secretion of prolactin (and growth hormone) suggesting IL-6 inhibits 
the functions of mammotrophs (lactotrophs) and somat trophs in the pituitary gland 
(Tomida et al., 2001). 
TNF-α, along with other proinflammatory cytokines such as IL-1α and IL-8, have 




from primary human decidual cells from term pregnancies. However, IL-6 treatment 
was not shown to alter basal decidual prolactin release. This study suggests a 
paracrine role for cytokines released by decidual macrophages in regulation of 
decidual prolactin expression (Jikihara and Handwerger, 1994). TNF-α 
administration to male rats was reported to decrease circulating prolactin but it did 
not alter the DOPAC:dopamine ratio in the hypothalamus or pituitary. However, both 
dopamine and DOPAC levels were raised in the anterior pituitary following TNF-α 
treatment (i.c.v.), indicating an increase in dopamine turnover which could mediate 
the suppressive effect on prolactin (de Laurentiis A, 2002). 
Both IL-6 and TNF-α are released following stress in early pregnancy ad are 
reputed to threaten pregnancy maintenance. Therefor, in order to investigate the 
effect of TNF-α and IL-6 in early pregnancy on prolactin and its regulation, d5.5 
pregnant mice were administered TNF-α or IL-6 (or vehicle). We aimed to use 
immunocytochemistry, double labelling for tyrosine hydroxylase and Fos, to 
determine whether there is an alteration in TIDA neurone activation following 
proinflammatory cytokine treatment in early pregnancy, and whether this is 
associated with reduced plasma prolactin/progesterone. 
 
4.5.9 Aim and hypotheses 
 
Aim: 
1. To determine the effect of TNF- α and IL-6 treatment on prolactin secretion 
and its regulation in early pregnancy. 
 
Hypotheses: 
1. TNF-α and IL-6 treatment decrease circulating prolactin and progesterone in 
early pregnancy. 











4.6.1 Effect of IL-6 and TNF-α on hormones and neuronal activation in early 
pregnancy 
4.6.1.1 Treatment 
d5.5 pregnant mice were gently restrained in a holding bag and either injected with 
recombinant mouse IL-6 (200ng in 100µl 0.4% BSA in PBS i.p; R&D Systems, Inc., 
Minneapolis, US; n = 7 (Zalcman et al., 1998, Dunn, 2006)), recombinant mouse 
TNF-α (3µg in 100µl 2% BSA in PBS; R&D Systems, Inc., Minneapolis, US; i.p; n 
= 7 (Sundgren-Andersson et al., 1998)) or vehicle (100µl 0.4% or 2% BSA in PBS 
i.p; n = 6, 5 respectively) around 10am (3h after lights on). Mice were returned to 
their home cages. Drugs were reconstituted according to manufacturer’s instructions 
(R&D Systems, Inc., Minneapolis, US) before dilution t  the desired dose. 
 
4.6.1.2 Blood/tissue collection and perfuse fixation 
After 90 min mice were quickly moved to an adjacent room and injected with an 
overdose of sodium pentobarbitone (0.3ml i.p; Centravet, 22106 Didan, France). 
Once the mouse was deeply anaesthetised (no signs of breathing, non-responsive to 
toe pinch) the heart was exposed. Blood was removed by cardiac puncture before the 
mouse was perfused with heparinised saline and then fix d with 4% 
paraformaldehyde (as described in General Methods section 2.9.1). The brains were 
carefully removed and stored overnight (4ºC) in 4% paraformaldehyde and 15 % 
sucrose solution. They were then cryoprotected in a 30% sucrose solution at 4ºC 
overnight. Following this the brains were frozen befor  sectioning. Blood was 
processed for plasma and frozen (-20°C) prior to use in assays. Following 
blood/tissue collection pregnancy status was checked by laparotomy and inspection 
of the uterine horns for evidence of implantation sites. 
 
4.6.1.3 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.2.2) for the mouse prolactin DuoSet 






4.6.1.4 Progesterone RIA 
Plasma samples (undiluted) were assayed in duplicate using a progesterone RIA kit 
(DSL-3900; kit 1; see section 2.6.1.2). 
 
4.6.1.5 Corticosterone RIA 
Plasma samples were diluted 1 in 200 and assayed in duplicate using a 
cortocosterone RIA kit (Corticosterone ImmunChem Double Antibody RIA kit; MP 
Biomedicals) (see section 2.6.3.2).  
 
4.6.1.6 Brain sectioning, tyrosine hydroxylase/Fos ICC and analysis 
Brains were sectioned using a freezing microtome with sl ces cut at 48µm. Coronal 
brain sections (containing PVN, arcuate nucleus, VMH and SON) were stored in 
cryoprotectant before double immunocytochemistry (ICC) was carried out for Fos 
and tyrosine hydroxylase (see section 2.10.3). Sections were processed and 
visualised using the avidin-biotin peroxidase complex (ABC) method with nickel 
DAB/DAB. 
Fos-positive cells (containing a dark grey/black nucle s) were counted in around 4 
sections per mouse for each area of interest (defined using (Franklin K, 1997)). This 
was carried out on coded slides using a light micros ope (20x or 40x objective). In 
addition to Fos only counts, the arcuate nucleus was also analysed the number of 
tyrosine hydroxylase cells colocalized with Fos (expr ssed as % of the total number 
of tyrosine hydroxylase cells). Cells with a dark gey/black nucleus and brown 
cytoplasmic staining were counted as double labelled (colocalisation). 
 
4.6.2 Statistics 
Statistical evaluation of the mean hormone concentrations and neuronal activation 
were determined by 1-way ANOVAs with a Holm-Sidak post-hoc test. Student t-
tests were used to evaluate whether there was a difference between the two vehicle 
groups (0.4% and 2% BSA in PBS) for each of the above parameters. The data from 
the two vehicle groups were pooled for the graphs and statistics as they were not 
significantly different for any of the parameters measured (Students t-test, ns). Data 







4.7.1 Effect of IL-6 and TNF-α on plasma hormones and neuronal activation in early 
pregnancy.  
4.7.1.1 Prolactin concentration 
IL-6 treatment had no significant effect on plasma prolactin concentration in d5.5 
pregnant mice but TNF-α significantly decreased prolactin compared to vehicl  and 
IL-6 treatment (1-way ANOVA, p<0.001 across treatment; Holm-Sidak p<0.05 
TNF-α vs. vehicle and vs. IL-6; Figure 4.10A).  
 
4.7.1.2 Progesterone concentration 
IL-6 treatment had no significant effect on plasma progesterone concentration in 
early pregnant mice but TNF-α significantly reduced circulating prolactin levels 
compared to vehicle and IL-6 treatment (1-way ANOVA, p<0.001 across treatment; 
Holm-Sidak p<0.05 TNF-α vs. vehicle and vs. IL-6; Figure 4.10B). 
 
4.7.1.3 Corticosterone concentration  
IL-6 and TNF-α treatment increased corticosterone levels in early pregnant mice (1-
way ANOVA, p<0.001 across treatment; Holm-Sidak p<0.05 TNF-α vs. vehicle and 
vs. IL-6; Figure 4.10C). Although a Holm-Sidak test following a 1-way ANOVA did 
not report a significant increase in corticosterone with IL-6, a Student t-test (IL-6 vs. 
vehicle) did reveal a significant change (p<0.05).   
 
4.7.1.4 Activation of TIDA neurones 
IL-6 and TNF-α treatment significantly increased the number of Fos-p sitive 
neurones per arcuate profile (Figure 4.11 A and B), in a similar manner, compared to 
vehicle (1-way ANOVA, p<0.01 across treatment; Figure 4.11 C). The proportion of 
activated TIDA neurones (presented as % Fos-positive tyrosine hydroxylase 
neurones) mildly increased following both IL-6 and TNF-α injection compared to 
vehicle (1-way ANOVA, p<0.01 across treatment; Figure 4.11 D). TNF-α treatment 



















4.7.1.5 Activation of other hypothalamic cell groups  
Supraoptic nucleus (SON):  
In the SON, IL-6 treatment had no significant effect on the number of Fos-positive 
nuclei in d5.5 pregnant mice compared to vehicle. TNF-α significantly increased Fos 
expression in the SON compared to both vehicle and IL-6 treatment (1-way 
ANOVA, p<0.001 across treatment; Holm-Sidak p<0.05 TNF-α vs. vehicle and vs. 
IL-6; Figure 4.12).  
Paraventricular nucleus (PVN): 
In both the mPVN and the pPVN, IL-6 treatment had no significant effect on the 
number of Fos-positive nuclei in early pregnant mice compared to vehicle. TNF-α 
significantly increased Fos expression in both PVN regions compared to vehicle and 
IL-6 treatment (1-way ANOVAs, p<0.001 across treatment; Holm-Sidak p<0.05 
TNF-α vs. vehicle and vs. IL-6; Figure 4.13).  
Ventromedial hypothalamus (VMH):  
In the VMH, IL-6 treatment mildly increased the number of Fos-positive nuclei in 
d5.5 pregnant mice compared to vehicle. TNF-α significantly increased Fos  
expression in the VMH compared to both vehicle and IL-6 treatment (1-way 
ANOVA, p<0.001 across treatment; Holm-Sidak p<0.05 IL-6 vs. vehicle, p<0.05 





































4.8 Discussion  
  
4.8.1 Effect of IL-6 and TNF-α on plasma hormones and TIDA neuronal activation in 
early pregnancy.  
The activity of cytokines associated with stress/LPS in early pregnancy may 
influence prolactin regulation, lead to suppression of prolactin secretion and threaten 
foetal survival. IL-6 and TNF-α are known to be detrimental to pregnancy 
maintenance (Carpentier et al., 2011) and were candid tes for our study into the 
effect of stress-induced pro-inflammatory cytokines on prolactin and its regulation. 
Serum TNF-α levels in early pregnant women have been reported to be elevated 
before miscarriage and may play a significant role in recurrent pregnancy loss 
(Çolakoglu et al., 2004). However, the role of IL-6 in pregnancy maintenance/loss is 
less clear. There are reports that IL-6 serum levels are higher in healthy pregnancies 
compared to women undergoing recurrent spontaneous abortion (Makhseed et al., 
2000) implying that IL-6 is pregnancy protective. However, decidual IL-6 expression 
and content in the amniotic fluid is associated with inflammation and preterm labour 
(El-Bastawissi et al., 2000, Bao et al., 2007). 
In support of a possible role for IL-6 and TNF-α in stress-induced adverse effect on 
pregnancy we have shown that circulating levels of these cytokines are increased 
following LPS treatment in early pregnancy (see section 3.3.2.3 and 3.3.3.1, 
respectively). IL-6 administration to d5.5 pregnant mice was found to mildly increase 
corticosterone levels, indicating activation the HPA stress axis, however, it had no 
significant effect on circulating prolactin or progesterone compared to vehicle. Thus 
stress-induced IL-6 release does not seem to underlie prolactin suppression following 
stress in early pregnancy. Conversely, TNF-α treatment significantly reduced both 
plasma prolactin and progesterone levels in early pregnant mice, in addition to 
robustly elevating corticosterone levels. Double ICC for Fos and tyrosine 
hydroxylase expression in the arcuate nucleus reveal d that both IL-6 and TNF-α 
mildly increased activation of TIDA neurones. Therefo , data demonstrate that 
TNF-α may be partly responsible for stress-reduced prolactin secretion through 
action directly at the pituitary lactotrophs since it does not strongly alter TIDA 




increases TNF-α release from lactotrophs while also decreasing prolactin release 
(Theas MS, 1998). 
 
4.8.2 Effect of IL-6 and TNF-α on neuronal activation in other hypothalamic nuclei  
Other hypothalamic nuclei seem to behave in a slightly different manner to those in 
the arcuate nucleus following IL-6 treatment. In cotrast to the general increase in 
the activation of the neuronal population of the arcu te nucleus, IL-6 did not 
stimulate Fos expression in the SON or PVN and onlymi dly increased Fos 
expression in the VMH. TNF-α treatment also increased Fos expression throughout 
the arcuate nucleus to a similar level as IL-6. However, TNF-α (like LPS) robustly 
increased activation in the SON, pPVN and VMH. Whether, as with LPS treatment, 
the pPVN response to TNF-α is attenuated in early pregnancy compared to virgins 
(possible reflecting oxytocin neurone response) is unknown at present as this study 
did not include the virgin groups required for comparison. Oxytocin is reported to be 
a key prolactin-releasing factor and is involved in the regulation of prolactin 
secretion (Freeman et al., 2000). For example, oxytocin is essential for the bi-daily 
prolactin surges observed in rats following cervical stimulation (McKee et al., 2007). 
Therefore, it is possible that TNF-α induces changes in oxytocin neurone activity and 
secretion of oxytocin in early pregnancy that could contribute to the reduced 
prolactin levels observed at this time. 
LPS treatment to d5.5 pregnant mice profoundly affected pregnancy rate, resulting in 
occult foetal loss. However, it is not known what effect the pro-inflammatory 
cytokines IL-6 and TNF-α have on resorption rate as all mice were sacrificed after 90 
min on d5.5 of pregnancy. In order to determine the eff ct on foetal survival the 
experiment would need to be repeated and mice sacrificed on d13.5 to allow 
resorption site analysis. 
IL-6 treatment had a minimal effect on neurone activ tion in a number of 
hypothalamic nuclei, compared to TNF-α. It is possible that if IL-6 was administered 
at a higher dose we may see a more profound effect on the pregnancy 
hormones/neuronal activation, as although the HPA axis was activated this was only 
observed as a relatively mild increase in corticosterone vs. vehicle when compared to 
TNF-α. However, previous studies using the same dose hav found that although 




IL-6 treatment, this dose was high enough to induce behavioural effects, 
mesocortical dopamine activity in the hippocampus and prefrontal cortex, and 
increase serotonin levels from the hypothalamus (Zalcm n et al., 1998, Dunn, 2006). 
The TNF-α dose used has previously been used in a study into the role of TNF-α in 
fever and was demonstrated to elicit hypothermal reactions (dependent on IL-6) but 
we did not measure body temperature (Sundgren-Andersson et al., 1998). 
Although both stressors activated the HPA axis and mil ly increased TIDA 
activation (as measured by Fos expression in the TIDA neurones) only TNF-α 
reduced prolactin and progesterone secretion, and activated a number of other 
hypothalamic nuclei. As both IL-6 and TNF-α mildly increased TIDA activation, but 
IL-6 had no effect on prolactin secretion, it does not appear that stress-reduced 
prolactin is completely due to the effects of  IL-6 or TNF-α on TIDA neurone 
dopamine activity. Rather, stress-reduced prolactin in early pregnancy may be as a 
result of proinflammatory cytokine effects on the TIDA neurones in combination 
with other mechanisms. For example, TNF-α in early pregnancy may act directly at 
the pituitary lactotrophs to suppress prolactin release possibly through triggering 
apoptosis of lactotrophs and consequently decreasing in prolactin secretion. 
The neuroendocrine mechanisms controlling prolactin are highly sensitive to 
cytokines and in order to test these mechanisms further experiments need to be 
carried out. A number of cytokines, including TNF-α, are known to activate the 
JAK2/STAT3 signalling pathway (Miscia et al., 2002, Romanatto et al., 2007). For 
example, Romanatto et al. have demonstrated that TNF-α activates JAK2/STAT3 
and modulates insulin and leptin signalling and action in the hypothalamus inhibiting 
food intake. To investigate the effect of stress on pro-inflammatory cytokine 
signalling in hypothalamus, ICC could be carried out f r pSTAT3 nuclear expression 
in stressed early pregnant mice. In addition, to investigate the role of cytokines in 
prolactin inhibition a range of cytokine receptor antagonists or blockers could be 
injected centrally prior to stress exposure and then TIDA/dopamine activity and 
prolactin secretion measured. This would allow us to test for cross-talk between 
cytokines/receptors and help ascertain the mechanism behind cytokine/stress-reduced 















5.1.1 Stress and anxiety during pregnancy 
Anxiety is thought to be a psychophysiological sign that the stress response has been 
initiated. The locus coeruleus (LC) is robustly activated following stressful stimuli 
and thus is regarded as an important part of the central ‘stress circuitry’. Mounting 
evidence also suggests a relationship between the central noradrenergic system and 
fear ⁄anxiety states and depression (Itoi and Sugimoto, 2010). Around 30% of women 
experience some type of anxiety disorder during their lif time and symptoms may 
change in these women during pregnancy and the postpartum period (Levine et al., 
2003). 
Maternal anxiety has adverse effects on pregnancy (Da an et al., 2002, Orr et al., 
2007) and women who experience more stress and anxiety during pregnancy have 
significantly higher rates of adverse birth outcomes e.g. low birth weight. Multiple 
studies report a relationship between increased risk of preterm birth and ‘pregnancy-
related’ or ‘state’ (response to environmental stressors) anxiety (Lobel et al., 1992, 
Rini et al., 1999, Dole et al., 2003). Pregnancy-specific anxiety refers to maternal 
worries or concerns related to pregnancy such as labour, delivery and health of the 
offspring (Rini et al., 1999). An early study found that anxiety in the first trimester 
(as well as the second and third) is associated with abnormalities during pregnancy 
and parturition e.g. threatened abortion, preterm labour (Gorsuch and Key, 1974). 
Anxiety and depression in the first trimester are also linked with the subsequent risk 
for preeclampsia (Kurki et al., 2000). In addition, maternal anxiety or depression are 
related to functioning and development of the offspring. For example, women who 
were anxious during pregnancy have infants with an elevated risk of having non-
optimal neuromotor development (van Batenburg-Eddes et al., 2009). 
 
5.1.2 Reproductive hormones and anxiety 
Both pregnancy and lactation are accompanied by behavioural changes, including an 
altered responsiveness to stress. For example, during late pregnancy (d21) rats 




to virgin females (Neumann et al., 1998). These altr tions have been associated with 
the changes in reproductive hormones at different rproductive states (Young and 
Cook, 2004). Systemic administration of progesteron t  ovariectomised rats leads to 
reduced anxiety-like responses, with an increase in open-arm exploration on the 
EPM. The addition of oestradiol attenuates this effect. It has therefore been 
suggested that anxiety behaviour varies across the oestrous cycle due to the 
modulatory effects of ovarian hormones (Mora et al., 1996). In males rats, 
progesterone administration i.p rapidly produces significant anxiolytic behavioural 
effects 30 min after administration (Gomez et al., 2002).  
The effect of oestradiol on anxiety is unclear; some studies report an anxiolytic effect 
of oestradiol administration in rats (Marcondes et al., 2001, Bowman et al., 2002), 
but others report an anxiogenic effect of oestradiol treatment in rats and mice (Mora 
et al., 1996, Morgan and Pfaff, 2001).Marcondes et al. (2001) report that anxiety 
levels of female rats were lower in proestrous than during di-estrous, and conclude 
that the levels of oestradiol modulate this response. Another study also demonstrated 
changes in anxiety across the reproductive cycle in rats, reporting low levels of 
anxiety during late proestrus when progesterone levls are elevated and high levels 
of anxiety at stages when progesterone levels are low (oestrous, metoestrous, 
dioestrous and d21 of gestation) (Zuluaga et al., 2005). Although these studies 
conclude that oestradiol or progesterone, respectively, lead to reduced anxiety-like 
behaviour during proestrous, prolactin levels are also greater on the afternoon of 
proestrous (Freeman et al., 2000) and may contribute to reduced anxiety. In support 
of this, i.c.v administration of prolactin to rats decreases anxiety-like behaviours on 
the EPM in a dose dependent manner. In contrast, down-regulation of brain prolactin 
receptors (long-form), using an antisense oligodeoxynucleotide infusion, increases 
anxiety-like behaviour (Torner et al., 2001). This demonstrates an anxiolytic effect of 
prolactin acting at the brain level. Furthermore, infusion of ovine prolactin to female 
rats attenuated the stress-induced increase in CRH. Accordingly, the CRH response 
was further elevated by antisense targeting of the prolactin receptors. This suggests 
that prolactin reduces responsiveness of the HPA axis via prolactin receptors in the 




2002). In humans, a correlation between anxiety levels and serum prolactin has also 
been reported (Jeffcoate et al., 1986).  
 
5.1.3 Behavioural assays for anxiety 
Measuring anxiety-like behaviour in rodents has mostly been undertaken using 
animal models of anxiety, such as the EPM and the open field test (OFT). These tests 
are both based on exposure to aversive unfamiliar places and exploit the natural 
avoidance behaviours of rodents to exposed and unprotected areas (Belzung and 
Griebel, 2001). Thus, these tests are based on an axiogenic agent e.g. unprotected 
arm on the EPM or open area in OFT, and the anxiety level is determined from the 
number of entries to unprotected areas and the time spent in these regions (Carola et 
al., 2002). However, the conclusions drawn from these two tests are often 
contradictory. For example, one study comparing C57BL/6 and BALB/6 strains 
report that C57BL/6 mice are not very anxious and highly active, while BALB/6 
mice are highly anxious and not very active in the OFT (Crawley et al., 1997). In 
contrast, another report states that these two strain  h ve similar anxiety and 
locomotor activity profiles when using a number of behaviour tests such as the EPM 
and OFT (Rogers et al., 1999). Discrepancies between studies from different groups 
may reflect differences in behavioural analysis criteria. In addition, Rogers et al. 
(1999) found that data obtained from different anxiety tests were discordant. Strain 
differences on the EPM did not correlate with the OFT, implying that they do not 
measure the same behavioural traits.  
Behavioural responses are typically recorded for 5 min as early studies revealed that 
rats demonstrated the most robust avoidance behaviours in this period (Montgomery, 
1955). Therefore, to test for anxiety behaviour following stress in early pregnancy, 
two commonly used behavioural tests were carried out for 5 min: the EPM and the 
OFT. As prolactin and progesterone are both reported to be anxiolytic stressed-









5.1.4 Aim and hypotheses 
 
Aim: 
1. To determine the effect of stress (LPS or 24h fasting) on anxiety behaviours 
in early pregnant mice. 
 
Hypotheses: 
1. LPS stress will increase anxiety-like behaviour in early pregnancy.  





























5.2.1 Effect of LPS stress on anxiety behaviour and plasma hormones 
5.2.1.1 Treatment 
Virgin and d5.5 pregnant mice were gently restrained i  a holding bag and injected 
with lipopolysaccharide (LPS; 12.5µg/100µl saline, i.p; E.coli E055:B5, Sigma, 
Poole, Dorset, UK; n = 6) (Hollis et al., 2005) or vehicle (saline; 100µl, i.p; n = 8) 
around 10am (3h after lights on). Mice were then returned to their home cages before 
carrying out the EPM. A second cohort of virgin and d5.5 pregnant mice were treated 
in the same way (LPS, n = 8, 11 respectively; vehicl , n = 7, 11 respectively) to 
provide another set of mice to carry out the OFT. 
 
5.2.1.2 Behavioural tests and blood collection 
A. Elevated plus maze 
Following 24h mice were removed from their home cage nd immediately moved to 
an adjacent room where the EPM was set up (see General M thods section 2.13.1 
and Figure 2.21).  The EPM is comprised of four arms (2 open, 2 closed) coming out 
from a central area (5x5cm square) on a 1m high cross-stand. The closed arms were 
enclosed by walls (15cm high x 30cm long x 5cm wide), while the open arms were 
completely open (30 cm long x 5cm wide (Carola et al., 2002)). The mice were then 
placed into the centre area (neutral area) of EPM and allowed to roam freely for 5 
min whilst being video recorded (experimenter left the behavioural room for 5 min). 
Immediately following the EPM test mice were moved to an adjacent room and 
killed by conscious decapitation (<1 min after removal from maze). Trunk blood was 
collected, processed for plasma and frozen (-20 oC) prior to use in assays. Following 
blood collection pregnancy status was checked by laparotomy and inspection of the 
uterine horns for evidence of implantation sites. 
The behavioural video was analysed manually for typical anxiety behaviour 
measures (Carola et al., 2002): the latency to first open arm entry, number of open 
arm entries, total number of entries (crude measure of overall locomotor activity) and 
percentage time spent open arms. In addition, investigation of the open arms was 
measured by counting the number of stretch attends performed (stretching out from 




Ashley Boyle (3rd year Physiology undergraduate summer student, The University of 
Edinburgh) assisted in carrying out this experiment and in video analysis. 
 
B. Open field test 
Mice were removed from their home cage, 24h after treatment, to an adjacent room 
containing the OFT (see General Methods section 2.13.  and Figure 2.22).  The OFT 
was carried out on an arena: board divided into 25 squares (5 x 5 squares; 10cm2) 
with a 15cm high wall (Kimura et al., 2009). The central 9 squares are considered to 
be the inner zone (more anxiogenic) and the outer 16 squares the outer zones (less 
anxiogenic). The mouse was placed onto the central square (in the inner zone) and 
allowed to move freely over the arena whilst being video recorded for 5 min 
(experimenter left the behavioural room for 5 min). Immediately following the test 
mice were moved to an adjacent room and killed by cons ious decapitation (<1 min 
after removal from maze). Trunk blood was collected, processed for plasma and 
frozen (-20 oC) prior to use in assays. Following blood collection pregnancy status 
was checked by laparotomy and inspection of the uterine horns for evidence of 
implantation sites. 
The behavioural video was analysed manually for percentage of time spent in the 
inner zone, number of inner zone entries, the number of crossings over the grid lines 
(to give indication of locomoter activity) and the number of times the mouse reared 
up/explored the outer wall (indication of activity and exploratory behaviour). 
Ciorstaidh McGlone (Neuroscience Masters student, The University of Edinburgh) 
assisted in carrying out this experiment and in video analysis. 
 
5.2.1.3 Prolactin ELISA 
Plasma samples were diluted 1 in 25 and assayed in duplicate using an adapted 
protocol (see General Methods section 2.7.2.2) for the mouse prolactin DuoSet 
ELISA kit (DY1445, R&D Systems, Inc., Minneapolis, US).  
 
5.2.1.4 Corticosterone RIA 
Plasma samples were diluted 1 in 200 and assayed in duplicate using a 
cortocosterone RIA kit (Corticosterone ImmunChem Double Antibody RIA kit; MP 




5.2.2 Effect of 24h fast on anxiety behaviour and plasma hormones 
5.2.2.1 Treatment 
Virgin and d5.5 pregnant mice were fasted for 24h (n = 6, 9 respectively), with food 
removed from their home cage at 10am (lights on at 7am), controls were allowed to 
feed normally (n = 7, 8 respectively) to provide mice for the EPM test. A second 
cohort of virgin and d5.5 pregnant mice were treated in the same way (24h fast, n =6, 
9 respectively; vehicle, n = 6, 10 respectively) to pr vide another set of mice to carry 
out the OFT. 
Kevin Hung (Physiology Honours student, The University of Edinburgh) assisted in 
carrying out these experiments and in video analysis. 
 
5.2.2.2 Behavioural tests and blood collection 
A. Elevated plus maze 
Following 24h mice were removed from their home cage nd immediately moved to 
an adjacent room where the EPM was set up. As with the LPS treatment experiment 
mice were recorded on the maze for 5 min and were killed by conscious decapitation 
immediately following the test. Trunk blood was collected, processed for plasma and 
frozen (-20 oC) prior to use in assays. Following blood collection pregnancy status 
was checked by laparotomy and inspection of the uterine horns for evidence of 
implantation sites. The behavioural video was analysed manually for the same 
anxiety behaviour measures as before (see section 5.2.1.2 A).   
 
B. Open field test 
Mice were removed from home cage following 24h to an adjacent room containing 
the OFT and were recorded on the maze for 5 min and were killed by conscious 
decapitation immediately following the test. Trunk blood was collected, processed 
for plasma and frozen (-20 oC) prior to use in assays. Following blood collection 
pregnancy status was checked by laparotomy and inspection of the uterine horns for 
evidence of implantation sites. 
The behavioural video was analysed manually for the same anxiety behaviour 






5.2.2.3 Plasma hormone levels 
Plasma samples were measured for prolactin and corticosterone using the same 
dilutions as described previously (section 5.2.1). 
 
5.2.3 Statistics 
Statistical evaluation of the mean hormone concentrations (prolactin and 
corticosterone) and behavioural parameters for eachgroup were determined by 2-
way ANOVAs with a Holm-Sidak post-hoc test.  Individual Student t-tests were 
carried out to compare treatments in virgin groups only for latency to open arm entry, 
and also to compare plasma prolactin levels following the behavioural tests with 
previously measured control prolactin levels where no behavioural tests were 
performed. p<0.05 was considered significant. Data are presented as group 


























5.3.1 Effect of LPS stress on EPM performance and plasma hormones 
5.3.1.1 Effect of LPS stress on EPM performance 
Latency to first open arm entry: 
Latency to first open arm entry showed no significant difference with treatment or 
group using a 2-way ANOVA (ns; for virgins: vehicle 7.8±7.1 sec, LPS 148.5±40.6 
sec; for pregnant: 109.8±73.3 sec, LPS 119.6±62.9). The latency was increased after 
LPS treatment in virgin mice only (Students t-test, p<0.001).  
 
Number of entries into open arms and total entries: 
In vehicle treated mice, early pregnant mice showed fewer entries into the open arms 
(calculated as a % of the total entries to open and closed arms) than virgin mice (2-
way ANOVA, interaction group x treatment p=0.001; Holm-Sidak post hoc, p<0.05 
vs. virgin vehicle; Figure 5.1 A). LPS treatment decreased the number of open arm 
entries in virgin mice (Holm-Sidak post hoc, p<0.05 vs. vehicle) but had had no 
significant effect in pregnant mice. 
The total number of entries (combine open and closed arm entries) was also lower in 
early pregnant mice than in virgins in the vehicle groups (2-way ANOVA, p<0.01 
across group, p<0.05 across treatment; Holm-Sidak post hoc, p<0.05 vs. virgin 
vehicle; Figure 5.1 B). LPS treatment reduced the total number of entries in the 
virgin group only (Holm-Sidak post hoc, p<0.05 vs. ehicle). 
 
Percentage time in open/closed arms: 
The percentage time spent in the open arms was lower in early pregnant mice than in 
virgin mice in the vehicle group (2-way ANOVA, interaction group x treatment 
p=0.001; Holm Sidak post hoc, p<0.05 vs. virgin vehicle; Figure 5.1 C). LPS 
treatment decreased the % time in the open arms in virgi  mice (Holm-Sidak post 
hoc, p<0.05 vs. vehicle) but had no significant effect in pregnant mice. 
Early pregnant mice spent more time in the closed arms than virgin mice in the 
vehicle groups (2-way ANOVA, interaction group x treatment p<0.05; Holm Sidak 
post hoc, p<0.05 vs. virgin vehicle; Figure 5.1 D) and LPS treatment increased the 







































Number of stretch attends: 
Early pregnant mice displayed fewer stretch attends than virgin mice in both the 
vehicle and LPS groups (2-way ANOVA, p<0.001 across group, p=0.001 across 
treatment; Holm Sidak post hoc, p<0.05 vs. virgin vehicle, p<0.05 vs. virgin LPS; 
Figure 5.2). After LPS treatment, there were fewer stretch attends in both groups, but 
this was only significant in the virgin group (Holm-Sidak post hoc, p<0.05).  
 
5.3.1.2 Effect of LPS stress on plasma prolactin and corticosterone (following EPM)  
Plasma prolactin levels were lower in early pregnant mice than in virgin mice 
(vehicle-treated) following the EPM (2-way ANOVA, p< 0.01 across group, p<0.001 
across treatment; Holm-Sidak p<0.05 vs. virgin vehicle; Figure 5.3 A). The prolactin 
levels of vehicle-treated virgin mice (24h) following the EPM were elevated 
compared to vehicle-treated virgin mice (90 min) that were not tested on the EPM  
(see chapter 3, Figure 3.3; Students t-test, p<0.01), suggesting the test itself is 
stimulating prolactin secretion in these mice. In co trast, the prolactin levels of 
vehicle-treated early pregnant mice (24h) following the EPM were reduced 
compared to vehicle-treated early pregnant mice (90 min) that were not tested on the 
EPM (Students t-test, p<0.01), suggesting the test itself is inhibiting prolactin 
secretion. LPS treatment reduced prolactin levels in virgin mice only (Holm-Sidak 
p<0.05 vs. vehicle) to a similar level as LPS-treated early pregnant mice. LPS 
treatment did not appear to significantly affect plasma prolactin levels in early 
pregnant mice but this may be a ceiling effect due to the already suppressed prolactin 
levels following the EPM.  
Plasma corticosterone levels were lower in early pregnant mice than in virgin mice 
(vehicle-treated) following the EPM (2-way ANOVA, p<0.05 across group; Holm-
Sidak p<0.05 vs. virgin vehicle; Figure 5.3 B). LPS treatment did not significantly 












































5.3.2 Effect of LPS stress on OFT performance and plasma hormones 
5.3.2.1 Effect of LPS stress on OFT performance 
The percentage time spent in the inner zone was similar in both virgin and early 
pregnant mice and was not significantly altered by LPS treatment (2-way ANOVA, 
ns; Figure 5.4 A). The number of entries to the inner zone was similar in virgin and 
early pregnant mice and was not significantly altered by LPS treatment (2-way 
ANOVA, ns; Figure 5.4 B).  
The number of inner zone crossings over the gridlines from one inner zone ‘box’ to 
another inner zone ‘box’ (expressed as a percentage of th  total crossings) was not  
significantly different between virgin and early pregnant mice. LPS treatment 
reduced the number of inner zone crossings in both virgin and pregnant mice (2-way 
ANOVA, p<0.01 across treatment; Holm-Sidak post hoc, p<0.05 vs. vehicle in both 
virgin and pregnant mice; Figure 5.4 C). The total number of crossings over the 
arena was similar in both virgin and early pregnant mice and was not significantly 
altered by LPS treatment (2-way ANOVA, ns; Figure 5.4 D).  
 
Wall rears: 
The total number of wall rears was lower in early pegnant mice than in virgin mice 
and was not significantly altered by LPS treatment (2-way ANOVA, p<0.001 across 
group; Holm-Sidak post hoc, p<0.05 vs. virgin; Figure 5.5).  
 
5.3.2.2 Effect of LPS stress on plasma prolactin and corticosterone (following OFT)  
Plasma prolactin levels were lower in early pregnant mice than in virgin mice 
following the OFT and was not significantly altered by treatment (2-way ANOVA, 
p<0.001 across group; Figure 5.6 A). As with the EPM prolactin levels of vehicle-
treated early pregnant mice (24h) following the OFT were reduced compared to 
vehicle-treated early pregnant mice (90 min) that were not tested on the OFT 
(Students t-test, p<0.01), suggesting the OFT is altering prolactin secretion, although 
in virgins the corresponding vehicle-treated mice (90 min) are not significantly 
different. Plasma corticosterone levels were similar in both virgin and pregnant 
vehicle-treated mice. LPS treatment significantly increased plasma corticosterone 
levels in both groups but more so in virgin mice (2-way ANOVA, p<0.05 across  















































5.3.3 Effect of 24h fast on EPM performance and plasm  hormones 
5.3.3.1 Effect of 24h fast on EPM performance 
Latency to first open arm entry: 
The latency to first open arm entry showed no significant differences between virgin 
and pregnant groups or between fasting and control groups (2-way ANOVA, ns; for 
virgins: control 17.0±10.0 sec, fast 3.5±1.9 sec; for pregnant: control 24.8±12.3 sec, 
fast 10.4±9.1 sec). 
 
Number of entries into open arms and total entries: 
The number of entries into the open arms (calculated s a % of the total entries to 
open and closed arms) was similar in virgin and early pregnant mice in the vehicle 
group. 24h fast increased the number of open arm entries in both virgin and pregnant 
but more so in virgin mice (2-way ANOVA, p<0.01 across group, p<0.001 across 
treatment, interaction treatment x group p=0.053; Holm-Sidak post hoc, p<0.05 vs. 
virgin 24h fast; Figure 5.7 A).  
The total number of entries was similar in virgin and pregnant control groups but was 
significantly higher in virgin vs. pregnant fasted groups (2-way ANOVA, p<0.05 
across group; Holm-Sidak post hoc, p<0.05 vs. virgin fast; Figure 5.7 B). 24h fast 
stress did not significantly affect the number of entri s in either group. 
 
Percentage time in open/closed arms: 
The percentage time spent in the open arms was similar in virgin and early pregnant 
mice in the vehicle group. 24h fasting increased the time spent in the open arms (2-
way ANOVA, p<0.05 across treatment; Figure 5.7 C). 
The percentage time spent in the closed arms was similar n virgin and early pregnant 
mice in the vehicle group. 24h fasting decreased th time spent in the closed arms in 
both virgin and early pregnant mice (2-way ANOVA, p<0.001 across treatment; 
Holm-Sidak post hoc, p<0.05 vs. vehicle; Figure 5.7 D). 
 
Number of stretch attends: 
Early pregnant mice showed more stretch attends than virgins in control groups (2-







































vs. virgin vehicle; Figure 5.8). 24h fasting increas d the number of stretch attends in 
virgins, but decreased it in pregnant mice (Holm-Sidak post hoc, p<0.05 vs. control).  
 
5.3.3.2 Effect of 24h fast on plasma prolactin and corticosterone (following EPM)  
Plasma prolactin levels were similar in virgin and early pregnant mice (vehicle-
treated) following the EPM. The prolactin levels of c ntrol virgin mice following the 
EPM were elevated compared to control virgin mice that were not tested on the EPM 
(see chapter 3, Figure 3.17; Students t-test, p<0.01), again suggesting the EPM test 
itself is stimulating prolactin secretion in these mice. 24h fasting decreased prolactin 
in early pregnancy only (2-way ANOVA, interaction group x treatment; Holm-Sidak 
p<0.05 vs. pregnant control, p<0.05 vs. virgin fast; Figure 5.9 A).  
Plasma corticosterone levels were similar in virgin and d5.5 pregnant control mice 
following the EPM. 24h fasting significantly increased corticosterone levels in both 
groups equally (2-way ANOVA, p<0.001 across treatment; Figure 5.9 B).  
 
5.3.4 Effect of 24h fast on OFT performance and plasm  hormones 
5.3.4.1 Effect of 24h fast on OFT performance 
The percentage time spent in the inner zone was similar in both virgin and early 
pregnant mice and was not significantly altered by fasting (2-way ANOVA, ns; 
Figure 5.10 A). The number of entries to the inner zone was similar in both control 
virgin and early pregnant mice. 24h fasting decreased the number of inner zone 
entries in early pregnant mice (2-way ANOVA, p<0.05 across treatment; Figure 5.10 
B).  
The number of inner zone crossings (expressed as a percentage of the total crossings) 
was not significantly different between virgin and early pregnant control mice. 
However, 24h fasting increased the number of crossing  in the inner zone in early 
pregnant mice (2-way ANOVA, p<0.01 across group; Holm-Sidak post hoc, p<0.05 
vs. virgin fast group; Figure 5.10 C). The total number of crossings over the arena 
was similar in both virgin and early pregnant mice and was not significantly altered 


















Number of wall rears: 
The total number of wall rears was significantly higher in early pregnant vs. virgin 
control mice (2-way ANOVA, interaction group x treatment p<0.05; Holm-sidak 
post hoc, p<0.05 vs. virgin control; Figure 5.11). 24h fasting significantly reduced 
the number of rears against the wall in early pregnant mice to a similar to virgin mice 
(Holm-Sidak post hoc, p<0.05 vs. virgin fast). 
 
5.3.4.2 Effect of 24h fast on plasma prolactin and corticosterone (following OFT)  
Plasma prolactin levels were similar in both virgin and d5.5 pregnant mice in control 
groups following the OFT. Fasting for 24h caused a significant reduction in plasma 
prolactin in the early pregnant group following theOFT (2-way ANOVA, p< 0.01 
across treatment; Holm-Sidak post hoc, p<0.05 vs. control in pregnant group only; 
Figure 5.12 A).  
Plasma corticosterone levels were significantly higher in virgin than early pregnant 
control mice. 24h fasting significantly increased corticosterone levels following the 
OFT in both groups to a similar level (2-way ANOVA, p<0.05 across group, 






























5.4.1 Effect of LPS on EPM and hormone response 
A number of immune stressors, including LPS, have previously been shown to 
activate the HPA axis and induce anxiety-like behaviours in rodents (Lacosta et al., 
1999). IL-1β and LPS injection (i.p) to male mice has been demonstrated to decrease 
open-arm entries and time spent in the open arms of an EPM, in a dose-dependent 
manner. In addition, the total number of entries to all arms were decreased indicating 
a reduction in locomotion and general activity (Swierg el and Dunn, 2007). Central 
administration of IL-1β and TNF-α to male rats also revealed anxiogenic effects on 
the EPM (Connor et al., 1998). Thus, we hypothesised that LPS administration 
would increase anxiety in virgin and early pregnant mice. Furthermore, we 
postulated that the anxiogenic response would be heightened in early pregnancy 
following LPS stress due to a reduction of anxiolytic prolactin. 
LPS administration had profound anxiogenic effects on the virgin mice, with the 
latency to enter the open arms increasing with LPS, while the time spent in the open 
arms and number of entries to the open arms significa tly decreased. In addition, the 
total number of arm entries (open and closed) and stretch attends performed were 
reduced by LPS, indicating a reduction in locomotion and risk assessment behaviour 
respectively. 
 Control early pregnant mice displayed higher anxiety-like behaviours compared to 
virgin mice, as they entered the open arm less often and spent less time in open arms 
than virgin control mice. LPS treatment in early pregnant mice appeared to have no 
effect on the anxiety-behavioural parameters measurd compared to controls. 
However, as anxiety levels were already high in early pregnancy (compared to 
virgins) this may be a ‘ceiling effect’ which masks any LPS-induced changes. 
Early pregnant mice behaved similarly to stressed virgin mice regardless of LPS 
treatment, indicating that early pregnant mice are more anxious in general than virgin 
mice. This is different to what is reported in mid pregnant (d11) mice which showed 
reduced anxiety on the light/dark choice test (Maestripieri and D'Amato, 1991) and 
in late pregnant (d18) rats (Neumann et al., 1998, Neumann, 2003)  where they 
display reduced fear and anxiety  on the EPM  (and HPA responses) compared to 




Plasma prolactin levels were elevated in vehicle-treated (24 h) virgin mice following 
the EPM compared to previously analysed vehicle-treated (90 min) virgin mice that 
were not tested on the EPM prior to blood sampling. This indicates that the EPM 
itself may be stimulating prolactin secretion, but LPS-treatment/stress prevents this. 
In contrast, prolactin levels of vehicle-treated early pregnant mice were suppressed 
following the EPM when compared to previously analysed vehicle-treated (90 min) 
early pregnant mice that were not tested on the EPM. This might indicate that the 
early pregnant mice were more stressed by the EPM and hence the prolactin levels 
decreased in vehicle-treated mice as well as LPS-treated mice. However, 
corticosterone responses do not appear to support this. Another possibility is that 
there could be some kind of delayed hyporesponsiveness in early pregnant mice to 
the injection 24h before.  
Prolactin levels in early pregnant mice did not differ with treatment which may 
contribute towards the lack of change observed in anxiety-like behaviours that were 
expected. However, in LPS-treated virgins there were increased anxiety behaviours 
following stress accompanied by decreased prolactin levels. 
Plasma corticosterone levels following the EPM were not significantly affected by 
LPS treatment administered 24h prior to the test. Therefore, LPS-induced 
corticosterone (as observed 90 min after injection; see Figure 3.3) is not sustained 
and after 24 h is only moderately affected. Circulating prolactin concentrations were 
not altered by LPS in early pregnant mice, but they too were lower than in virgin 
mice. 
It is difficult to conclude the effect of the LPS vs. the EPM itself on corticosterone 
and prolactin within this experiment as there were not any ‘no EPM’ controls 
included. A comparison using data for mice sacrificed 90 min after treatment 
provided an insight into the effect of the EPM itself on prolactin. However, it would 
have been useful to include virgin and pregnant mice that were treated with saline or 
LPS and were then killed 24h later to provide plasm from this time point for assays 
without completing the EPM.  
The measurement of latency to first open arm entry does not appear to be a good 
indicator of anxiety as in this experiment the data was very variable, mainly due to 




placed in the centre square. The aim had been to place the animal at an angle/position 
that they were neither looking directly at the open nor closed arm (diagonally across 
the centre square) but this proved problematic due to the mice moving around, 
coupled with the handler wanting to restrain them as little as possible. Thus, it would 
have been better to place all animals pointing specifically at the closed arm as 
described in other studies (Connor et al., 1998, Swiergiel and Dunn, 2007). 
High levels of oestrogens (as associated with oestru ) are known to have anxiolytic 
effects and therefore virgin mice in oestrous should have been discarded. However, 
virgin mice were not smear tested and therefore the day of the cycle was unknown 
for each mouse.  
 
5.4.2 Effect of LPS on OFT and hormone response 
It has been demonstrated that IL-1β or LPS injections (i.p) to male mice decrease the 
number of crossing in the centre of the arena (inner zone) of an OFT (Swiergiel and 
Dunn, 2007). However, Swiergiel and Dunn (2007) also reported a decrease in the 
number of crossings and rears in the outer zone, indicating a reduction in general 
activity and thus do not provide unequivocal support for IL-1β or LPS-induced 
anxiety  (Swiergiel and Dunn, 2007). In our study we found that there was no 
significant difference in the percentage time spent in the inner zone or number of 
entries to the inner zone with either treatment or gr up (virgin vs. pregnant mice). 
The mice spent around 80% of their time in the outer zone, demonstrating 
thigmotaxis (tendency to remain close to the outer walls). There was, however, a 
significant decrease in the number of crossing made in the inner zone with LPS 
treatment in both virgins and pregnant mice. As there was no significant change in 
the total number of crossings (indicating there wasno alteration in the general 
activity of any of the mice), the reduction in inner zone exploration (crossings) 
indicates an increase in anxiety-like behaviour with LPS treatment. The number of 
rears against the wall (‘vertical exploration’) was not affected by LPS treatment 
although pregnant mice reared less than virgin mice. Th refore, it appears that LPS 
treatment mildly induces anxiety-like behaviour, decreasing exploration of the inner 





As described earlier with the EPM, prolactin levels following the OFT in early 
pregnant mice were suppressed (compared to 90 min data) and did not differ with 
treatment. This may again be a ‘ceiling effect’ of the already robustly suppressed 
prolactin levels. Therefore, we cannot conclude that LPS is definitely not having an 
effect on prolactin secretion. As a difference in plasma prolactin levels with 
treatment was not apparent following the OFT this may partly explain why only very 
mild changes in anxiety-like behaviours were observed. In virgin mice there was also 
no change in prolactin levels with LPS treatment but levels were higher in virgins 
than early pregnant mice. There does not appear to be an association with decreased 
prolactin levels and increased anxiety behaviours following stress as early pregnant 
mice (who have lower prolactin than virgins) have very similar anxiety behaviour 
profiles to virgin mice with the exception of performing less outer zone rears. This is 
in contrast to the EPM where it was found that LPS had a more profound effect on 
virgin mice, increasing anxiety behaviours. This is curious as it has been shown in a 
relations study of EPM and OFT in C57BL/6 mice that movements and rears in the 
OFT were linearly correlated with enclosed arm visits on the EPM (Lalonde and 
Strazielle, 2008). 
The plasma corticosterone levels following the OFT were increased by LPS 
treatment in both virgin and early pregnant mice. This differs to the corticosterone 
levels following the EPM where a difference with treatment was not observed. 
However, the levels are all in a similar range to the previous experiment, although 
differences with LPS were mild and not significant following the EPM. It may be 
that the anxiety tests themselves are eliciting varying degrees of stress responses.  
 
5.4.3 Effect of 24h fast on EPM and hormone response 
It was hypothesised that 24h fasting would lead to increased anxiety-like behaviour 
in early pregnant mice, possibly via predicated increased corticosterone (and CRH) 
and decreased prolactin secretion. In addition, the lev ls of circulating ghrelin are 
reported to increase with fasting in humans and rodents  (Cummings et al., 2001, 
Briatore et al., 2006) and ghrelin is considered to be anxiogenic (Carlini et al., 2002).  
Ghrelin is a peptide found in the hypothalamus and the stomach and is known to 
stimulate release of growth hormone from the pituitary (Kojima et al., 1999). Plasma 




decreasing following food consumption (Cummings et al., 2001). In rodents it has 
been shown that ghrelin plays a role in hypothalamic regulation of homeostasis. The 
administration of ghrelin (i.c.v) to rats robustly stimulates feeding, increasing food 
intake and body weight (Asakawa et al., 2001a, Nakaz to et al., 2001). Studies 
looking into the behavioural effects of ghrelin have reported that central 
administration of ghrelin to male rats increased anxiety-like behaviours on the EPM 
(Carlini et al., 2002). Similarly, effects on anxiety-like behaviour in mice have been 
described after both i.p or i.c.v ghrelin administration (Asakawa et al., 2001b). It has 
been reported that the underlying mechanism behind t e anxiogenic effects of ghrelin 
involves CRH. Administration of a CRH receptor antagonist significantly reduced 
the ghrelin-induced anxiogenic effects on an EPM. In addition, administration of 
ghrelin to male mice increased CRH mRNA expression in the hypothalamus 
(Asakawa et al., 2001b). CRH receptor type 1 is report d to mediate emotional 
stress-induced disruption of food intake and behavioural changes in rats (Hotta et al., 
1999). Tail pinch stress increases expression of ghrelin in the stomach (Asakawa et 
al., 2001b) as does starvation stress (48h fasting) (Asakawa et al., 2001a).  
Despite previous reports indicating that fasting may le d to an increase in anxiety-
like behaviour (possibly via increased CRH or ghrelin) we did not demonstrate this. 
Both virgin and early pregnant fasted mice spent significantly more time on the open 
arms of the EPM and entered them more often than control animals, implying that 
they are less anxious. However, as these animals were fasted it is more likely that 
this demonstrates increased exploration activity in the search to find food and is 
motivated by hunger. Fasted early pregnant mice entr d the open arms significantly 
less often than fasted virgin mice and also displayed a reduction in total entries 
(locomotor activity) indicating fasted pregnant mice are less active than fasted virgin 
mice, which could account for the reduced number of entries to the open arm. The 
latency to enter the open arms tended to be shorter in fasted mice although this was 
not significant and data was highly variable. Contrl pregnant mice displayed 
heightened risk assessment behaviour with more stretch attends performed compared 
to virgin mice, perhaps indicating they are more cautious. However, fasted pregnant 
mice performed less stress attends compared to both con rol pregnant mice and 




case that they are ‘false-positives’ as they do not seem to correlate with the other 
parameters measured. 
Overall fasting appears to reduce anxiety-like/increase exploratory behaviour in spite 
of the fact 24h fasting robustly increases corticoserone levels in both virgin and 
pregnant mice. As with the LPS study, the EPM itself appears to stimulate prolactin 
release in virgin mice, although this is independent of fasting treatment. Control 
early pregnant prolactin levels were similar to both the virgin groups and as expected 
24h fasting suppressed plasma prolactin levels in early pregnant mice. However, 
plasma prolactin concentrations do not seem to havean association with anxiety 
behaviours as predicted. Although prolactin levels decrease with fasting in early 
pregnant mice this was not reflected in EPM performance. 
It would be interesting to measure the circulating ghrelin levels of our 24h fasted 
mice to establish if these levels have risen as is sumed. If not this could be part of 
the reason why we do not see increased anxiety with 24h fasting. However, our study 
was not the only one to find this as another fasting study (15h fast) on mice reported 
no significant effect of fasting on anxiety measure (Hata et al., 2001). 
  
5.4.4 Effect of 24h fast on OFT and hormone response 
As with the EPM, it was hypothesised that 24h fasting would lead to increased 
anxiety-like behaviours in early pregnant mice on the OFT. As already mentioned it 
has been reported that fasting increases ghrelin expression (Asakawa et al., 2001a) 
and central administration of ghrelin increases anxiety as measured by an EPM 
(Carlini et al., 2002). However, Carlini et al. also reported that central administration 
of ghrelin to male rats had no effect on any OFT parameter measured (e.g. time in 
the inner zone, locomotion, rearing) except for causing an increase in freezing 
behaviour (total absence of body or head movement) at high doses (3nmol/µl) 
(Carlini et al., 2002).  
We have found that 24h fasting had no significant effect on the time spent in the 
inner zone in either virgin or early pregnant mice. The number of inner zone entries 
and crossings were also not altered by fasting in virgins. Although the number of 
entries into the inner zone significantly decreased in fasted pregnant mice, the 
number of inner crossings increased and overall there was not a change in 




mice. Consistent with the idea that rears against the wall represent ‘vertical 
exploration’ the number of rears carried out by virgin mice was not altered with 
fasting either. Although, rearing behaviour was higher in the pregnant vs. virgin 
control group and was decreased by fasting in early pregnant mice, behaviour on the 
OFT overall did not indicate an increase in anxiety behaviour in either virgins or 
pregnant mice. In addition, OFT behaviour following 24h fasting did not indicate an 
increase in exploratory behaviour (as it did in the EPM). A study looking into the 
effect of chronic food deprivation (maintenance at 80% original body weight) also 
did not observe an increase in anxiety-like behaviour but they did report increased 
activity in an OFT in food deprived rats (after 8 days on food restricted diet) along 
with increased circulating corticosterone (Heiderstadt et al., 2000). 
Prolactin levels were unchanged by fasting in virgin mice following the OFT, but 
were decreased by fasting in early pregnant mice as expected. Once again circulating 
prolactin levels did not reflect anxiety-related behaviour levels. Our data suggest that 
fasting does not alter anxiety-like behaviour as measured by the OFT despite a strong 
increase in corticosterone levels following 24h fasting in both virgins and early 
pregnant mice. 
Overall, 24h fasting lead to enhanced exploratory behaviour (reduced anxiety) in 
early pregnant mice. In hindsight 24h fasting may not have been a suitable treatment 
to use in order to determine the effects of stress in early pregnancy on anxiety 
behaviour. The drive to explore (presumably motivated by hunger in order to find 
food) following fasting appears to be robust and to take over/mask stress-induced 



















Chapter 6: General Discussion 
 
6.1 Stress effects on pregnancy hormones in early pregnancy 
Stress exposure in early pregnancy in mice significantly reduces levels of the crucial 
pregnancy hormones which are ordinarily elevated at this time e.g. progesterone 
(Joachim et al., 2003). We found that stress exposure (immune and 24h fast) on 
pregnancy day d5.5 diminished circulating progesteron  levels and we also 
demonstrated for the first time that basal plasma prolactin levels were robustly 
reduced by stress in early pregnancy as hypothesised. Th  effect of stress on the bi-
daily prolactin peaks observed in rodents in early p egnancy is not known at present 
but we expect that these peaks would also be reduced by stress. An additional 
experiment involving stress exposure during these peaks would be needed to confirm 
this. As prolactin is known to facilitate progesterone secretion from the corpus 
luteum in early pregnancy in rodents (Erlebacher et al., 2004), the attenuated 
prolactin response to stress may contribute to the stress-reduced progesterone levels 
simultaneously observed. In addition, stress profoundly affected pregnancy 
maintenance, with LPS treatment leading to occult foe al loss, while 24h fast reduced 
pregnancy rate from 70% to 36%. 
 
6.2 Potential mechanisms leading to stress-reduced prolactin in early pregnancy  
6.2.1 TIDA activation and dopamine activity 
We found that stress significantly decreases circulating prolactin in mice during early 
pregnancy and thus we sought to establish the mechanism(s) behind this. As 
dopamine derived from the TIDA neurones is the main inhibitor of prolactin release 
from the lactotrophs we hypothesised that a reduction in prolactin secretion would be 
associated with a corresponding increase in TIDA neurone activity. Indeed the stress-
induced attenuation in circulating prolactin levels was accompanied by a parallel 
increase in TIDA neurone activation following either LPS immune stress or 24h fast 
in early pregnancy, as indicated by increased Fos expression in tyrosine-positive 
neurones in the arcuate nucleus. The rise in TIDA activ tion with stress in early 
pregnancy was significant but mild (<15% of TIDA neurones activated with either 
stressor). In virgin mice this stress-induced elevation of TIDA activity was not 




post-copulation. It is known that these neurones have already adapted by d5.5 to 
mediate the neurogenic reflex and initiate the bi-daily prolactin surge profile 
observed in rodents, therefore, these alterations may confer the slight changes 
observed with stress. 
Although it has been previously reported that Fos expr ssion in TIDA neurones 
following an immune challenge reflects alterations in prolactin secretion (Hollis et 
al., 2005), Fos is not considered the most accurate indicator of TIDA neurone 
activation (Hoffman et al., 1994, Hoffman and Lyo, 2002). Thus, Fos expression in 
TIDA neurones may only serve as a weak marker of TIDA neurone activation 
following acute stimulation, e.g. LPS, which may explain why we see only a 
relatively mild increase in TIDA activation. Therefore, due to this fact, we also 
measured the DOPAC content and the DOPAC:dopamine ratio in the median 
eminence, both of which have been utilized previously to measure dopamine activity 
(Andrews and Grattan, 2003). The DOPAC content levels w re found to be higher in 
virgin than early pregnant vehicle-treated mice (though not significant, likely due to 
the high variability), which may account for the increase in basal prolactin secretion 
in early pregnancy. DOPAC levels were appeared lower in LPS-treated virgins 
compared to vehicle-treated virgins. However, surprisingly, no change in DOPAC 
levels were observed with LPS treatment in early pregnant mice, despite a robust 
reduction in plasma prolactin. The ratio of DOPAC:dopamine revealed a similar 
pattern to DOPAC content alone in the median eminence. Although the basal 
DOPAC:dopamine ratios tended to be higher in virgins compared to  pregnant mice, 
we found that again LPS immune stress did not significa tly alter the 
DOPAC:dopamine ratio in early pregnant mice. Thus, DOPAC content and the 
DOPAC:dopamine ratios did not reflect the stress-altered prolactin levels observed in 
early pregnant mice, or indeed the unaltered prolactin levels displayed in virgin mice.  
Overall, alterations in dopamine activity in the median eminence do not appear to 
underlie the stress-reduced prolactin secretion observed in early pregnant mice. In 
addition, dopamine activity in the TIDA neurone terminals is not analogous to Fos 
expression in TIDA neurones in early pregnant mice. As these data imply that 
stressors do not alter prolactin levels via TIDA dopamine secretion, it is not likely 




are responsible e.g. kisspeptin (Szawka et al., 2010) and the opioids (Andrews and 
Grattan, 2002). However, it is possible that stress-induced reduction of other 
prolactin-releasing factors which are reported to act directly at the lactotrophs 
contribute towards prolactin suppression e.g. oxytocin, TRH (Ben-Jonathan et al., 
2008). Although, regarding TRH, it has recently been shown that direct application 
of TRH to mouse pituitary slices did not stimulate prolactin secretion from 
lactotrophs (unlike oxytocin) as observed in rats (He et al., 2011). 
 
6.2.2 Prolactin negative feedback 
In support of the conclusion that stress does not lead to reduced prolactin release by 
increased TIDA activity we also found that stress does not alter prolactin negative 
feedback to the TIDA neurones in early pregnancy.  
As previously described, LPS administration and 24h fast in early pregnancy both 
robustly diminish circulating prolactin in mice. Additional treatment with oPRL was 
found to decrease murine plasma prolactin in non-stres ed early pregnant mice as 
expected, demonstrating that prolactin negative feedback had been driven (DeMaria 
et al., 1999, Anderson et al., 2006a). However, although stress reduced plasma 
prolactin, oPRL supplementation did not further decrease it in early pregnancy, 
perhaps because levels have already been substantially reduced and further changes 
are minimal. Although stress alone decreased plasma prol ctin levels in early 
pregnancy this was not the case with STAT5 signallig. In stressed early pregnant 
mice the percentage of pSTAT5-positive TIDA neurones was found to be low and 
comparable to non-stressed mice, indicating that negative feedback via the pSTAT5 
signalling pathway was not altered by stress alone (at basal prolactin levels).  
In contrast, it is possible that at the time of the bi-daily prolactin surges in early 
pregnancy enhanced prolactin negative feedback does contribute to the assumed 
reduction in these prolactin peaks. We demonstrated  robust increase in the 
expression of pSTAT5 in TIDA neurones following stress (indicating elevated 
prolactin signal transduction) in early pregnant mice that were co-administered 
oPRL. This suggests that when prolactin levels are high (e.g. during prolactin surges 
in early pregnancy) stress exposure enhances prolactin negative feedback to the 
TIDA neurones, suppressing further prolactin release and consequently reducing 




To conclude, enhanced prolactin negative feedback, via prolactin receptor-induced 
signalling, does not underlie stress-induced suppression of basal prolactin in early 
pregnancy. This further reinforces the idea that stres -reduced prolactin is not due to 
enhanced TIDA activity, responsiveness or sensitivity. Thus, other stress-related 
factors must be responsible, perhaps directly affecting prolactin secretion at the 
lactotrophs.  
 
6.2.3 Stress-induced cytokines 
One possible stress-related mechanism driving prolactin suppression is increased 
activity of cytokines associated with stress/LPS. We have found that both LPS and 
24h fasting lead to an increase in circulating IL-6 and LPS treatment also robustly 
increases plasma TNF-α in early pregnancy. IL-6 and TNF-α are both known to be 
detrimental to pregnancy maintenance and also can ativate the HPA axis (Chrousos, 
1995, Tsigos and Chrousos, 2002). The principal action of these cytokines has been 
suggested to be through stimulating the release of CRH and vasopressin from the 
hypothalamus, however, we do not show this in early pregnancy where the CRH 
response to stress was attenuated. Proinflammatory cytokines can also cause direct 
effects at the pituitary level inducing ACTH releas from the anterior pituitary in 
vitro and in vivo (McCann et al., 1994).  
IL-6 administration to early pregnant mice was found to mildly increase 
corticosterone levels, indicating activation of theHPA stress axis as expected, 
however, it had no significant effect on either circulating prolactin or progesterone 
levels compared to vehicle. Therefore, it does not seem that stress-induced IL-6 
release is responsible for prolactin suppression following stress in early pregnancy. 
Conversely, TNF-α treatment in early pregnancy significantly decreased both plasma 
prolactin and progesterone levels, in addition to robustly elevating corticosterone 
levels. While we found that both pro-inflammatory cytokines led to a mild increase 
in TIDA activation (increased Fos expression), only TNF-α reduced plasma 
progesterone and prolactin in early pregnancy, thusagain supporting the notion that 
TIDA activity is not accountable for stress-reduced prolactin. So, as it does not 
strongly induce TIDA activation data demonstrate that TNF-α may be partly 
responsible for stress-reduced prolactin secretion through other mechanisms such as 




6.2.4 Sex steroids and TNF-α 
6.2.4.1 Effects of progesterone on prolactin regulation 
It has been reported in rodents that TIDA neurones express steroid receptors 
(progesterone and oestrogen) during pregnancy. Thus, t e e hormones may 
contribute towards regulation of maternal prolactin secretion by direct actions on the 
TIDA neurones (Steyn et al., 2007). Progesterone is able to suppress TIDA neurone 
activity on the afternoon of proestrous and enhances th  pre-ovulatory prolactin 
surge in rats. Phosphorylated tyrosine hydroxylase lev ls and tyrosine hydroxylase 
activity in the median eminence are reported to decrease concomitantly with the pre-
ovulatory rise in progesterone (Liu and Arbogast, 2008). In addition, progesterone 
administration prior to the preovulatory progesterone surge in rats also decreases 
tyrosine hydroxylase phosphorylation state, while increasing activity of phosphatase 
2A (potential mediator of phosphorylation of serine sit s on tyrosine hydroxylase) in 
the median eminence. These changes were also accompanied by a premature rise in 
serum prolactin, indicating a role for progesterone in stimulating prolactin release on 
the afternoon of proestrous (Liu and Arbogast, 2008, Liu and Arbogast, 2010).  
Less is reported about the effects of progesterone on TIDA neurones and prolactin 
secretion in early pregnancy. Whether stress rapidly affects the level of 
expression/action of progesterone receptors on TIDA neurones in early pregnancy is 
unknown at present. However, this seems unlikely as we have found that altered 
TIDA responsiveness is not responsible for stress-rduced prolactin in early 
pregnancy. 
A human study looking into the regulatory role of progesterone on decidual prolactin 
production in early pregnancy reported that progesterone plays only a facilitatory 
role in prolactin regulation. Patients were treated with the anti-progestin mifepristone 
for 24-36h before elective pregnancy termination and decidual tissue was collected 
from these patients as well as from women who had not been pre-treated.  Production 
of prolactin by decidual parietalis (part of the deci ua lining the uterus) decreased 
over time and production from patients pre-treated with mifepristone was found to be 
significantly lower than controls. However, decidual prolactin production by decidua 
capsularis (to which trophoblast was attached) was m intained over the 5 culture 




progesterone may facilitate in prolactin production by maintaining decidual 
differentiation and other trophoblast derived factors are able to maintain decidual 
prolactin production (Wu et al., 1990). Subsequent studies also suggest that the 
induction of prolactin synthesis is dependent upon rogesterone-induced 
decidualisation (Brosens et al., 1999).  
 
6.2.4.2 Progesterone and pro-inflammatory cytokines 
Progesterone is thought to play a facilitatory role in providing a pregnancy protective 
immune milieu e.g. by reducing Th1 cytokine production and increasing Th2 
cytokine production (Arck et al., 2007). For example, it has been shown that 
progesterone reduces levels of TNF-α mRNA and protein production from LPS-
treated mouse macrophages in vitro (Miller and Hunt, 1998). However, we have 
shown that shown that TNF-α administration to early pregnant mice robustly reduces 
circulating progesterone levels and therefore a stres -induced increase in TNF-α may 
prevent or mask the inhibitory actions of progesteron . 
 
6.2.4.3 Oestrogen and TNF-α action at the lactotrophs 
Although receptors for progesterone and oestrogen are reported on the lactotrophs 
little is known about a role for progesterone directly at the lactotrophs on prolactin 
regulation, however more is reported on effects of oestrogen at lactotrophs 
(Stefaneanu, 1997). Typically oestrogen is considere  to be a prolactin releasing 
factor. However, stress(restraint)-induced oestrogen secretion in early pregnant rats 
(MacNiven et al., 1992) and chronic oestrogenisation of ovariectomised rats is 
reported to raise TNF-α levels. In support of a proposed role for TNF-α in stress-
reduced prolactin secretion, i  vitro studies have revealed that LPS treatment 
increases TNF-α release from lactotrophs while also decreasing prolactin release 
(Theas MS, 1998). TNF-α abrogates oestrogen-induced prolactin release in both 
lactotroph cultures and in the pituitary cells from variectomised rats (Theas MS, 
1998, Theas et al., 2000). Therefore, it seems that s ress-induced elevated oestrogen 
levels counteract their stimulatory actions on prolactin release by enhancing TNF-α 
levels. It has been confirmed that TNF-α reduces anterior pituitary cell proliferation 




2002). Thus, stress-induced changes in oestrogen may impact on TNF-α activity at 
the anterior pituitary and subsequently affect prolactin production and release. 
 
6.2.4.4 Oestrogen-dependent TNF-α action on lactotrophs 
Both mitosis and apoptosis occur during the oestrou cycle, pregnancy and lactation 
in the pituitary cells (Yin and Arita, 2000, Candolfi et al., 2006). Oestrogens are 
widely accepted to be modulators of pituitary cell r newal and sensitise cells to 
mitogenic and apoptotic signals (Seilicovich, 2010, Zaldivar et al., 2011). It has been 
recently suggested that oestrogen sensitises anterior pituitary cells to TNF-α and 
LPS-induced apoptosis through suppression of pro-inflammatory NF-κB (regulator 
of cell survival) (Eijo et al., 2011) whose signalling is activated by LPS and TNF-α 
(Li and Stark, 2002). Oestrogen administration to anterior pituitary cells from female 
rats increases expression of both TNF-α and TNF-α receptors (TNFR1), particularly 
in the lactotrophs (Zaldivar et al., 2011). Furthermo e, TNF-α release and TNFR1 
expression is higher in the anterior pituitary glands of proestrous rats (when 
oestradiol levels are elevated) compared to diestrou  ats (Theas, Pisera et al. 2000; 
Zaldivar, Magri et al. 2011). Thus, stress-induced increase in TNF-α and oestrogen in 
early pregnancy may directly impact on the pituitary l ctotrophs to enhance 
apoptosis of lactotrophs and consequently decrease prolactin secretion. However, 
whether stress can rapidly induce lactotroph apoptosis via TNF-α in only 90min 
remains to be determined as previously mentioned studies measured prolactin release 
and active cell number from cell cultures after an 8h-2d incubation with TNF-α. 
 
6.2.4.5 TNF-α induced activation of hypothalamic nuclei 
We also found that TNF-α robustly increased activation in the SON, pPVN and
VMH. Whether the pPVN response to TNF-α is similar to LPS and is attenuated in 
early pregnancy compared to virgins (possibly reflecting oxytocin neurone response) 
is currently unknown.  Increased activation in the SON (as indicated by Fos 
expression) may imply an increase in oxytocin activity/secretion, which would not 
lead to suppression of prolactin release. However, th e are studies which indicate 
that Fos expression does not always correlate with the spike activity of 
magnocellular neurones in the SON (Luckman et al., 1994) and enhanced Fos 




secretion. For example, central administration of the peptide α-melanocyte-
stimulating hormone or an agonist for its receptor MC4 induces Fos expression in the 
SON, however, they both reduce electrical activity of oxytocin neurones in the SON 
(in vivo). Accordingly, central administration of α-melanocyte-stimulating hormone 
reduces oxytocin secretion into the bloodstream in rats (Sabatier et al., 2003). In 
contrast, central administration of MC4 receptor agonists increase oxytocin release 
from dendrites in isolated SONs. Thus, it seems that α-melanocyte-stimulating 
hormone can induce different effects on systemic and dendritic oxytocin release 
which is dissociated from Fos expression and electrical activity (Sabatier et al., 
2003). Therefore, although following stress in early p egnant mice we observed 
increased Fos expression in the SON, oxytocin secretion may not have risen and thus 
does not stimulate prolactin secretion. 
 
6.2.4.6 Future ideas to investigate stress-induced proinflammatory cytokines and 
prolactin secretion in early pregnancy 
In order to investigate the role of proinflammatory cytokines, including TNF-α, on 
the mechanisms controlling prolactin secretion furthe  experiments need to be 
conducted. A number of cytokines, including TNF-α, activate the JAK2/STAT3 
signalling pathway (Miscia et al., 2002, Romanatto et al., 2007). The effect of stress 
on pro-inflammatory cytokine signalling in the hypothalamus and pituitary could be 
carried out by immunocytochemistry for pSTAT3 nuclear xpression in stressed and 
control early pregnant mice. Furthermore, by blocking a range of pro-inflammatory 
cytokines (e.g. through direct administration of cytokine specific antagonists to the 
brain) prior to stress exposure in early pregnancy, the role of certain cytokines in 
prolactin inhibition could be determined. This would help to ascertain the 
mechanism(s) responsible for cytokine/stress-reduced prolactin in early pregnancy. 
A new powerful system to monitor hormone secretion fr m rodent pituitary slices 
has recently been described. This is achieved by using an adapted fluorescence 
microscope and transgenic rodents with fluorescent proteins targeted to specific 
secretory vesicles e.g. prolactin granules of lactotrophs, and thus, these are co-
secreted with the hormone. Using this system in trasgenic mice dopamine has been 
shown to decrease fluorescence protein output and oxytocin to increase it in a dose 




RIA) (He et al., 2011). It may therefore be possible to introduce a range of (stress-
induced) pro-inflammatory cytokines (including TNF-α) to pituitary slices of virgin 
and early pregnant mice and monitor their effect on prolactin secretion from the 
lactotrophs. As this technique allows long perfusion times (up to 8h) the same slice 
may be stimulated multiple times with various factors/cytokines (with sufficient 
washing) which would reduce the number of animals required and enhance the 
reliability when comparing different experimental vriables. This system further 
enhances our understanding of secretion from a large population of cells in their 
normal topographical organisation (which is important for secretory responses in the 
pituitary) and importantly fills the void between si gle cell monitoring (exocytosis; 
milliseconds) and  release into the bloodstream (minutes) (He et al., 2011). 
 
6.3 The effect of stress in early pregnancy on the HPA axis 
Our data demonstrate that stress, both immune and fasting, activates the HPA axis, 
leading to the expected hormonal secretory responses i  arly and mid pregnant 
mice, as observed in virgins (Brunton et al., 2008). This emphasises the reports that 
the hyporesponsiveness of the HPA axis to stress in late pregnancy does not emerge 
until after d10.5 (Douglas et al., 2003). Consequently high glucocorticoid levels 
induced by stress exposure may impact on a variety of mechanisms required for 
pregnancy establishment and maintenance.  
In early gestation, it has been suggested that the actions of glucocorticoids are 
balanced between positive pregnancy-protective effects (e.g. suppression of natural 
killer cells (Krukowski et al., 2011), promotion oftrophoblast growth and invasion, 
stimulation of hCG) and adverse pregnancy-threatening effects (e.g. inhibition of 
placental growth, induction of placental/decidual apoptosis) (Michael and 
Papageorghiou, 2008). Although we do not address the pecific roles of 
glucocorticoids, our data implies that high levels of glucocorticoids are possible at 
this stage in pregnancy and they may be detrimental to reproductive success. 
Analysis of the hypothalamic responses to LPS stres in early pregnancy 
unexpectedly revealed that nur77 and CRH mRNA respon es in the pPVN were 
attenuated in early-mid gestation compared to virgins, extending previous reports of 
attenuated responses in late pregnancy (Douglas et al., 2003). This is in contrast to 




from the secretory HPA axis responses to LPS (at least at this time-point after stress 
exposure). As CRH responses were attenuated very early in pregnancy it may be that 
CRH neurone responses are adapted by early pregnancy factors such as the mating-
induced neurogenic reflex, pregnancy hormones and cytokines. It is not clear how 
neuronal activity can be attenuated while secretory responses remain robust, although 
we found that pPVN vasopressin mRNA responses to LPS in early pregnancy were 
maintained and similar to virgins. This is intriguing as vasopressin is reported to be 
synthesised in some of the same pPVN neurones as CRH and appears to be co-
released with CRH at the median eminence (Wang and Majzoub, 2011). The robust 
vasopressin response to LPS suggests that vasopressin (synergistic secretagogue), in 
the absence of CRH, may alone drive the high corticos erone responses observed.  In 
addition, LPS and other stress-induced cytokines may directly act at the pituitary and 
adrenals to induce hormone secretion directly, thusbypassing the PVN (John and 
Buckingham, 2003).  
The reduction of CRH responses in the pPVN  mirrors the lack of strong TIDA 
neurone activation following stress in early pregnancy. A study looking into the 
distribution of CRH-receptor-like immunoreactivity n the rat hypothalamus found it 
to be expressed in arcuate nucleus populations, includi g TIDA neurones. However, 
CRH-immunoreactive fiber innervation of the arcuate nucleus was very sparse and 
therefore it seems unlikely that they play a major role in TIDA neurone regulation 
(Campbell et al., 2003).  
Unlike pPVN CRH neurones not all neuronal responses ar  suppressed by stress, for 
example the responses from brainstem nuclei (NTS, RVLM) and the vasopressin 
responses from the pPVN are robust following stress in early pregnancy. The 
discovery that stress-induced vasopressin and CRH responses differ in early 
pregnancy reveals a curious dissociation between different subsets of pPVN neuronal 
populations and how this occurs remains to be determin d. Differential activation of 
various neuronal populations in the hypothalamus and brainstem following stress 
exposure indicate that stress leads to selective activation of neurones through 
complex and thus far unknown/untested pregnancy-related mechanisms. For 
example, the distribution of sex steroid receptors on neurones and whether they 





6.4 The effect of stress in early pregnancy on the PVN and brainstem noradrenergic 
pathways 
LPS, via cytokines, is able to activate the brainstem noradrenergic pathways to the 
hypothalamus (Brunton et al., 2008). We found that LPS stress increases the 
activation of LC neurones in early pregnant and virgin mice. However, neurones in 
the LC appear to display a generally lower response i  early pregnancy compared to 
virgins, which may potentially contribute to the attenuated response of the pPVN 
(e.g. lower CRH and nur77 mRNA and Fos nuclear respon e compared to virgins 
following LPS). In addition, although the LC response to stress appeared lower in 
early pregnancy compared to virgins, the overall number of neurones activated in the 
LC was low. However, the response to LPS was greater in he noradrenergic 
neurones of the NTS and RVLM, which respond more to LPS administration in early 
pregnancy compared to virgin mice. This suggests that an adaptation has occurred in 
these neurones to increase their sensitivity to certain stimuli which may contribute 
towards to the mildly exaggerated response to stress ob erved by the TIDA neurones. 
The release of noradrenaline in the hypothalamus has been temporally linked with 
plasma secretory surges of prolactin in the rat oestr u  cycle (Szawka et al., 2007), 
with the LC implicated to be involved in regulating prolactin surges during oestrous 
(Szawka et al., 2005). However, evidence indicates that neurones of the LC are not 
involved stress-induced changes in prolactin secretion (Poletini et al., 2006). 
Likewise, although the NTS and RVLM are activated by cytokines, no association 
with prolactin secretion has been reported at present. 
As with LPS, we also show a mild increase in TIDA neurone activation with 24h 
fasting stress in early pregnancy but whether this is accompanied by noradrenergic 
activation in the NTS, LC or RVLM is not known as this was not analysed.  
However, it has been reported that food ingestion is critical for the expression of Fos 
in the noradrenergic cells of the LC and NTS in rodents (Johnstone et al., 2006) and 
therefore in fasted mice we may not expect to observe an increase in Fos activation 
in the brainstem. 
 
6.5 The effect of immune stress in early pregnancy o  anxiety-related behaviour 
A number of immune stressors, including LPS, have be n reported to activate the 




Therefore, we hypothesised that LPS administration w uld increase anxiety-like 
behaviours in virgin and early pregnant mice and further postulated that in early 
pregnancy the anxiogenic response following LPS stres  would be enhanced because 
of the reduction in anxiolytic prolactin (and progesterone). Increased prolactin levels 
during pregnancy elevate neurogenesis in the subventricular zone of the lateral 
ventricle of the maternal brain and is essential for normal postpartum behaviour 
(Larsen and Grattan, 2010). It has been reported that in early pregnancy low prolactin 
leads to a reduction in neurogenesis and is associated with later heightened 
postpartum anxiety. In addition, the female offspring of these mothers also display 
increased anxiety (Larsen and Grattan, in press). However, it has not been reported 
what the acute effects of stress or low prolactin are on maternal anxiety during early 
pregnancy itself. 
We found that LPS administration (24h before behavioural testing) had profound 
anxiogenic effects on the virgin mice and also decreased their locomotion activity 
compared to vehicle-treated mice when tested on the EPM.  However, in early 
pregnant mice LPS treatment appeared to have no effect on the anxiety-behavioural 
parameters measured compared to controls. This may be partly explained by the fact 
that vehicle-treated pregnant mice displayed higher anxiety-like behaviours 
compared to virgins and as anxiety levels were already high in early pregnancy this 
may be a ‘ceiling effect’ which masks any LPS-induced hanges. Data indicate that 
mice are generally more anxious in early pregnancy compared to virgins which is in 
contrast to reports in mid (d11) (Maestripieri and D'Amato, 1991) and in late 
pregnancy (d18) (Neumann et al., 1998, Neumann, 2003). 
The lack of effect of stress on anxiety in early pregnancy may be associated with the 
relatively unaltered levels of circulating prolactin following the EPM. It seems that 
the EPM itself has a profound effect on prolactin levels in early pregnant mice 
reducing them (compared to mice not tested on the EPM) regardless of treatment. 
However, stressed virgin mice displayed heightened anxiety responses to stress 
compared to both controls and early pregnant mice, which was accompanied by a 
reduction in the anxiolytic prolactin (similar to levels in the pregnant mice). 
Further analysis of anxiety-like behaviour using an OFT revealed a mild increase in 




in early pregnant mice as was hypothesised. Once again, in early pregnancy a 
difference in plasma prolactin levels with treatment was not apparent following the 
OFT which may partly explain why only very mild of changes in anxiety-like 
behaviours were observed. 
In addition, the lack of predicted increase in anxiety-responsiveness in early 
pregnancy may be related to the attenuated PVN responses to stress that we have 
previously reported. It has been shown in many studies that CRH administration or 
overproduction of CRH increases anxiety-like behaviours in rodents (Van Gaalen et 
al., 2002). In addition, vasopressin is also reported to modulate anxiety-related 
behaviours. Studies using rats that are bred for either a high or low anxiety-related 
trait reveal that the increased anxiety-levels in the former are due to a polymorphism 
in the promoter region of the vasopressin gene, resulting in increased hypothalamic 
vasopressin activity. High anxiety bred rats display increased expression of 
vasopressin mRNA in the PVN and release. In support of an anxiogenic role for 
vasopressin, studies using these high anxiety rats have revealed that intra-PVN 
treatment of a vasopressin receptor antagonist reduces anxiety behaviours (Wigger et 
al., 2004). In mice, preliminary data also indicates that there is a correlation between 
anxiety behaviour and the expression of vasopressin in the PVN. In mice bred for 
high anxiety the intra-PVN expression of vasopressin is significantly higher than in 
mice bred for low anxiety (Landgraf et al., 2007). 
Therefore, a combination of high CRH and vasopressin PVN responses in virgin 
mice may contribute towards the heightened anxiety-b haviours observed on the 
EPM following LPS. In contrast, in early pregnancy the attenuated CRH response 
and lower PVN activation (Fos expression) following stress compared to virgins may 
partly explain why the anxiety responses to LPS were lower in early pregnancy than 
virgins. 
 
6.6 The effect of 24h fast in early pregnancy on anxiety-related behaviour 
It was also hypothesised that 24h fasting would leato increased anxiety-like 
behaviour in early pregnant mice, possibly via predicated increased corticosterone, 
decreased prolactin secretion and elevated levels of circulating ghrelin which is 
reported to increase with fasting in rodents  (Cummings et al., 2001, Briatore et al., 




demonstrate this though and found that both virgin and early pregnant fasted mice 
displayed reduced anxiety-like and increased exploratory behaviours (likely 
motivated by hunger) despite increased corticosterone esponses.  
Although 24h fasting suppressed plasma prolactin levels in early pregnant mice as 
expected, plasma prolactin concentrations do not seem to have an association with 
anxiety behaviours. It would be interesting to know what the circulating ghrelin 
levels of our 24h fasted mice are to determine if they have raised as is assumed. If 
not this could also contribute to explaining why we do not see heightened anxiety-
like behaviour with 24h fasting as predicted. In addition, as previously indicated Fos 
expression in the SON, VMH and PVN was very low andwas not altered by 24h 
fasting. Therefore, a change in the CRH and vasopresin responses to fasting (as seen 
following LPS) are unlikely to be accountable for the mild changes observed in 
anxiety/exploratory behaviours. We did, however, observe an increase in activation 
of neurones in the arcuate nucleus following fasting which may indicate an impact on 
appetite-regulating factors such as neuropeptide Y (NPY). Mild fasting (24h) in male 
rats has been reported to increase NPY mRNA expression in the hypothalamic 
arcuate and dorsomedial nuclei (Marks et al., 1992) and NPY administration dose-
dependently suppresses prolactin secretion from lactotrophs in vitro (Wang et al., 
1996). Therefore, it may be that fasting in early pegnant mice heightens the NPY 
response compared to virgins due to an unknown pregnancy-related factor and thus 
contributes to reducing plasma prolactin levels. In addition, NPY is considered a 
potent anxiolytic agent and this role is supported by reports of the expression of 
receptors for NPY in brain regions associated with anxiety such as the amygdala 
(Sajdyk et al., 2004). Multiple studies have demonstrated that central administration 
of NPY produces anxiolytic responses under stress or anxiety-inducing situations, for 
example NPY treatment (i.c.v) in male mice reduced anxiety-related behaviours on 
the EPM, light/dark test and also increased locomotr activity in the OFT (Karlsson 
et al., 2005). Therefore, presumed increased NPY due to fasting in both virgin and 
early pregnant mice may be partly responsible for the reduced anxiety-like 
behaviours and increased exploratory behaviours observed following 24h fasting. 
In contrast to the EPM, the OFT did not indicate an increase in anxiety behaviour or 




prolactin levels decreased by fasting in early pregnant mice as expected, circulating 
prolactin levels once again did not reflect anxiety-related behaviour levels.  
Overall, data from both behavioural experiments do not support our hypothesis that 
fasting would lead to enhanced anxiety-like behaviour n early pregnant mice and 
due to the drive to explore (likely motivated by hunger) 24h fasting may not have 
been a suitable treatment to use to measure the effects of stress in early pregnancy on 
anxiety behaviour.  
 
6.6 Summary 
To summarise, we have found in mice that the secretory HPA response to stress in 
early pregnancy is robust and comparable to the virgins, although early pregnant 
mice seem to display enhanced anxiety levels compared to virgins. Stress in early 
pregnancy profoundly reduces plasma progesterone and prolactin levels, increases 
circulating levels of pregnancy-threatening proinflammatory cytokines (e.g. TNF-α) 
and consequently threatens pregnancy maintenance. Stress-induced suppression of 
prolactin is not entirely due to enhanced TIDA neurone activation, dopamine activity 
or prolactin negative feedback as expected. Therefore, other stress-related factors 
must also be responsible, for example, stress may lead to a decrease in prolactin-
releasing factors that act at the pituitary level (this remains to be tested). Stress-
induced cytokines e.g. TNF-α are likely contenders and may act directly at 
lactotrophs to impede prolactin secretion in early p egnancy (see Figure 6.1). In 
support of this theory lactotrophs are known to expr ss receptors for TNF-α and 
TNF-α treatment reduces anterior pituitary cell proliferation and prolactin release in 
an oestrogen-dependent manner. We have shown that TNF-α treatment in early 
pregnancy decreases both progesterone and prolactin se tion, while only mildly 
increasing TIDA activation, suggesting that TNF-α acts directly at the pituitary to 
suppress prolactin. Further work is required to fully investigate the mechanism 
behind this.  
Furthermore, we propose that there is an overlapping role for stress-increased 
glucocorticoid action on reduced pregnancy hormone secretion by enhancing pro-
inflammatory cytokine release following stress in early pregnancy (see Figure 6.2). 




production and release of proinflammatory cytokines (e.g. TNF-α) and result in a 
decrease of pregnancy hormone levels. Low circulating progesterone and prolactin 
would allow proinflammatory levels to further rise as the inhibitory effect of these 
hormones on pro-inflammatory cytokines would be suppressed.  A rise in 
glucocorticoids/proinflammatory cytokine levels together with depleted plasma 
progesterone/prolactin in early gestation may increase the risk of pregnancy 
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Appendix A: Suppliers/Chemicals index 
 
Reagent Company Code 
Acetic anhydride Sigma-Aldrich A6404 
Anti-fos Ab  Santa Cruz SC-52 
Anti-TH Ab Millipore AB152 
Ammonium chloride  BDH 271495R 
‘AnalR’ formamide  BDH 103264R 
Aprotinin Sigma-Aldrich A1153 - 10MG 
Biotinylated anti rabbit Ig Vector BA-1000 




sulphate 12 hydrate 
BDH 2775845 
Corticosterone RIA MP Biomedicals 7120102 
Denhardt’s solution Sigma-Aldrich D2532 
Deionised Formamide Sigma-Aldrich F9037 
Developer Kodak D19 Ilford/Lizars  







DPX mountant VWR 360294 
Disodium hydrogen  
orthophosphate  
BDH 103834G 
Dithiothretol (DTT) Sigma-Aldrich D9779 
Emulsion (Ilford) Calumet P9281 
Ethylene diamine 
tetracetic acid (EDTA) 
Sigma-Aldrich E5134 
Ethylene glycol Sigma-Aldrich 102466 
FBS (heat-inactivated) Invitrogen 10108157 (100ml) 
Gelatine  BDH 440454B 
Glycerol Fisher Scientific G/0600/17 
Heparin Sigma-Aldrich H0777-500KU 
Hydrogen peroxide (30%) Sigma-Aldrich H1009 
Interleukin-6 (recombinant 
mouse) 
R&D System 406-ML-005 
Lipopolysaccharide (LPS) 
E055:B5 (E.coli) 





Mouse IL-6 DuoSet 
ELISA 
R&D Systems DY406 
Mouse prolactin DuoSet 
ELISA 
R&D Stems DY1445 




Normal sheep serum Sigma-Aldrich S2263 
Ovine prolactin  Sigma-Aldrich L6520 






Cell Signalling Tech 
(supplied by New England 
Biolabs) 
9351-S 
Potassium chloride Sigma-Aldrich P3911 or 9541 
Progesterone 
radioimmunoassay (kit 1) 
Oxford Bioinnovations DSL 3900 
Progesterone 
radioimmunoassay (kit 2) 
MP Biomedicals 07814701 
Reagent Diluent (DuoSet 
ELISA) 
R&D Systems DY995 
RNase A Sigma-Aldrich  
QIAGEN quick nucleotide 
removal kit 
QIAGEN 28304 
S35 dATP 9.25MB Perkin Elmer NEG034H 
Salmon sperm DNA Sigma-Aldrich D9156 
Sodium acetate Sigma-Aldrich S9513 
Sodium bicarbonate Sigma-Aldrich S8875 




Substrate solution (DuoSet 
ELISA) 
R&D Systems DY999 
Sucrose  Sigma-Aldrich  S7903 or 179949 
Toludine blue Sigma-Aldrich  
Triethanolamine (TEA) Sigma-Aldrich T1377 
Tris Sigma-Aldrich T8524 
Tris-HCL VWR 441514A 
Tri-sodium citrate Sigma-Aldrich S4641 
Triton X-100 Sigma-Aldrich T9284 
Tumour necrosis factor-α 
(recombinant mouse) 
R&D Systems 410-MT-050 
Vectastain ABC elite kit Vector Labs PK6101 
Wash buffer (DuoSet 
ELISA) 
R&D Systems WA126 









Appendix B: General solutions 
 
Solutions for perfuse fixation  
• Heparinised saline (0.9%): 1L dH2O + 9g NaCl + 129mg Heparin  
• Phosphate buffer (PB) (1L of 1M PB; pH 7.3-7.4): 1L dH2O (heated) + 115g disodium 
hydrogen orthophosphate (Na2HPO4.2H2O) + 27.2g Sodium dihydrogen orthophosphate 
(NaH2PO4.H2O). 
• 4% paraformaldehyde in phosphate buffer (PB) (pH7.3-7.4):  500ml dH2O (heated) +  
40g PAF + few drops of 10M NaOH solution (to dissolve the powder),  + 500ml 0.2M 
PB. 
• 2% PFA + 15% sucrose in 0.1M PB:  (for 500ml) 250mls 30% sucrose + 250mls 4% 
PFA. 
• 30% sucrose: 30g sucrose / 100ml in 0.1M PB. 
• Cryoprotectant: (for 1L) 200ml glycerol + 300ml ethylene glycol + 500ml 0.1M PBS. 
Solutions for immunocytochemistry 
• Phosphate Buffer (see section above) 
• 0.1M PB + 0.3% Triton X-100 (PBT): 3ml Triton X-100 + 1000ml 0.1M PB. 
• 0.1M phosphate buffered saline (PBS; 0.9%): 9g NaCl + 1000ml 0.1M PB.  
•  3% normal sheep serum (NSS) in 0.1M PBT: 3ml NSS + 97ml 0.1M PBT. 
• 0.3% hydrogen peroxide in 0.1M PB: 1ml 30% H2O2 + 99ml 0.1M PB. 
• 1M sodium acetate buffer: 82g sodium acetate anhydrous + 1000ml dH2O, pH 6 with 
glacial acetic acid. 
• DAB concentrate (25mg/ml):1g Diaminobenzidine tetrachloride + 40ml dH2O (warm). 
• Nickel-DAB visualisation solution: (for 100ml) 50ml 0.2M sodium acetate buffer + 2.5g 
Nickel II sulphate + 0.08g ammonium chloride + 25mg in 1ml DAB + 49ml dH2O 
+100µl H2O2. 
• DAB visualisation solution: (for 100ml) 50ml 0.2M sodium acetate buffer + 25mg in 
1ml DAB + 49ml dH2O +100µl H2O2. 
• Tris buffered saline (TBS; 0.05M Trizma, 0.15M NaCl; pH 7.6): 6.05g Trizma + 8.85g 
NaCl + 1000ml dH2O. 
• ‘Incubation solution’ for pSTAT5 protocol (0.05M TBS,0.3% triton X-100, 0.25% 
BSA): 600ml TBS + 1.8ml triton-x +1.5g BSA. 





Solutions for mounting and staining brain sections 
• Gelatine for subbing slides: 2.5g gelatine to 500ml dH2O, add 0.25g chromium 
potassium sulphate. 
• Acetic Alcohol Fixative (AAF): 10ml 40% formaldehyde + 5ml glacial acetic acid 
(100%) + 85ml absolute alcohol. 
• Toludine Blue: 1% toluidine blue in dH2O. 
Solutions for in situ hybridisation  
• 1M Phosphate buffered saline (PBS; pH7.3-7.4): 1L dH2O (heated) + 115g Disodium 
hydrogen orthophosphate (Na2HPO4.2H2O) + 29.64g Sodium dihydrogen 
orthophosphate (NaH2PO4.H2O) + 85g NaCL 
• 4% Paraformaldehyde (PAF) in 0.1M PBS (pH 7.2): (250ml) 10g PAF + 250ml 0.1M 
PBS + few drops of 10M NaCl. 
• Triethanolamine (TEA)/actetic anhydride solution: 3.725ml TEA + 0.625ml acetic 
anhydride + 1050µl concentrated HCl, made up to 250ml with ddH2O. 
• RNase Buffer : 1.12g Tris 8.0 (10mM) + 23.2g NaCl (0.5M) + 0.32g EDTA (1mM), 
made up tp 800ml in ddH2O. 
• Diethylpyrocarbonate (DEPC) water (0.01%): 1ml DEPC + 999ml ddH2O. 
• Hybridisation Buffer: To make 50ml combine the following: 12ml 5M NaCl (292mg/ml) 
+ 1ml Tris pH 7.6 (149mg/ml) + 1ml Denhardts solution (1.6% BSA 200mg/ml, 6% 
Ficoll 100mg/ml, 6% PVP 100mg/ml) + 400µl EDTA (250mM) + 5ml dextran sulphate 
25% + 500µl NaPPI 5% (50mg/ml) + 200µl yeast tRNA (35mg/ml) + 250µl yeast total 
RNA (20mg/ml) + 1ml salmon testes DNA (10mg/ml) + 330µl Poly(A) (15mg/ml) + 
25ml formamide, made up to 50ml with ddH2O.  
• 20 X Standard sodium citrate (SSC) stock: 175.4g NaCl + 88.2g Tri-sodium citrate, 
made up to 1L with sterile ddH2O.  
• Developer (Kodak D19): 157g + 500ml ddH2O. 
• Fixer (Ilford Hypam): 100ml fixer stock + 400ml ddH2O. 
Solutions for haemotoxylin and eosin counter staining 
• Haemotoxylin:  bought in ready made (0.4% haemotoxylin) 
• 70% Acid alcohol: 700ml absolute alcohol (100%) + 300ml dH2O + 10ml HCl (conc) 
• Scott’s Tap Water Substitute (STWS): 20g magnesium s lphate + 3.5g sodium 
bicarbonate + 1000ml dH2O 
• 1% Eosin: 10g + 1000mls dH2O 




Appendix C: Publications and presented abstracts 
Publications: 
Parker VJ, Menzies JR, and Douglas AJ (2011) Differential changes in the 
hypothalamic-pituitary-adrenal axis and prolactin responses to stress in early 
pregnant mice. Journal of Neuroendocrinology, 23: 1066-1078 (Original article). 
Parker VJ, Arck PC, and Douglas AJ (2011) Reciprocal br in-body neuro-endocrine-
immune interactions: role in maintaining pregnancy. Advances in Neuroimmune 
Biology (in press) (Review).  
Parker VJ and Douglas AJ (2010) Stress in early pregnancy: maternal neuro-
endocrine-immune responses and effects. Journal of Reproductive Immunology, 85: 
86-92 (Review).  
Conference Abstracts:  
Parker VJ, Menzies JR and Douglas AJ (2011) Hypothalamic mechanisms mediating 
inhibition of prolactin secretion following stress in early pregnancy. Physiology 
2011, The Physiological Society (Oral).  
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international conference (Oral). 
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